Primary Purpose
| primary_purpose | Study_Count |
|---|---|
| Treatment | 581 |
| Prevention | 102 |
| Diagnostic | 41 |
| Supportive Care | 38 |
| Other | 37 |
| Health Services Research | 16 |
| Basic Science | 6 |
| Screening | 5 |
| Device Feasibility | 2 |
regCOVID
Craig Mayer, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD
_See the full regCOVID repository with detailed results at https://github.com/lhncbc/r-snippets-bmi/tree/master/regCOVID —
Study Counts
| Type | Study_count |
|---|---|
| Total_Studies | 1649 |
| interventional | 828 |
| Observational | 695 |
| Registry | 126 |
Studies over Time
Total studies by type over time
```
Interventional Trials
Intervention Type
| intervention_type | Study_Count |
|---|---|
| Drug | 238 |
| Drug|placebo | 152 |
| Biological | 78 |
| Other | 72 |
| Device | 41 |
| Behavioral | 40 |
| Drug|Other | 36 |
| Diagnostic Test | 31 |
| Biological|placebo | 25 |
| Procedure | 20 |
| Biological|Drug | 12 |
| Biological|Other | 10 |
| Dietary Supplement | 9 |
| Radiation | 7 |
| Dietary Supplement|Drug | 6 |
| Device|Other | 5 |
| Biological|Drug|placebo | 3 |
| Combination Product | 3 |
| Combination Product|Drug | 3 |
| Device|Drug|Procedure | 3 |
| Dietary Supplement|Other | 3 |
| Dietary Supplement|placebo | 3 |
| Biological|Other|placebo | 2 |
| Device|Drug | 2 |
| Device|Drug|Radiation | 2 |
| Device|placebo | 2 |
| Device|Procedure | 2 |
| Dietary Supplement|Drug|placebo | 2 |
| Drug|Other|placebo | 2 |
| Behavioral|Diagnostic Test | 1 |
| Behavioral|Other | 1 |
| Biological|Device|Other | 1 |
| Biological|Genetic|Other | 1 |
| Diagnostic Test|Dietary Supplement | 1 |
| Diagnostic Test|Drug|Other|placebo | 1 |
| Diagnostic Test|Other | 1 |
| Dietary Supplement|Drug|Other | 1 |
| Drug|placebo|Procedure | 1 |
| Drug|placebo|Radiation | 1 |
| Drug|Procedure | 1 |
| Other|placebo | 1 |
| Other|Procedure | 1 |
| Other|Radiation | 1 |
Count of Studies by Intervention (normalized and mapped)
Interventions over Time
Weekly studies for each interventionStudies by Country
| Country | Study_Count |
|---|---|
| United States | 263 |
| France | 72 |
| China | 59 |
| Spain | 44 |
| Italy | 29 |
| United Kingdom | 25 |
| Brazil | 23 |
| Canada | 23 |
| Mexico | 21 |
| Iran, Islamic Republic of | 17 |
| Belgium | 15 |
| Egypt | 15 |
| Russian Federation | 15 |
| Germany | 14 |
| Turkey | 13 |
| Denmark | 11 |
| Pakistan | 10 |
| Greece | 9 |
| Argentina | 8 |
| India | 8 |
| Sweden | 8 |
| Australia | 6 |
| Israel | 6 |
| Netherlands | 6 |
| Saudi Arabia | 6 |
| Switzerland | 6 |
| Poland | 5 |
| Hong Kong | 4 |
| Singapore | 4 |
| Austria | 3 |
| Bangladesh | 3 |
| Norway | 3 |
| Qatar | 3 |
| Chile | 2 |
| Hungary | 2 |
| Indonesia | 2 |
| Iraq | 2 |
| Korea, Republic of | 2 |
| South Africa | 2 |
| United States|Canada | 2 |
| United States|China|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Netherlands|Singapore|Spain|Sweden|Switzerland|Taiwan|United Kingdom | 2 |
| Argentina|Brazil|Canada|Chile|France|Germany|Israel|Italy|Japan|Russian Federation|Spain | 1 |
| Austria|Belgium|France|Luxembourg | 1 |
| Austria|Denmark|Germany | 1 |
| Austria|Germany | 1 |
| Bahrain | 1 |
| Belarus | 1 |
| Belgium|Brazil|France|Germany|Italy|Spain | 1 |
| Belgium|France|Monaco | 1 |
| Belgium|Germany | 1 |
| Bosnia and Herzegovina | 1 |
| Bulgaria|Germany | 1 |
| Canada|Mongolia | 1 |
| Canada|United States | 1 |
| China|Indonesia | 1 |
| China|Italy | 1 |
| Czechia | 1 |
| Denmark|Germany|Hungary | 1 |
| Dominican Republic | 1 |
| Ecuador | 1 |
| France|Monaco | 1 |
| French Guiana | 1 |
| Germany|Sweden | 1 |
| Gibraltar | 1 |
| Honduras | 1 |
| Iceland | 1 |
| India|United Kingdom | 1 |
| Japan | 1 |
| Jordan | 1 |
| Kazakhstan | 1 |
| Malaysia | 1 |
| North Macedonia | 1 |
| Puerto Rico | 1 |
| Romania | 1 |
| Rwanda | 1 |
| Slovenia | 1 |
| Taiwan | 1 |
| Thailand | 1 |
| Thailand|United Kingdom | 1 |
| Tunisia | 1 |
| Ukraine | 1 |
| United States|Argentina|Brazil|Germany|Italy|Japan|Mexico|Russian Federation|Spain|United Kingdom | 1 |
| United States|Austria|France|Israel|Spain|United Kingdom | 1 |
| United States|Brazil | 1 |
| United States|Brazil|Canada|Mexico | 1 |
| United States|Canada|Denmark|France|Germany|Italy|Netherlands|Spain|United Kingdom | 1 |
| United States|Canada|Spain | 1 |
| United States|Denmark|Germany|Greece|Japan|Korea, Republic of|Mexico|Singapore|Spain|United Kingdom | 1 |
| United States|Denmark|Japan|Korea, Republic of|Mexico|Singapore|Spain|United Kingdom | 1 |
| United States|France|Germany|Italy|Russian Federation|Spain|United Kingdom | 1 |
| United States|France|Netherlands|Spain|United Kingdom | 1 |
| United States|France|Spain|United Kingdom | 1 |
| United States|Germany|Italy|Russian Federation|Spain|United Kingdom | 1 |
| United States|Israel | 1 |
| United States|Kenya|Mexico|Peru|South Africa | 1 |
| Vietnam | 1 |
Sites per Study
| Site_count | Study_Count |
|---|---|
| 1 | 528 |
| 2 | 74 |
| 3 | 37 |
| 4 | 31 |
| 5 | 17 |
| 6 | 20 |
| 7 | 15 |
| 8 | 13 |
| 9 | 13 |
| 10 | 6 |
| 11 | 8 |
| 12 | 7 |
| 13 | 4 |
| 14 | 8 |
| 15 | 3 |
| 16 | 2 |
| 17 | 2 |
| 18 | 1 |
| 20 | 1 |
| 21 | 1 |
| 22 | 3 |
| 24 | 3 |
| 25 | 2 |
| 26 | 1 |
| 27 | 2 |
| 28 | 1 |
| 30 | 1 |
| 31 | 3 |
| 32 | 2 |
| 33 | 1 |
| 37 | 1 |
| 38 | 1 |
| 39 | 1 |
| 40 | 1 |
| 47 | 2 |
| 48 | 1 |
| 59 | 1 |
| 60 | 1 |
| 61 | 1 |
| 62 | 2 |
| 65 | 1 |
| 67 | 1 |
| 68 | 1 |
| 69 | 1 |
| 183 | 1 |
| 184 | 1 |
Phase
| Phase | Study_Count |
|---|---|
| N/A | 270 |
| Phase 2 | 230 |
| Phase 3 | 129 |
| Phase 2/Phase 3 | 55 |
| Phase 1/Phase 2 | 50 |
| Phase 4 | 44 |
| Phase 1 | 37 |
| Early Phase 1 | 13 |
Number of Arms
| Number_of_Arms | Count_of_Studies |
|---|---|
| 1 | 157 |
| 2 | 509 |
| 3 | 80 |
| 4 | 46 |
| 5 | 9 |
| 6 | 8 |
| 7 | 2 |
| 8 | 3 |
| 9 | 1 |
| 11 | 1 |
| 12 | 1 |
| 13 | 1 |
| 15 | 1 |
| 17 | 1 |
| 21 | 1 |
| 30 | 1 |
| NA | 6 |
Number of Updates
| Count of Versions | Count of Studies |
|---|---|
| 1 | 223 |
| 2 | 226 |
| 3 | 173 |
| 4 | 96 |
| 5 | 39 |
| 6 | 18 |
| 7 | 20 |
| 8 | 7 |
| 9 | 8 |
| 10 | 6 |
| 11 | 5 |
| 12 | 2 |
| 13 | 1 |
| 17 | 1 |
| 18 | 1 |
| 19 | 2 |
Update History Change Type
| Change Type | Count_of_Changes | Count_of_Studies | ratio |
|---|---|---|---|
| Study Status | 1544 | 605 | 2.552066 |
| Contacts/Locations | 928 | 474 | 1.957806 |
| None (earliest Version on record) | 828 | 828 | 1.000000 |
| Recruitment Status | 487 | 431 | 1.129930 |
| Outcome Measures | 337 | 254 | 1.326772 |
| Eligibility | 311 | 212 | 1.466981 |
| Oversight | 284 | 264 | 1.075758 |
| Study Description | 247 | 189 | 1.306878 |
| Study Identification | 239 | 191 | 1.251309 |
| Study Design | 214 | 167 | 1.281437 |
| Arms | 210 | 166 | 1.265060 |
| Interventions | 210 | 166 | 1.265060 |
| Sponsor/Collaborators | 97 | 81 | 1.197531 |
| Conditions | 82 | 69 | 1.188406 |
| IPDSharing | 32 | 30 | 1.066667 |
| References | 26 | 25 | 1.040000 |
| Documents | 11 | 10 | 1.100000 |
| Results Submission Events | 1 | 1 | 1.000000 |
Enrollment Metrics by Phase
| Measure | Early.Phase.1 | N.A | Phase.1 | Phase.1.Phase.2 | Phase.2 | Phase.2.Phase.3 | Phase.3 | Phase.4 |
|---|---|---|---|---|---|---|---|---|
| Min. | 9.00000 | 4.000 | 5.00000 | 5.0 | 5.0000 | 12.0000 | 1.0000 | 10.0000 |
| 1st Qu. | 10.00000 | 49.000 | 27.00000 | 24.5 | 50.0000 | 120.0000 | 230.0000 | 84.5000 |
| Median | 50.00000 | 100.000 | 40.00000 | 47.5 | 112.0000 | 320.0000 | 450.0000 | 185.0000 |
| Mean | 57.61538 | 5748.856 | 58.10811 | 380.1 | 234.7174 | 982.6909 | 931.9535 | 410.1818 |
| 3rd Qu. | 100.00000 | 342.750 | 90.00000 | 187.5 | 210.0000 | 524.5000 | 1032.0000 | 600.5000 |
| Max. | 150.00000 | 506517.000 | 168.00000 | 7600.0 | 10000.0000 | 15000.0000 | 10078.0000 | 2014.0000 |
Trial Group Type
| group_type | Group_Count |
|---|---|
| Experimental | 1016 |
| Active Comparator | 303 |
| Placebo Comparator | 255 |
| No Intervention | 180 |
| Other | 96 |
| Sham Comparator | 8 |
| NA | 6 |
Intervention Model
| intervention_model | Study_Count |
|---|---|
| Parallel Assignment | 599 |
| Single Group Assignment | 176 |
| Sequential Assignment | 27 |
| Crossover Assignment | 13 |
| Factorial Assignment | 13 |
Vaccines
| nct_id | brief_title | link |
|---|---|---|
| NCT04276896 | Immunity and Safety of Covid-19 Synthetic Minigene Vaccine | https://ClinicalTrials.gov/show/NCT04276896 |
| NCT04283461 | Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04283461 |
| NCT04299724 | Safety and Immunity of Covid-19 aAPC Vaccine | https://ClinicalTrials.gov/show/NCT04299724 |
| NCT04313127 | Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults | https://ClinicalTrials.gov/show/NCT04313127 |
| NCT04324606 | A Study of a Candidate COVID-19 Vaccine (COV001) | https://ClinicalTrials.gov/show/NCT04324606 |
| NCT04336410 | Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT04336410 |
| NCT04341389 | A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector) | https://ClinicalTrials.gov/show/NCT04341389 |
| NCT04352608 | Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04352608 |
| NCT04357028 | Measles Vaccine in HCW | https://ClinicalTrials.gov/show/NCT04357028 |
| NCT04368988 | Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS (COVID-19) Nanoparticle Vaccine With/Without Matrix-M Adjuvant | https://ClinicalTrials.gov/show/NCT04368988 |
| NCT04368728 | Study to Describe the Safety, Tolerability, Immunogenicity, and Potential Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04368728 |
| NCT04380532 | Tableted COVID-19 Therapeutic Vaccine | https://ClinicalTrials.gov/show/NCT04380532 |
| NCT04380701 | A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04380701 |
| NCT04400838 | Investigating a Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04400838 |
| NCT04405076 | Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older | https://ClinicalTrials.gov/show/NCT04405076 |
| NCT04412538 | Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 | https://ClinicalTrials.gov/show/NCT04412538 |
| NCT04405908 | SCB-2019 as COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04405908 |
| NCT04453852 | Monovalent Recombinant COVID19 Vaccine | https://ClinicalTrials.gov/show/NCT04453852 |
| NCT04444674 | COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection | https://ClinicalTrials.gov/show/NCT04444674 |
| NCT04445194 | Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine | https://ClinicalTrials.gov/show/NCT04445194 |
| NCT04449276 | A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults | https://ClinicalTrials.gov/show/NCT04449276 |
| NCT04445389 | Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults | https://ClinicalTrials.gov/show/NCT04445389 |
Phase
| phase | Study_Count |
|---|---|
| Phase 1 | 9 |
| Phase 1/Phase 2 | 9 |
| Phase 2 | 2 |
| Phase 2/Phase 3 | 1 |
| Phase 3 | 1 |
Country
| country | Study_Count |
|---|---|
| Australia | 3 |
| Belgium | 1 |
| Canada | 1 |
| China | 7 |
| Egypt | 1 |
| Germany | 2 |
| Korea, Republic of | 1 |
| Mongolia | 1 |
| South Africa | 1 |
| United Kingdom | 2 |
| United States | 4 |
Site Count
| Site_count | Study_Count |
|---|---|
| 1 | 11 |
| 2 | 2 |
| 3 | 3 |
| 4 | 1 |
| 6 | 2 |
| 10 | 1 |
| 20 | 1 |
| 25 | 1 |
Arms
| number_of_arms | Study_Count |
|---|---|
| 1 | 3 |
| 2 | 3 |
| 3 | 5 |
| 4 | 2 |
| 5 | 1 |
| 6 | 1 |
| 8 | 2 |
| 12 | 1 |
| 13 | 1 |
| 15 | 1 |
| 21 | 1 |
| 30 | 1 |
Enrollment
| Measure | Vaccine |
|---|---|
| Min | 20 |
| 1st Qu | 111 |
| Median | 179 |
| Mean | 1158 |
| 3rd Qu | 708 |
| Max | 10260 |
Model
| intervention_model | Study_Count |
|---|---|
| Crossover Assignment | 1 |
| Parallel Assignment | 9 |
| Sequential Assignment | 9 |
| Single Group Assignment | 3 |
Group Types
| group_type | Group_Count |
|---|---|
| Experimental | 95 |
| Active Comparator | 37 |
| Placebo Comparator | 18 |
Update Count
| Count of Versions | Count of Studies |
|---|---|
| 1 | 2 |
| 2 | 6 |
| 3 | 6 |
| 4 | 3 |
| 5 | 2 |
| 6 | 1 |
| 9 | 1 |
| 10 | 1 |
Change Type
| Change Type | Count_of_Changes | Count_of_Studies | ratio |
|---|---|---|---|
| Study Status | 57 | 20 | 2.850000 |
| Contacts/Locations | 31 | 18 | 1.722222 |
| None (earliest Version on record) | 22 | 22 | 1.000000 |
| Recruitment Status | 17 | 14 | 1.214286 |
| Study Design | 14 | 7 | 2.000000 |
| Study Identification | 14 | 10 | 1.400000 |
| Arms | 13 | 7 | 1.857143 |
| Interventions | 13 | 7 | 1.857143 |
| Eligibility | 11 | 5 | 2.200000 |
| Outcome Measures | 8 | 6 | 1.333333 |
| Oversight | 8 | 8 | 1.000000 |
| Study Description | 8 | 4 | 2.000000 |
| Conditions | 5 | 2 | 2.500000 |
| Sponsor/Collaborators | 4 | 4 | 1.000000 |
| IPDSharing | 2 | 2 | 1.000000 |
| References | 1 | 1 | 1.000000 |
Observational Studies
Studies by Country
| Country | Study_Count |
|---|---|
| France | 171 |
| United States | 96 |
| Italy | 52 |
| Egypt | 40 |
| United Kingdom | 36 |
| Turkey | 35 |
| China | 34 |
| Spain | 31 |
| Germany | 20 |
| Switzerland | 16 |
| Canada | 12 |
| Denmark | 12 |
| Belgium | 11 |
| India | 9 |
| Austria | 8 |
| Norway | 8 |
| Brazil | 7 |
| Hong Kong | 7 |
| Sweden | 6 |
| Argentina | 5 |
| Mexico | 5 |
| Russian Federation | 5 |
| Greece | 4 |
| Hungary | 4 |
| Israel | 4 |
| Malaysia | 3 |
| Monaco | 3 |
| Portugal | 3 |
| Singapore | 3 |
| Australia | 2 |
| Czechia | 2 |
| France|French Guiana | 2 |
| Luxembourg | 2 |
| Netherlands | 2 |
| Poland | 2 |
| Saudi Arabia | 2 |
| Algeria | 1 |
| Australia|Canada|China|France|Gambia|Germany|Israel|Italy|Malaysia|Poland|Portugal|Romania|Singapore|Switzerland | 1 |
| Austria|Belgium|Czechia|Denmark|France|Germany|Greece|Hungary|Israel|Italy|Lithuania|Netherlands|Poland|Portugal|Russian Federation|Spain|Sweden|Switzerland|United Kingdom | 1 |
| Belgium|Italy|United Kingdom | 1 |
| Brazil|Chile|Uruguay | 1 |
| Burkina Faso | 1 |
| Colombia | 1 |
| Denmark|France|Germany|Norway | 1 |
| Ecuador | 1 |
| Finland|France|Germany|Italy|Sweden|United Kingdom | 1 |
| France|Germany|Spain | 1 |
| France|Guadeloupe|Martinique | 1 |
| France|Martinique | 1 |
| Germany|Romania | 1 |
| Iran, Islamic Republic of | 1 |
| Italy|Romania|United Kingdom | 1 |
| Italy|San Marino | 1 |
| Jordan | 1 |
| Korea, Republic of | 1 |
| Pakistan | 1 |
| Qatar | 1 |
| Slovenia | 1 |
| Spain|United States|Denmark|France|Germany|Italy|United Kingdom | 1 |
| United Arab Emirates | 1 |
| United States|Albania|Australia|Czechia|France|Germany|Hong Kong|Israel|Italy|Lebanon|Norway|Poland|Spain|Sweden|Taiwan | 1 |
| United States|Argentina|Armenia|Australia|Bolivia|Chile|Costa Rica|Czechia|Germany|Guatemala|Italy|Lebanon|Mexico|Netherlands|Nigeria|Puerto Rico|Saudi Arabia|Spain|Tunisia|Turkey|Venezuela | 1 |
| United States|Argentina|Botswana|Brazil|Kenya|Malawi|Mexico|Mozambique|Peru|South Africa|Tanzania|Zambia|Zimbabwe | 1 |
| United States|Egypt|Germany|Peru|Singapore | 1 |
| United States|Egypt|Iran, Islamic Republic of | 1 |
| United States|Malawi|Mozambique|Peru|South Africa|Tanzania|Zambia|Zimbabwe | 1 |
| United States|United Kingdom | 1 |
Sites per Study
| Site_count | Study_Count |
|---|---|
| 1 | 566 |
| 2 | 41 |
| 3 | 23 |
| 4 | 7 |
| 5 | 11 |
| 6 | 7 |
| 7 | 6 |
| 8 | 3 |
| 9 | 4 |
| 10 | 1 |
| 11 | 2 |
| 12 | 1 |
| 13 | 1 |
| 14 | 2 |
| 16 | 1 |
| 17 | 3 |
| 19 | 1 |
| 20 | 2 |
| 21 | 1 |
| 22 | 1 |
| 23 | 1 |
| 34 | 1 |
| 41 | 1 |
| 42 | 1 |
| 58 | 1 |
| 60 | 1 |
| 69 | 1 |
| 81 | 1 |
| 97 | 1 |
| 128 | 1 |
| 614 | 1 |
Number of Updates
| Count of Versions | Count of Studies |
|---|---|
| 1 | 302 |
| 2 | 242 |
| 3 | 80 |
| 4 | 34 |
| 5 | 12 |
| 6 | 5 |
| 7 | 4 |
| 8 | 2 |
| 9 | 1 |
| 11 | 2 |
| 12 | 1 |
| 13 | 1 |
| 18 | 1 |
| 19 | 1 |
| 24 | 1 |
| 28 | 1 |
| 31 | 1 |
| 34 | 1 |
| 41 | 1 |
| 53 | 1 |
| 59 | 1 |
Update History Change Type
| Change Type | Count_of_Changes | Count_of_Studies | ratio |
|---|---|---|---|
| Study Status | 964 | 393 | 2.452926 |
| None (earliest Version on record) | 695 | 695 | 1.000000 |
| Contacts/Locations | 327 | 228 | 1.434211 |
| Recruitment Status | 212 | 186 | 1.139785 |
| Study Description | 154 | 130 | 1.184615 |
| Outcome Measures | 143 | 129 | 1.108527 |
| Study Identification | 132 | 120 | 1.100000 |
| Study Design | 98 | 88 | 1.113636 |
| Eligibility | 94 | 83 | 1.132530 |
| Oversight | 82 | 78 | 1.051282 |
| Groups | 51 | 44 | 1.159091 |
| Interventions | 51 | 44 | 1.159091 |
| Sponsor/Collaborators | 50 | 46 | 1.086957 |
| Conditions | 39 | 37 | 1.054054 |
| References | 17 | 17 | 1.000000 |
| IPDSharing | 5 | 5 | 1.000000 |
| Documents | 4 | 3 | 1.333333 |
Enrollment Metrics
| Measure | Observational |
|---|---|
| Min | 5.00 |
| 1st Qu | 100.00 |
| Median | 300.00 |
| Mean | 40874.28 |
| 3rd Qu | 1000.00 |
| Max | 10000000.00 |
Observation Model
| observational_model | Study_Count |
|---|---|
| Cohort | 432 |
| Case-Only | 89 |
| Other | 74 |
| Case-Control | 59 |
| Ecologic or Community | 27 |
| Case-Crossover | 8 |
| Family-Based | 5 |
| NA | 1 |
Time Perspective
| time_perspective | Study_Count |
|---|---|
| Prospective | 404 |
| Retrospective | 157 |
| Cross-Sectional | 85 |
| Other | 48 |
| NA | 1 |
Registries
Studies by Country
| Country | Study_Count |
|---|---|
| France | 21 |
| United States | 18 |
| Spain | 13 |
| Italy | 10 |
| Turkey | 7 |
| Germany | 6 |
| Belgium | 5 |
| Sweden | 5 |
| China | 3 |
| Denmark | 3 |
| Switzerland | 3 |
| United Kingdom | 3 |
| Austria | 2 |
| Bangladesh | 2 |
| Egypt | 2 |
| Mexico | 2 |
| Norway | 2 |
| Poland | 2 |
| Russian Federation | 2 |
| Australia | 1 |
| Belgium|France | 1 |
| Brazil | 1 |
| Canada | 1 |
| China|Hong Kong|Spain | 1 |
| France|Martinique | 1 |
| Hungary | 1 |
| Netherlands | 1 |
| Qatar | 1 |
| Singapore | 1 |
| Tunisia | 1 |
| Ukraine | 1 |
| United States|Brazil|Colombia|France|Spain | 1 |
| United States|Canada|Israel|Japan|Serbia|Spain|United Kingdom | 1 |
| United States|Poland | 1 |
Sites per Study
| Site_count | Study_Count |
|---|---|
| 1 | 97 |
| 2 | 8 |
| 3 | 1 |
| 4 | 2 |
| 6 | 1 |
| 7 | 2 |
| 9 | 1 |
| 10 | 1 |
| 11 | 2 |
| 15 | 1 |
| 17 | 2 |
| 18 | 1 |
| 27 | 1 |
| 31 | 1 |
| 38 | 1 |
| 41 | 1 |
| 47 | 1 |
| 61 | 1 |
| 75 | 1 |
Number of Updates
| Count of Versions | Count of Studies |
|---|---|
| 1 | 53 |
| 2 | 44 |
| 3 | 19 |
| 4 | 5 |
| 5 | 2 |
| 6 | 1 |
| 7 | 1 |
| 12 | 1 |
Update History Change Type
| Change Type | Count_of_Changes | Count_of_Studies | ratio |
|---|---|---|---|
| None (earliest Version on record) | 126 | 126 | 1.000000 |
| Study Status | 126 | 73 | 1.726027 |
| Contacts/Locations | 65 | 40 | 1.625000 |
| Recruitment Status | 34 | 33 | 1.030303 |
| Study Description | 24 | 21 | 1.142857 |
| Outcome Measures | 23 | 20 | 1.150000 |
| Study Design | 23 | 21 | 1.095238 |
| Study Identification | 23 | 21 | 1.095238 |
| Eligibility | 12 | 12 | 1.000000 |
| Oversight | 12 | 12 | 1.000000 |
| Groups | 9 | 9 | 1.000000 |
| Interventions | 9 | 9 | 1.000000 |
| Sponsor/Collaborators | 7 | 7 | 1.000000 |
| Conditions | 6 | 6 | 1.000000 |
| References | 5 | 5 | 1.000000 |
| Documents | 4 | 2 | 2.000000 |
| More Information | 3 | 1 | 3.000000 |
| IPDSharing | 2 | 2 | 1.000000 |
| Results | 1 | 1 | 1.000000 |
| Results Submission Events | 1 | 1 | 1.000000 |
Enrollment Metrics
| Measure | Registries |
|---|---|
| Min | 1.00 |
| 1st Qu | 100.00 |
| Median | 300.00 |
| Mean | 28528.09 |
| 3rd Qu | 1432.75 |
| Max | 3000000.00 |
Registry Model
| observational_model | Study_Count |
|---|---|
| Cohort | 92 |
| Case-Control | 15 |
| Case-Only | 11 |
| Other | 7 |
| Ecologic or Community | 1 |
Time Perspective
| time_perspective | Study_Count |
|---|---|
| Prospective | 96 |
| Other | 22 |
| Cross-Sectional | 8 |
Follow-up
| target_duration | Study_Count |
|---|---|
| 1 Year | 19 |
| 6 Months | 15 |
| 1 Month | 14 |
| 12 Months | 13 |
| 3 Months | 10 |
| 2 Months | 6 |
| 2 Years | 5 |
| 1 Day | 4 |
| 30 Days | 4 |
| 4 Weeks | 4 |
| 20 Years | 3 |
| 14 Days | 2 |
| 2 Weeks | 2 |
| 28 Days | 2 |
| 3 Weeks | 2 |
| 3 Years | 2 |
| 5 Years | 2 |
| 1 Week | 1 |
| 10 Days | 1 |
| 14 Weeks | 1 |
| 18 Months | 1 |
| 20 Days | 1 |
| 20 Months | 1 |
| 21 Days | 1 |
| 24 Months | 1 |
| 5 Days | 1 |
| 5 Months | 1 |
| 6 Weeks | 1 |
| 60 Days | 1 |
| 7 Days | 1 |
| 7 Months | 1 |
| 8 Weeks | 1 |
| 9 Months | 1 |
| 9 Weeks | 1 |
Overview of trials
Interventional Trials
| nct_id | brief_title | link |
|---|---|---|
| NCT04244591 | Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure | https://ClinicalTrials.gov/show/NCT04244591 |
| NCT04252118 | Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19 | https://ClinicalTrials.gov/show/NCT04252118 |
| NCT04251871 | Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04251871 |
| NCT04252274 | Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04252274 |
| NCT04252885 | The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection | https://ClinicalTrials.gov/show/NCT04252885 |
| NCT04263402 | The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia | https://ClinicalTrials.gov/show/NCT04263402 |
| NCT04255017 | A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia | https://ClinicalTrials.gov/show/NCT04255017 |
| NCT04254874 | A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia | https://ClinicalTrials.gov/show/NCT04254874 |
| NCT04264533 | Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia | https://ClinicalTrials.gov/show/NCT04264533 |
| NCT04261270 | A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia | https://ClinicalTrials.gov/show/NCT04261270 |
| NCT04331613 | Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS | https://ClinicalTrials.gov/show/NCT04331613 |
| NCT04275245 | Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia | https://ClinicalTrials.gov/show/NCT04275245 |
| NCT04261517 | Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04261517 |
| NCT04269525 | Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia | https://ClinicalTrials.gov/show/NCT04269525 |
| NCT04282902 | A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection | https://ClinicalTrials.gov/show/NCT04282902 |
| NCT04276688 | Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment | https://ClinicalTrials.gov/show/NCT04276688 |
| NCT04280224 | NK Cells Treatment for COVID-19 | https://ClinicalTrials.gov/show/NCT04280224 |
| NCT04304313 | A Pilot Study of Sildenafil in COVID-19 | https://ClinicalTrials.gov/show/NCT04304313 |
| NCT04275414 | Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04275414 |
| NCT04273763 | Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19) | https://ClinicalTrials.gov/show/NCT04273763 |
| NCT04279197 | Treatment of Pulmonary Fibrosis Due to 2019-nCoV Pneumonia With Fuzheng Huayu | https://ClinicalTrials.gov/show/NCT04279197 |
| NCT04273321 | Efficacy and Safety of Corticosteroids in COVID-19 | https://ClinicalTrials.gov/show/NCT04273321 |
| NCT04276896 | Immunity and Safety of Covid-19 Synthetic Minigene Vaccine | https://ClinicalTrials.gov/show/NCT04276896 |
| NCT04343794 | Using Biovitals® Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19 | https://ClinicalTrials.gov/show/NCT04343794 |
| NCT04280588 | Fingolimod in COVID-19 | https://ClinicalTrials.gov/show/NCT04280588 |
| NCT04280705 | Adaptive COVID-19 Treatment Trial (ACTT) | https://ClinicalTrials.gov/show/NCT04280705 |
| NCT04283461 | Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04283461 |
| NCT04288102 | Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04288102 |
| NCT04291729 | Evaluation of Ganovo （Danoprevir ） Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04291729 |
| NCT04292899 | Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Severe Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04292899 |
| NCT04292730 | Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment | https://ClinicalTrials.gov/show/NCT04292730 |
| NCT04308317 | Tetrandrine Tablets Used in the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04308317 |
| NCT04299724 | Safety and Immunity of Covid-19 aAPC Vaccine | https://ClinicalTrials.gov/show/NCT04299724 |
| NCT04304053 | Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention | https://ClinicalTrials.gov/show/NCT04304053 |
| NCT04303507 | Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting | https://ClinicalTrials.gov/show/NCT04303507 |
| NCT04306055 | Blood Donor Recruitment During Epidemic of COVID-19 | https://ClinicalTrials.gov/show/NCT04306055 |
| NCT04310228 | Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019 | https://ClinicalTrials.gov/show/NCT04310228 |
| NCT04305106 | Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT | https://ClinicalTrials.gov/show/NCT04305106 |
| NCT04304690 | COVID-19 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic | https://ClinicalTrials.gov/show/NCT04304690 |
| NCT04305457 | Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04305457 |
| NCT04306393 | Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19 | https://ClinicalTrials.gov/show/NCT04306393 |
| NCT04308668 | Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2 | https://ClinicalTrials.gov/show/NCT04308668 |
| NCT04316377 | Norwegian Coronavirus Disease 2019 Study | https://ClinicalTrials.gov/show/NCT04316377 |
| NCT04311177 | Losartan for Patients With COVID-19 Not Requiring Hospitalization | https://ClinicalTrials.gov/show/NCT04311177 |
| NCT04312009 | Losartan for Patients With COVID-19 Requiring Hospitalization | https://ClinicalTrials.gov/show/NCT04312009 |
| NCT04315948 | Trial of Treatments for COVID-19 in Hospitalized Adults | https://ClinicalTrials.gov/show/NCT04315948 |
| NCT04315480 | Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis | https://ClinicalTrials.gov/show/NCT04315480 |
| NCT04311697 | Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure | https://ClinicalTrials.gov/show/NCT04311697 |
| NCT04315298 | Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04315298 |
| NCT04313322 | Treatment of COVID-19 Patients Using Wharton’s Jelly-Mesenchymal Stem Cells | https://ClinicalTrials.gov/show/NCT04313322 |
| NCT04313127 | Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults | https://ClinicalTrials.gov/show/NCT04313127 |
| NCT04312243 | NO Prevention of COVID-19 for Healthcare Providers | https://ClinicalTrials.gov/show/NCT04312243 |
| NCT04313023 | The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04313023 |
| NCT04312997 | The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04312997 |
| NCT04323514 | Use of Ascorbic Acid in Patients With COVID 19 | https://ClinicalTrials.gov/show/NCT04323514 |
| NCT04321174 | COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir | https://ClinicalTrials.gov/show/NCT04321174 |
| NCT04315896 | Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial) | https://ClinicalTrials.gov/show/NCT04315896 |
| NCT04320056 | Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19) | https://ClinicalTrials.gov/show/NCT04320056 |
| NCT04318015 | Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial) | https://ClinicalTrials.gov/show/NCT04318015 |
| NCT04317092 | Tocilizumab in COVID-19 Pneumonia (TOCIVID-19) | https://ClinicalTrials.gov/show/NCT04317092 |
| NCT04317040 | CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment | https://ClinicalTrials.gov/show/NCT04317040 |
| NCT04323527 | Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 | https://ClinicalTrials.gov/show/NCT04323527 |
| NCT04321928 | Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary | https://ClinicalTrials.gov/show/NCT04321928 |
| NCT04319900 | Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia | https://ClinicalTrials.gov/show/NCT04319900 |
| NCT04319445 | Mindfulness During COVID-19 | https://ClinicalTrials.gov/show/NCT04319445 |
| NCT04318444 | Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04318444 |
| NCT04324606 | A Study of a Candidate COVID-19 Vaccine (COV001) | https://ClinicalTrials.gov/show/NCT04324606 |
| NCT04318431 | Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children | https://ClinicalTrials.gov/show/NCT04318431 |
| NCT04325867 | Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19 | https://ClinicalTrials.gov/show/NCT04325867 |
| NCT04320953 | Non-contact Endoscopy at Covid-19 Outbreak | https://ClinicalTrials.gov/show/NCT04320953 |
| NCT04320238 | Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff | https://ClinicalTrials.gov/show/NCT04320238 |
| NCT04319731 | A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure | https://ClinicalTrials.gov/show/NCT04319731 |
| NCT04330690 | Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial | https://ClinicalTrials.gov/show/NCT04330690 |
| NCT04328961 | Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP) | https://ClinicalTrials.gov/show/NCT04328961 |
| NCT04328129 | Household Transmission Investigation Study for COVID-19 in French Guiana | https://ClinicalTrials.gov/show/NCT04328129 |
| NCT04323345 | Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus | https://ClinicalTrials.gov/show/NCT04323345 |
| NCT04322682 | Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) | https://ClinicalTrials.gov/show/NCT04322682 |
| NCT04322396 | Proactive Prophylaxis With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04322396 |
| NCT04322344 | Escin in Patients With Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04322344 |
| NCT04321616 | The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients | https://ClinicalTrials.gov/show/NCT04321616 |
| NCT04321421 | Hyperimmune Plasma for Critical Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04321421 |
| NCT04321096 | The Impact of Camostat Mesilate on COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04321096 |
| NCT04320615 | A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04320615 |
| NCT04321278 | Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II) | https://ClinicalTrials.gov/show/NCT04321278 |
| NCT04327349 | Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial | https://ClinicalTrials.gov/show/NCT04327349 |
| NCT04326920 | Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC) | https://ClinicalTrials.gov/show/NCT04326920 |
| NCT04323800 | Convalescent Plasma to Stem Coronavirus (CSSC-001) | https://ClinicalTrials.gov/show/NCT04323800 |
| NCT04322773 | Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure | https://ClinicalTrials.gov/show/NCT04322773 |
| NCT04322123 | Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19) | https://ClinicalTrials.gov/show/NCT04322123 |
| NCT04321993 | Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04321993 |
| NCT04322565 | Colchicine Counteracting Inflammation in COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04322565 |
| NCT04371601 | Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019 | https://ClinicalTrials.gov/show/NCT04371601 |
| NCT04353271 | Trial of Hydroxychloroquine In Covid-19 Kinetics | https://ClinicalTrials.gov/show/NCT04353271 |
| NCT04336462 | Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19 | https://ClinicalTrials.gov/show/NCT04336462 |
| NCT04328285 | Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers | https://ClinicalTrials.gov/show/NCT04328285 |
| NCT04327505 | Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04327505 |
| NCT04326452 | Treating COVID-19 With a Bidirectional Oxygenation Valve | https://ClinicalTrials.gov/show/NCT04326452 |
| NCT04325893 | Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease | https://ClinicalTrials.gov/show/NCT04325893 |
| NCT04325061 | Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19 | https://ClinicalTrials.gov/show/NCT04325061 |
| NCT04324996 | A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19 | https://ClinicalTrials.gov/show/NCT04324996 |
| NCT04324528 | Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation | https://ClinicalTrials.gov/show/NCT04324528 |
| NCT04324489 | DAS181 for Severe COVID-19: Compassionate Use | https://ClinicalTrials.gov/show/NCT04324489 |
| NCT04324073 | Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI | https://ClinicalTrials.gov/show/NCT04324073 |
| NCT04324021 | Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection. | https://ClinicalTrials.gov/show/NCT04324021 |
| NCT04324463 | Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial | https://ClinicalTrials.gov/show/NCT04324463 |
| NCT04327206 | BCG Vaccination to Protect Healthcare Workers Against COVID-19 | https://ClinicalTrials.gov/show/NCT04327206 |
| NCT04355962 | Sevoflurane in COVID-19 ARDS (SevCov) | https://ClinicalTrials.gov/show/NCT04355962 |
| NCT04329533 | Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04329533 |
| NCT04326790 | The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention | https://ClinicalTrials.gov/show/NCT04326790 |
| NCT04326426 | ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04326426 |
| NCT04326036 | Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04326036 |
| NCT04325906 | Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS | https://ClinicalTrials.gov/show/NCT04325906 |
| NCT04324190 | DIgital Online SuPport for COVID-19 StrEss | https://ClinicalTrials.gov/show/NCT04324190 |
| NCT04327401 | COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III | https://ClinicalTrials.gov/show/NCT04327401 |
| NCT04327388 | Sarilumab COVID-19 | https://ClinicalTrials.gov/show/NCT04327388 |
| NCT04331899 | Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19 | https://ClinicalTrials.gov/show/NCT04331899 |
| NCT04328493 | The Vietnam Chloroquine Treatment on COVID-19 | https://ClinicalTrials.gov/show/NCT04328493 |
| NCT04328467 | Pre-exposure Prophylaxis for SARS-Coronavirus-2 | https://ClinicalTrials.gov/show/NCT04328467 |
| NCT04328441 | Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine | https://ClinicalTrials.gov/show/NCT04328441 |
| NCT04328012 | COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04328012 |
| NCT04336254 | Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04336254 |
| NCT04329195 | ACE Inhibitors or ARBs Discontinuation in Context of SARS-CoV-2 Pandemic | https://ClinicalTrials.gov/show/NCT04329195 |
| NCT04333368 | Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS | https://ClinicalTrials.gov/show/NCT04333368 |
| NCT04331054 | Protective Role of Inhaled Steroids for Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04331054 |
| NCT04348370 | BCG Vaccine for Health Care Workers as Defense Against COVID 19 | https://ClinicalTrials.gov/show/NCT04348370 |
| NCT04332107 | Azithromycin for COVID-19 Treatment in Outpatients Nationwide | https://ClinicalTrials.gov/show/NCT04332107 |
| NCT04331600 | Chloroquine as Antiviral Treatment in Coronavirus Infection 2020 | https://ClinicalTrials.gov/show/NCT04331600 |
| NCT04331470 | Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04331470 |
| NCT04329923 | The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine) | https://ClinicalTrials.gov/show/NCT04329923 |
| NCT04329832 | Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19 | https://ClinicalTrials.gov/show/NCT04329832 |
| NCT04328480 | The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients. | https://ClinicalTrials.gov/show/NCT04328480 |
| NCT04376515 | Harnessing Online Peer Education Online Support Intervention for COVID-19 (HOPE COVID-19) | https://ClinicalTrials.gov/show/NCT04376515 |
| NCT04352348 | Cohort of Patients Infected With SARS-CoV2 (COVID-19) or Suspected of Being | https://ClinicalTrials.gov/show/NCT04352348 |
| NCT04347174 | A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients | https://ClinicalTrials.gov/show/NCT04347174 |
| NCT04343651 | Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04343651 |
| NCT04342182 | Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study) | https://ClinicalTrials.gov/show/NCT04342182 |
| NCT04336332 | Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19 | https://ClinicalTrials.gov/show/NCT04336332 |
| NCT04335305 | Checkpoint Blockade in COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04335305 |
| NCT04335123 | Study of Open Label Losartan in COVID-19 | https://ClinicalTrials.gov/show/NCT04335123 |
| NCT04333355 | Safety in Convalescent Plasma Transfusion to COVID-19 | https://ClinicalTrials.gov/show/NCT04333355 |
| NCT04332991 | Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease | https://ClinicalTrials.gov/show/NCT04332991 |
| NCT04332094 | Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04332094 |
| NCT04331808 | CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI) | https://ClinicalTrials.gov/show/NCT04331808 |
| NCT04331366 | Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19 | https://ClinicalTrials.gov/show/NCT04331366 |
| NCT04329650 | Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04329650 |
| NCT04330638 | Treatment of COVID-19 Patients With Anti-interleukin Drugs | https://ClinicalTrials.gov/show/NCT04330638 |
| NCT04339712 | Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction | https://ClinicalTrials.gov/show/NCT04339712 |
| NCT04338009 | Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019 | https://ClinicalTrials.gov/show/NCT04338009 |
| NCT04335136 | Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04335136 |
| NCT04335097 | Sensor Based Vital Signs Monitoring of Covid 19 Patients During Home Isolation | https://ClinicalTrials.gov/show/NCT04335097 |
| NCT04334265 | Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019 | https://ClinicalTrials.gov/show/NCT04334265 |
| NCT04334044 | Treatment of SARS Caused by COVID-19 With Ruxolitinib | https://ClinicalTrials.gov/show/NCT04334044 |
| NCT04333589 | Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive | https://ClinicalTrials.gov/show/NCT04333589 |
| NCT04333550 | Application of Desferal to Treat COVID-19 | https://ClinicalTrials.gov/show/NCT04333550 |
| NCT04333420 | Open-label, Randomized Study of IFX-1 in Patients With Severe COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04333420 |
| NCT04333407 | Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial. | https://ClinicalTrials.gov/show/NCT04333407 |
| NCT04333225 | Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers | https://ClinicalTrials.gov/show/NCT04333225 |
| NCT04331834 | Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04331834 |
| NCT04331795 | Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis | https://ClinicalTrials.gov/show/NCT04331795 |
| NCT04335279 | Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program | https://ClinicalTrials.gov/show/NCT04335279 |
| NCT04347226 | Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04347226 |
| NCT04345523 | Convalescent Plasma Therapy vs. SOC for the Treatment of COVID19 in Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04345523 |
| NCT04340349 | Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals | https://ClinicalTrials.gov/show/NCT04340349 |
| NCT04339660 | Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04339660 |
| NCT04337541 | Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System | https://ClinicalTrials.gov/show/NCT04337541 |
| NCT04335851 | Video-Based Exercises and Well-Being During Social Isolation | https://ClinicalTrials.gov/show/NCT04335851 |
| NCT04335786 | Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease | https://ClinicalTrials.gov/show/NCT04335786 |
| NCT04335071 | Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04335071 |
| NCT04334928 | Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel | https://ClinicalTrials.gov/show/NCT04334928 |
| NCT04334850 | Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04334850 |
| NCT04334629 | LIBERATE Trial in COVID-19 | https://ClinicalTrials.gov/show/NCT04334629 |
| NCT04334382 | Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19 | https://ClinicalTrials.gov/show/NCT04334382 |
| NCT04335084 | A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04335084 |
| NCT04334512 | A Study of Quintuple Therapy to Treat COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04334512 |
| NCT04334460 | Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects | https://ClinicalTrials.gov/show/NCT04334460 |
| NCT04348409 | Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04348409 |
| NCT04343053 | Pro-thrombotic Status in Patients With SARS-Cov-2 Infection | https://ClinicalTrials.gov/show/NCT04343053 |
| NCT04340544 | Hydroxychloroquine for the Treatment of Mild COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04340544 |
| NCT04337008 | Renin Angiotensin System - CoronaVirus | https://ClinicalTrials.gov/show/NCT04337008 |
| NCT04336904 | Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19 | https://ClinicalTrials.gov/show/NCT04336904 |
| NCT04336774 | CAPTION AI to Minimize Risk of COVID Exposure | https://ClinicalTrials.gov/show/NCT04336774 |
| NCT04335552 | Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04335552 |
| NCT04336410 | Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT04336410 |
| NCT04338568 | Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study | https://ClinicalTrials.gov/show/NCT04338568 |
| NCT04342650 | Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04342650 |
| NCT04341116 | Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04341116 |
| NCT04343092 | Efficacy of Ivermectin as Add on Therapy in COVID19 Patients | https://ClinicalTrials.gov/show/NCT04343092 |
| NCT04341675 | Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04341675 |
| NCT04338841 | HOME-CoV: Hospitalization or Outpatient ManagEment of Patients With a SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04338841 |
| NCT04338828 | Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED | https://ClinicalTrials.gov/show/NCT04338828 |
| NCT04349631 | A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19 | https://ClinicalTrials.gov/show/NCT04349631 |
| NCT04346797 | CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort | https://ClinicalTrials.gov/show/NCT04346797 |
| NCT04344951 | Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial | https://ClinicalTrials.gov/show/NCT04344951 |
| NCT04340557 | Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04340557 |
| NCT04339816 | Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial | https://ClinicalTrials.gov/show/NCT04339816 |
| NCT04338074 | TXA and Corona Virus 2019 (COVID19) in Outpatients | https://ClinicalTrials.gov/show/NCT04338074 |
| NCT04337918 | Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04337918 |
| NCT04384380 | Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04384380 |
| NCT04353674 | Modulation of Hyperinflammation in COVID-19 | https://ClinicalTrials.gov/show/NCT04353674 |
| NCT04352933 | PROLIFIC ChemoprophylaxisTrial (COVID-19) | https://ClinicalTrials.gov/show/NCT04352933 |
| NCT04347031 | A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19 | https://ClinicalTrials.gov/show/NCT04347031 |
| NCT04346147 | Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19 | https://ClinicalTrials.gov/show/NCT04346147 |
| NCT04345848 | Preventing COVID-19 Complications With Low- and High-dose Anticoagulation | https://ClinicalTrials.gov/show/NCT04345848 |
| NCT04345614 | A Study of CM4620-Injectable Emulsion (IE) in Patients With Severe COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04345614 |
| NCT04344210 | Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus | https://ClinicalTrials.gov/show/NCT04344210 |
| NCT04342169 | University of Utah COVID-19 Hydrochloroquine Trial | https://ClinicalTrials.gov/show/NCT04342169 |
| NCT04341493 | Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04341493 |
| NCT04341441 | Will Hydroxychloroquine Impede or Prevent COVID-19 | https://ClinicalTrials.gov/show/NCT04341441 |
| NCT04341415 | Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome | https://ClinicalTrials.gov/show/NCT04341415 |
| NCT04341389 | A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector) | https://ClinicalTrials.gov/show/NCT04341389 |
| NCT04341038 | Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury | https://ClinicalTrials.gov/show/NCT04341038 |
| NCT04340050 | COVID-19 Convalescent Plasma | https://ClinicalTrials.gov/show/NCT04340050 |
| NCT04339426 | Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04339426 |
| NCT04338958 | Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation | https://ClinicalTrials.gov/show/NCT04338958 |
| NCT04341922 | A Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04341922 |
| NCT04364893 | Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19 | https://ClinicalTrials.gov/show/NCT04364893 |
| NCT04358081 | Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04358081 |
| NCT04350580 | Polyvalent Immunoglobulin in COVID-19 Related ARds | https://ClinicalTrials.gov/show/NCT04350580 |
| NCT04348383 | Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19. | https://ClinicalTrials.gov/show/NCT04348383 |
| NCT04347681 | Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04347681 |
| NCT04346693 | An Open Randomized Study of Dalargin Effectiveness in Patients With Severe and Critical Manifestations of SARS-COVID-19 | https://ClinicalTrials.gov/show/NCT04346693 |
| NCT04346420 | Impact of the Double-Trunk Mask on Oxygenation Titration in COVID-19 | https://ClinicalTrials.gov/show/NCT04346420 |
| NCT04345653 | Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers | https://ClinicalTrials.gov/show/NCT04345653 |
| NCT04344236 | Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04344236 |
| NCT04344106 | Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study | https://ClinicalTrials.gov/show/NCT04344106 |
| NCT04343768 | An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial | https://ClinicalTrials.gov/show/NCT04343768 |
| NCT04343755 | Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04343755 |
| NCT04343261 | Convalescent Plasma in the Treatment of COVID 19 | https://ClinicalTrials.gov/show/NCT04343261 |
| NCT04343248 | Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF) | https://ClinicalTrials.gov/show/NCT04343248 |
| NCT04342728 | Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation | https://ClinicalTrials.gov/show/NCT04342728 |
| NCT04342689 | The Role of Resistant Starch in COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04342689 |
| NCT04342663 | A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04342663 |
| NCT04341207 | Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients | https://ClinicalTrials.gov/show/NCT04341207 |
| NCT04344457 | Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19 | https://ClinicalTrials.gov/show/NCT04344457 |
| NCT04342221 | Hydroxychloroquine for COVID-19 | https://ClinicalTrials.gov/show/NCT04342221 |
| NCT04344587 | Awake Prone Position for Early Hypoxemia in COVID-19 | https://ClinicalTrials.gov/show/NCT04344587 |
| NCT04341142 | Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER | https://ClinicalTrials.gov/show/NCT04341142 |
| NCT04353037 | PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine | https://ClinicalTrials.gov/show/NCT04353037 |
| NCT04351906 | Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04351906 |
| NCT04348513 | Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04348513 |
| NCT04347980 | Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19 | https://ClinicalTrials.gov/show/NCT04347980 |
| NCT04346589 | Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients | https://ClinicalTrials.gov/show/NCT04346589 |
| NCT04345692 | A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04345692 |
| NCT04344015 | COVID-19 Plasma Collection | https://ClinicalTrials.gov/show/NCT04344015 |
| NCT04344730 | Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04344730 |
| NCT04344431 | Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04344431 |
| NCT04344080 | Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04344080 |
| NCT04344041 | COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial) | https://ClinicalTrials.gov/show/NCT04344041 |
| NCT04343989 | A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04343989 |
| NCT04343976 | Pegylated Interferon Lambda Treatment for COVID-19 | https://ClinicalTrials.gov/show/NCT04343976 |
| NCT04346615 | Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen | https://ClinicalTrials.gov/show/NCT04346615 |
| NCT04343729 | Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19 | https://ClinicalTrials.gov/show/NCT04343729 |
| NCT04343963 | Pyridostigmine in Severe SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04343963 |
| NCT04390178 | Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04390178 |
| NCT04351724 | Austrian CoronaVirus Adaptive Clinical Trial (COVID-19) | https://ClinicalTrials.gov/show/NCT04351724 |
| NCT04348929 | Birth Experience During COVID-19 Confinement | https://ClinicalTrials.gov/show/NCT04348929 |
| NCT04345991 | Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort | https://ClinicalTrials.gov/show/NCT04345991 |
| NCT04345549 | Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak | https://ClinicalTrials.gov/show/NCT04345549 |
| NCT04345289 | Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04345289 |
| NCT04345276 | Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04345276 |
| NCT04344600 | Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection | https://ClinicalTrials.gov/show/NCT04344600 |
| NCT04344561 | Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation | https://ClinicalTrials.gov/show/NCT04344561 |
| NCT04344535 | Convalescent Plasma vs. Standard Plasma for COVID-19 | https://ClinicalTrials.gov/show/NCT04344535 |
| NCT04344444 | Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease | https://ClinicalTrials.gov/show/NCT04344444 |
| NCT04344288 | Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection | https://ClinicalTrials.gov/show/NCT04344288 |
| NCT04342897 | A Study of LY3127804 in Participants With COVID-19 | https://ClinicalTrials.gov/show/NCT04342897 |
| NCT04348305 | Hydrocortisone for COVID-19 and Severe Hypoxia | https://ClinicalTrials.gov/show/NCT04348305 |
| NCT04347538 | Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04347538 |
| NCT04347382 | Honey & Nigella Sativa Trial Against COVID-19 | https://ClinicalTrials.gov/show/NCT04347382 |
| NCT04345419 | A Real-life Experience on Treatment of Patients With COVID 19 | https://ClinicalTrials.gov/show/NCT04345419 |
| NCT04356495 | Treatments to Decrease the Risk of Hospitalization or Death in Elderly Outpatients With Symptomatic SARS-CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04356495 |
| NCT04349410 | The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol | https://ClinicalTrials.gov/show/NCT04349410 |
| NCT04349371 | Saved From COVID-19 | https://ClinicalTrials.gov/show/NCT04349371 |
| NCT04463433 | Psychological Intervention for Parent-child Relationship and Couple Relationship Under COVID-19 in China | https://ClinicalTrials.gov/show/NCT04463433 |
| NCT04360824 | Covid-19 Associated Coagulopathy | https://ClinicalTrials.gov/show/NCT04360824 |
| NCT04359251 | Different PEEP Settings of COVID-19 Induced ARDS | https://ClinicalTrials.gov/show/NCT04359251 |
| NCT04357340 | The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04357340 |
| NCT04355728 | Use of UC-MSCs for COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04355728 |
| NCT04350281 | Double Therapy With IFN-beta 1b and Hydroxychloroquine | https://ClinicalTrials.gov/show/NCT04350281 |
| NCT04349241 | Efficacy and Safety of Favipiravir in Management of COVID-19 | https://ClinicalTrials.gov/show/NCT04349241 |
| NCT04348864 | COVID-19 Antibody Self-testing Using Virtual Point-of-care | https://ClinicalTrials.gov/show/NCT04348864 |
| NCT04348695 | Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19. | https://ClinicalTrials.gov/show/NCT04348695 |
| NCT04348656 | CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1) | https://ClinicalTrials.gov/show/NCT04348656 |
| NCT04348500 | Clazakizumab (Anti-IL- 6 Monoclonal) Compared to Placebo for COVID19 Disease | https://ClinicalTrials.gov/show/NCT04348500 |
| NCT04347954 | PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19) | https://ClinicalTrials.gov/show/NCT04347954 |
| NCT04347239 | Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04347239 |
| NCT04346667 | Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds | https://ClinicalTrials.gov/show/NCT04346667 |
| NCT04346017 | Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome | https://ClinicalTrials.gov/show/NCT04346017 |
| NCT04382391 | Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms | https://ClinicalTrials.gov/show/NCT04382391 |
| NCT04361916 | Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino) | https://ClinicalTrials.gov/show/NCT04361916 |
| NCT04357808 | Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID) | https://ClinicalTrials.gov/show/NCT04357808 |
| NCT04357106 | COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma | https://ClinicalTrials.gov/show/NCT04357106 |
| NCT04355143 | Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19) | https://ClinicalTrials.gov/show/NCT04355143 |
| NCT04354831 | A Study Evaluating the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04354831 |
| NCT04354610 | Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04354610 |
| NCT04353596 | Stopping ACE-inhibitors in COVID-19 | https://ClinicalTrials.gov/show/NCT04353596 |
| NCT04352608 | Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04352608 |
| NCT04351542 | Ayurveda for Flu Like Illness During Covid-19 Outbreak | https://ClinicalTrials.gov/show/NCT04351542 |
| NCT04351763 | Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms | https://ClinicalTrials.gov/show/NCT04351763 |
| NCT04351620 | High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19 | https://ClinicalTrials.gov/show/NCT04351620 |
| NCT04351581 | Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04351581 |
| NCT04351191 | PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds | https://ClinicalTrials.gov/show/NCT04351191 |
| NCT04350736 | First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19 | https://ClinicalTrials.gov/show/NCT04350736 |
| NCT04350684 | Umifenovir in Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04350684 |
| NCT04350671 | Interferon Beta 1a in Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04350671 |
| NCT04350593 | Dapagliflozin in Respiratory Failure in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04350593 |
| NCT04350320 | Trial to Study the Benefit of Colchicine in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04350320 |
| NCT04349228 | Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals | https://ClinicalTrials.gov/show/NCT04349228 |
| NCT04349098 | Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04349098 |
| NCT04348435 | A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19 | https://ClinicalTrials.gov/show/NCT04348435 |
| NCT04346446 | Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04346446 |
| NCT04347915 | The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04347915 |
| NCT04357327 | Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04357327 |
| NCT04356534 | Convalescent Plasma Trial in COVID -19 Patients | https://ClinicalTrials.gov/show/NCT04356534 |
| NCT04355897 | CoVID-19 Plasma in Treatment of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04355897 |
| NCT04355637 | Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia | https://ClinicalTrials.gov/show/NCT04355637 |
| NCT04355364 | Efficacy and Safety of Aerosolized Intra-tracheal Dornase Alfa Administration in Patients With COVID19-induced ARDS (COVIDORNASE) | https://ClinicalTrials.gov/show/NCT04355364 |
| NCT04355026 | Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04355026 |
| NCT04351516 | Test and Treat COVID 65plus+ | https://ClinicalTrials.gov/show/NCT04351516 |
| NCT04351347 | The Efficacy of Ivermectin and Nitazoxanide in COVID-19 Treatment | https://ClinicalTrials.gov/show/NCT04351347 |
| NCT04351152 | Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Hospitalized Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04351152 |
| NCT04351243 | A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE). | https://ClinicalTrials.gov/show/NCT04351243 |
| NCT04353336 | Efficacay of Chloroquine in COVID-19 Treatment | https://ClinicalTrials.gov/show/NCT04353336 |
| NCT04359290 | Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS | https://ClinicalTrials.gov/show/NCT04359290 |
| NCT04367662 | Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19 | https://ClinicalTrials.gov/show/NCT04367662 |
| NCT04361838 | The COVID-19 ICU PRAYER Study | https://ClinicalTrials.gov/show/NCT04361838 |
| NCT04361344 | Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04361344 |
| NCT04358939 | Prone Position in Patients on High-flow Nasal Oxygen Therapy for COVID-19 (HIGH-PRONE-COVID-19) | https://ClinicalTrials.gov/show/NCT04358939 |
| NCT04354870 | COVID-19 PrEP HCW HCQ Study | https://ClinicalTrials.gov/show/NCT04354870 |
| NCT04354428 | Treatment for COVID-19 in High-Risk Adult Outpatients | https://ClinicalTrials.gov/show/NCT04354428 |
| NCT04354259 | Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19 | https://ClinicalTrials.gov/show/NCT04354259 |
| NCT04353284 | Camostat Mesylate in COVID-19 Outpatients | https://ClinicalTrials.gov/show/NCT04353284 |
| NCT04353206 | Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure | https://ClinicalTrials.gov/show/NCT04353206 |
| NCT04353128 | Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers. | https://ClinicalTrials.gov/show/NCT04353128 |
| NCT04352751 | Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020 | https://ClinicalTrials.gov/show/NCT04352751 |
| NCT04358549 | Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19 | https://ClinicalTrials.gov/show/NCT04358549 |
| NCT04359264 | Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a Randomized Controlled Trial | https://ClinicalTrials.gov/show/NCT04359264 |
| NCT04373044 | Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04373044 |
| NCT04364009 | Anakinra for COVID-19 Respiratory Symptoms | https://ClinicalTrials.gov/show/NCT04364009 |
| NCT04363853 | Tocilizumab Treatment in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04363853 |
| NCT04361942 | Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV) | https://ClinicalTrials.gov/show/NCT04361942 |
| NCT04357782 | Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation | https://ClinicalTrials.gov/show/NCT04357782 |
| NCT04356690 | Etoposide in Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04356690 |
| NCT04356482 | CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19 | https://ClinicalTrials.gov/show/NCT04356482 |
| NCT04355936 | Telmisartan for Treatment of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04355936 |
| NCT04355351 | Study of Immune Response During SARS-CoV-2 Infection - (COVID-19) | https://ClinicalTrials.gov/show/NCT04355351 |
| NCT04355247 | Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm | https://ClinicalTrials.gov/show/NCT04355247 |
| NCT04377308 | Fluoxetine to Reduce Intubation and Death After COVID19 Infection | https://ClinicalTrials.gov/show/NCT04377308 |
| NCT04357730 | Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04357730 |
| NCT04376034 | Convalescent Plasma Collection and Treatment in Pediatrics and Adults | https://ClinicalTrials.gov/show/NCT04376034 |
| NCT04358614 | Baricitinib Therapy in COVID-19 | https://ClinicalTrials.gov/show/NCT04358614 |
| NCT04357028 | Measles Vaccine in HCW | https://ClinicalTrials.gov/show/NCT04357028 |
| NCT04363814 | Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04363814 |
| NCT04356937 | Efficacy of Tocilizumab on Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04356937 |
| NCT04374084 | Moxibustion Plus Cupping in Convalescent Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04374084 |
| NCT04368845 | Telerehabilitation in Patients With COVID-19 After Hospitalization. The ATHLOS Study | https://ClinicalTrials.gov/show/NCT04368845 |
| NCT04368156 | Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms | https://ClinicalTrials.gov/show/NCT04368156 |
| NCT04366063 | Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04366063 |
| NCT04362085 | Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care | https://ClinicalTrials.gov/show/NCT04362085 |
| NCT04359901 | Sarilumab for Patients With Moderate COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04359901 |
| NCT04359680 | Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers | https://ClinicalTrials.gov/show/NCT04359680 |
| NCT04359537 | Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19 | https://ClinicalTrials.gov/show/NCT04359537 |
| NCT04359277 | A Randomized Trial of Anticoagulation Strategies in COVID-19 | https://ClinicalTrials.gov/show/NCT04359277 |
| NCT04358003 | Plasma Adsorption in Patients With Confirmed COVID-19 | https://ClinicalTrials.gov/show/NCT04358003 |
| NCT04357990 | Kerecis Oral and Nasal Spray for Treating the Symptoms of COVID-19 | https://ClinicalTrials.gov/show/NCT04357990 |
| NCT04357366 | suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE) | https://ClinicalTrials.gov/show/NCT04357366 |
| NCT04358068 | Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19 | https://ClinicalTrials.gov/show/NCT04358068 |
| NCT04359797 | COVID-19 Patient Positioning Pragmatic Trial | https://ClinicalTrials.gov/show/NCT04359797 |
| NCT04364763 | A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study) | https://ClinicalTrials.gov/show/NCT04364763 |
| NCT04413864 | Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19 | https://ClinicalTrials.gov/show/NCT04413864 |
| NCT04363385 | Collection of Biological Samples With Clinical Characterization of Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04363385 |
| NCT04362176 | Passive Immunity Trial of Nashville II for COVID-19 | https://ClinicalTrials.gov/show/NCT04362176 |
| NCT04361526 | Pilot Study on Cytokine Filtration in COVID-19 ARDS | https://ClinicalTrials.gov/show/NCT04361526 |
| NCT04359862 | Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection | https://ClinicalTrials.gov/show/NCT04359862 |
| NCT04359810 | Plasma Therapy of COVID-19 in Critically Ill Patients | https://ClinicalTrials.gov/show/NCT04359810 |
| NCT04359329 | Estrogen Patch for COVID-19 Symptoms | https://ClinicalTrials.gov/show/NCT04359329 |
| NCT04358926 | Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19) | https://ClinicalTrials.gov/show/NCT04358926 |
| NCT04358783 | Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia | https://ClinicalTrials.gov/show/NCT04358783 |
| NCT04363736 | A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04363736 |
| NCT04373200 | Human Ab Response & immunoMONItoring of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04373200 |
| NCT04366882 | Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04366882 |
| NCT04366323 | Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04366323 |
| NCT04366245 | Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04366245 |
| NCT04366089 | Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora | https://ClinicalTrials.gov/show/NCT04366089 |
| NCT04365101 | Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 (CYNK-001-COVID-19) | https://ClinicalTrials.gov/show/NCT04365101 |
| NCT04364737 | Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04364737 |
| NCT04364594 | COVID-19 Search in Conjunctival Cells | https://ClinicalTrials.gov/show/NCT04364594 |
| NCT04361474 | Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity | https://ClinicalTrials.gov/show/NCT04361474 |
| NCT04361214 | Leflunomide in Mild COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04361214 |
| NCT04360980 | The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04360980 |
| NCT04360837 | PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) Patients | https://ClinicalTrials.gov/show/NCT04360837 |
| NCT04360811 | Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04360811 |
| NCT04361396 | Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04361396 |
| NCT04362137 | Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID) | https://ClinicalTrials.gov/show/NCT04362137 |
| NCT04377750 | The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation | https://ClinicalTrials.gov/show/NCT04377750 |
| NCT04368377 | Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04368377 |
| NCT04366947 | Intravascular Access in Suspected/Confirmed COVID-19 Patient | https://ClinicalTrials.gov/show/NCT04366947 |
| NCT04366297 | Intravascular Access of COVID-19 Patient Under Personal Protective Equipment | https://ClinicalTrials.gov/show/NCT04366297 |
| NCT04366271 | Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04366271 |
| NCT04365582 | OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome | https://ClinicalTrials.gov/show/NCT04365582 |
| NCT04364022 | Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland | https://ClinicalTrials.gov/show/NCT04364022 |
| NCT04363502 | Use of the Interleukin-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04363502 |
| NCT04363450 | Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP) | https://ClinicalTrials.gov/show/NCT04363450 |
| NCT04363437 | COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19 | https://ClinicalTrials.gov/show/NCT04363437 |
| NCT04363346 | Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia | https://ClinicalTrials.gov/show/NCT04363346 |
| NCT04361253 | Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy | https://ClinicalTrials.gov/show/NCT04361253 |
| NCT04393961 | At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study | https://ClinicalTrials.gov/show/NCT04393961 |
| NCT04385095 | Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection | https://ClinicalTrials.gov/show/NCT04385095 |
| NCT04372589 | Antithrombotic Therapy to Ameliorate Complications of COVID-19 ( ATTACC ) | https://ClinicalTrials.gov/show/NCT04372589 |
| NCT04368988 | Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS (COVID-19) Nanoparticle Vaccine With/Without Matrix-M Adjuvant | https://ClinicalTrials.gov/show/NCT04368988 |
| NCT04368923 | Management of Covid-19 Patients During Home Isolation | https://ClinicalTrials.gov/show/NCT04368923 |
| NCT04368260 | Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04368260 |
| NCT04368000 | Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization | https://ClinicalTrials.gov/show/NCT04368000 |
| NCT04367168 | Colchicine Twice Daily During 10 Days as an Option for the Treatment of Symptoms Induced by Inflammation in Patients With Mild and Severe Coronavirus Disease | https://ClinicalTrials.gov/show/NCT04367168 |
| NCT04366960 | Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04366960 |
| NCT04366791 | Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19 | https://ClinicalTrials.gov/show/NCT04366791 |
| NCT04365972 | Attention Bias Modification for Reducing Health Anxiety During the Coronavirus Pandemic | https://ClinicalTrials.gov/show/NCT04365972 |
| NCT04365608 | Prehospital Intubation of COVID-19 Patient With Personal Protective Equipment | https://ClinicalTrials.gov/show/NCT04365608 |
| NCT04365309 | Protective Effect of Aspirin on COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04365309 |
| NCT04365257 | Prazosin to Prevent COVID-19 (PREVENT-COVID Trial) | https://ClinicalTrials.gov/show/NCT04365257 |
| NCT04365127 | Progesterone for the Treatment of COVID-19 in Hospitalized Men | https://ClinicalTrials.gov/show/NCT04365127 |
| NCT04363827 | Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04363827 |
| NCT04363606 | Chronic Fatigue Etiology and Recovery in Covid-19 Patients: the Role of Fatigability | https://ClinicalTrials.gov/show/NCT04363606 |
| NCT04363593 | Serology COVID-19 From the Cornwall Hospital Union | https://ClinicalTrials.gov/show/NCT04363593 |
| NCT04362813 | Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia | https://ClinicalTrials.gov/show/NCT04362813 |
| NCT04363372 | A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19 | https://ClinicalTrials.gov/show/NCT04363372 |
| NCT04365153 | Canakinumab in Covid-19 Cardiac Injury (The Three C Study) | https://ClinicalTrials.gov/show/NCT04365153 |
| NCT04366050 | Ramipril for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04366050 |
| NCT04392778 | Clinical Use of Stem Cells for the Treatment of Covid-19 | https://ClinicalTrials.gov/show/NCT04392778 |
| NCT04372017 | Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04372017 |
| NCT04365699 | Cardiovascular Effects of COVID-19 | https://ClinicalTrials.gov/show/NCT04365699 |
| NCT04364802 | COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients | https://ClinicalTrials.gov/show/NCT04364802 |
| NCT04428268 | Chloroquine + Losartan Compared to Chloroquine Alone for the Treatment of COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04428268 |
| NCT04373824 | Max Ivermectin- COVID 19 Study Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study | https://ClinicalTrials.gov/show/NCT04373824 |
| NCT04370782 | Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting | https://ClinicalTrials.gov/show/NCT04370782 |
| NCT04365738 | Pulmonary Rehabilitation in Post-Acute Period of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04365738 |
| NCT04365985 | Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19 | https://ClinicalTrials.gov/show/NCT04365985 |
| NCT04389710 | Convalescent Plasma for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04389710 |
| NCT04379453 | Robot Assisted Percutaneous Cardiovascular Intervention as a Strategy to Reduce or Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses | https://ClinicalTrials.gov/show/NCT04379453 |
| NCT04374565 | Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia | https://ClinicalTrials.gov/show/NCT04374565 |
| NCT04372693 | Unplanned Shifting to Online Distance Learning: Nursing Students’ Perception and Achievement | https://ClinicalTrials.gov/show/NCT04372693 |
| NCT04370262 | Multi-site Adaptive Trials for COVID-19 | https://ClinicalTrials.gov/show/NCT04370262 |
| NCT04369456 | Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients | https://ClinicalTrials.gov/show/NCT04369456 |
| NCT04369365 | A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic | https://ClinicalTrials.gov/show/NCT04369365 |
| NCT04369066 | COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie | https://ClinicalTrials.gov/show/NCT04369066 |
| NCT04367831 | Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04367831 |
| NCT04367545 | Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04367545 |
| NCT04367077 | MultiStem Administration for COVID-19 Induced ARDS (MACoVIA) | https://ClinicalTrials.gov/show/NCT04367077 |
| NCT04366180 | Evaluation of the Probiotic Lactobacillus Coryniformis K8 on COVID-19 Prevention in Healthcare Workers | https://ClinicalTrials.gov/show/NCT04366180 |
| NCT04368728 | Study to Describe the Safety, Tolerability, Immunogenicity, and Potential Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04368728 |
| NCT04410354 | Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19 | https://ClinicalTrials.gov/show/NCT04410354 |
| NCT04406181 | Psychological Well-being of Patients Awaiting for Cardiac Surgery During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04406181 |
| NCT04379154 | Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04379154 |
| NCT04376476 | Host-pathogen Interactions During SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04376476 |
| NCT04371640 | Sirolimus in COVID-19 Phase 1 | https://ClinicalTrials.gov/show/NCT04371640 |
| NCT04371510 | Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients | https://ClinicalTrials.gov/show/NCT04371510 |
| NCT04371419 | COVID-19 Health Messaging to Underserved Communities | https://ClinicalTrials.gov/show/NCT04371419 |
| NCT04371393 | MSCs in COVID-19 ARDS | https://ClinicalTrials.gov/show/NCT04371393 |
| NCT04371029 | Impact of Neck Inspiratory Muscle Activation During Sleep in ICU Patients After a COVID 19 ARDS | https://ClinicalTrials.gov/show/NCT04371029 |
| NCT04370886 | Recruit Blood Donors Via SMS During Epidemic of COVID-19 | https://ClinicalTrials.gov/show/NCT04370886 |
| NCT04369469 | Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia | https://ClinicalTrials.gov/show/NCT04369469 |
| NCT04385810 | Description of Ophthalmologic Injuries in Intensive Care During the SARS-CoV2 Epidemic - COVID19 | https://ClinicalTrials.gov/show/NCT04385810 |
| NCT04384588 | COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID) | https://ClinicalTrials.gov/show/NCT04384588 |
| NCT04380532 | Tableted COVID-19 Therapeutic Vaccine | https://ClinicalTrials.gov/show/NCT04380532 |
| NCT04378712 | Hydrogen/Oxygen Mixed Gas Inhalation for Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04378712 |
| NCT04375202 | Colchicine in COVID-19: a Pilot Study | https://ClinicalTrials.gov/show/NCT04375202 |
| NCT04372186 | A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04372186 |
| NCT04370938 | Provider Burnout During COVID-19 | https://ClinicalTrials.gov/show/NCT04370938 |
| NCT04371367 | Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE ) | https://ClinicalTrials.gov/show/NCT04371367 |
| NCT04370288 | Clinical Application of Methylene Blue for Treatment of Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04370288 |
| NCT04369820 | C5a Receptor Expression - COVID-19 (C5-COV) | https://ClinicalTrials.gov/show/NCT04369820 |
| NCT04408066 | COVID-19: A POC Test Under Research & Evaluation | https://ClinicalTrials.gov/show/NCT04408066 |
| NCT04379531 | LDCT in COVID-19 Pneumonia: a Prospective Moscow Study | https://ClinicalTrials.gov/show/NCT04379531 |
| NCT04374942 | Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus? | https://ClinicalTrials.gov/show/NCT04374942 |
| NCT04374032 | Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04374032 |
| NCT04373460 | Convalescent Plasma to Limit SARS-CoV-2 Associated Complications | https://ClinicalTrials.gov/show/NCT04373460 |
| NCT04373161 | Home Pulse Oximeter Use in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04373161 |
| NCT04373135 | Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19 | https://ClinicalTrials.gov/show/NCT04373135 |
| NCT04372680 | WeanINg From Mechanical Ventilation for ARDS CovId-19 Patients Guided by Combined Thoracic UltraSound | https://ClinicalTrials.gov/show/NCT04372680 |
| NCT04370834 | Tocilizumab for Patients With Cancer and COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04370834 |
| NCT04372628 | Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19 | https://ClinicalTrials.gov/show/NCT04372628 |
| NCT04378738 | Social Media and Covid19 Pandemic | https://ClinicalTrials.gov/show/NCT04378738 |
| NCT04377789 | Effect of Quercetin on Prophylaxis and Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04377789 |
| NCT04375124 | Treatment of Angiotensin Peptide (1-7) for COVID-19 | https://ClinicalTrials.gov/show/NCT04375124 |
| NCT04374786 | Effects of Mobile App in House Staff Health and Well-being During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04374786 |
| NCT04373707 | Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19 | https://ClinicalTrials.gov/show/NCT04373707 |
| NCT04379271 | A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator’s Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19) | https://ClinicalTrials.gov/show/NCT04379271 |
| NCT04374461 | A Study of N-acetylcysteine in Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04374461 |
| NCT04373733 | Early Intervention in COVID-19: Favipiravir Verses Standard Care | https://ClinicalTrials.gov/show/NCT04373733 |
| NCT04376788 | Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04376788 |
| NCT04374019 | Novel Agents for Treatment of High-risk COVID-19 Positive Patients | https://ClinicalTrials.gov/show/NCT04374019 |
| NCT04374591 | Home-based Treatment of Computed Tomography and Clinically Suspected Novel COVID-19 With Adjuvant Inhalable Sodium Bicarbonate: A Preliminary Case Series | https://ClinicalTrials.gov/show/NCT04374591 |
| NCT04374526 | Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression. | https://ClinicalTrials.gov/show/NCT04374526 |
| NCT04374539 | Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial | https://ClinicalTrials.gov/show/NCT04374539 |
| NCT04392531 | Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19 | https://ClinicalTrials.gov/show/NCT04392531 |
| NCT04376814 | Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19 | https://ClinicalTrials.gov/show/NCT04376814 |
| NCT04375098 | Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04375098 |
| NCT04394455 | Brief Cognitive Behavioral Therapy Versus Crisis Intervention Therapy Through Telepsychiatry on Psychiatric Symptoms | https://ClinicalTrials.gov/show/NCT04394455 |
| NCT04376593 | PET/CT Imaging in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04376593 |
| NCT04391712 | Cold Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease | https://ClinicalTrials.gov/show/NCT04391712 |
| NCT04388527 | COVID-19 Convalescent Plasma for Mechanically Ventilated Population | https://ClinicalTrials.gov/show/NCT04388527 |
| NCT04385043 | Hyperimmune Plasma in Patients With COVID-19 Severe Infection | https://ClinicalTrials.gov/show/NCT04385043 |
| NCT04380818 | Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19 | https://ClinicalTrials.gov/show/NCT04380818 |
| NCT04379336 | BCG Vaccination for Healthcare Workers in COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04379336 |
| NCT04378803 | Mindfulness Training for Seniors | https://ClinicalTrials.gov/show/NCT04378803 |
| NCT04377672 | Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04377672 |
| NCT04377659 | Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04377659 |
| NCT04377620 | Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT) | https://ClinicalTrials.gov/show/NCT04377620 |
| NCT04377477 | COVID-19 Pneumonitis Low Dose Lung Radiotherapy (COLOR-19) | https://ClinicalTrials.gov/show/NCT04377477 |
| NCT04375397 | Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury | https://ClinicalTrials.gov/show/NCT04375397 |
| NCT04376684 | Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease | https://ClinicalTrials.gov/show/NCT04376684 |
| NCT04392713 | Efficacy of Ivermectin in COVID-19 | https://ClinicalTrials.gov/show/NCT04392713 |
| NCT04389372 | Effectiveness and Acceptability of MINDFULNESS by Smartphone, for Patients With Chronic Migraine and Medication Overuse | https://ClinicalTrials.gov/show/NCT04389372 |
| NCT04383613 | Prone Positioning for Patients on General Medical Wards With COVID19 | https://ClinicalTrials.gov/show/NCT04383613 |
| NCT04381884 | Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04381884 |
| NCT04379661 | SUNLIGHT Study: Online Support Groups for MS to Address COVID-19 | https://ClinicalTrials.gov/show/NCT04379661 |
| NCT04379492 | A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19 | https://ClinicalTrials.gov/show/NCT04379492 |
| NCT04379076 | InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort | https://ClinicalTrials.gov/show/NCT04379076 |
| NCT04378920 | A Study of Trans Crocetin in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 Disease (LEAF-4L7520/4L6715) | https://ClinicalTrials.gov/show/NCT04378920 |
| NCT04377711 | A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04377711 |
| NCT04379037 | Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04379037 |
| NCT04433910 | A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04433910 |
| NCT04385901 | Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth | https://ClinicalTrials.gov/show/NCT04385901 |
| NCT04383535 | Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia | https://ClinicalTrials.gov/show/NCT04383535 |
| NCT04382768 | Inhaled Ibuprofen to Treat COVID-19 | https://ClinicalTrials.gov/show/NCT04382768 |
| NCT04382092 | Co-infection Management in COVID-19 Critically Ill | https://ClinicalTrials.gov/show/NCT04382092 |
| NCT04381858 | Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04381858 |
| NCT04380701 | A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04380701 |
| NCT04380519 | Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04380519 |
| NCT04380376 | Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia | https://ClinicalTrials.gov/show/NCT04380376 |
| NCT04390477 | Study to Evaluate the Effect of a Probiotic in COVID-19 | https://ClinicalTrials.gov/show/NCT04390477 |
| NCT04390022 | Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial | https://ClinicalTrials.gov/show/NCT04390022 |
| NCT04390139 | Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04390139 |
| NCT04384497 | Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study | https://ClinicalTrials.gov/show/NCT04384497 |
| NCT04382040 | A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19 | https://ClinicalTrials.gov/show/NCT04382040 |
| NCT04381962 | A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2) | https://ClinicalTrials.gov/show/NCT04381962 |
| NCT04381377 | Efficacy and Safety of Polyoxidonium® in Hospitalized Patients With Coronavirus Disease COVID-19 | https://ClinicalTrials.gov/show/NCT04381377 |
| NCT04380961 | A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19 | https://ClinicalTrials.gov/show/NCT04380961 |
| NCT04380909 | ROCO - Self-help for People With Psychological Distress Due to the Covid-19 Situation | https://ClinicalTrials.gov/show/NCT04380909 |
| NCT04382586 | Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants | https://ClinicalTrials.gov/show/NCT04382586 |
| NCT04381000 | Quarantine and Telerehabilitation in Chronic Pain Patients During COVID-19 Pandemic. | https://ClinicalTrials.gov/show/NCT04381000 |
| NCT04382066 | Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04382066 |
| NCT04381936 | Randomised Evaluation of COVID-19 Therapy | https://ClinicalTrials.gov/show/NCT04381936 |
| NCT04382755 | Zilucoplan® in Improving Oxygenation and Short- and Long-term Outcome of COVID-19 Patients With Acute Hypoxic Respiratory Failure | https://ClinicalTrials.gov/show/NCT04382755 |
| NCT04380688 | Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. | https://ClinicalTrials.gov/show/NCT04380688 |
| NCT04405986 | Exploring Brain Damages After COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04405986 |
| NCT04394416 | Trial of Imatinib for Hospitalized Adults With COVID-19 | https://ClinicalTrials.gov/show/NCT04394416 |
| NCT04390464 | mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R) | https://ClinicalTrials.gov/show/NCT04390464 |
| NCT04389294 | HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists | https://ClinicalTrials.gov/show/NCT04389294 |
| NCT04386694 | Photobiomodulation Therapy Combined With Static Magnetic Field in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04386694 |
| NCT04384965 | Accelerated iTBS for Depressed Patients During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04384965 |
| NCT04382729 | Neuromuscular Electrical Stimulation in Patients With COVID19 Associated Pneumonia | https://ClinicalTrials.gov/show/NCT04382729 |
| NCT04382547 | Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells | https://ClinicalTrials.gov/show/NCT04382547 |
| NCT04381988 | A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy | https://ClinicalTrials.gov/show/NCT04381988 |
| NCT04382053 | Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04382053 |
| NCT04394377 | Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial | https://ClinicalTrials.gov/show/NCT04394377 |
| NCT04400929 | Using GM-CSF as a Host Directed Therapeutic Against COVID-19 | https://ClinicalTrials.gov/show/NCT04400929 |
| NCT04382651 | Study of Efficacy and Safety of MAS825 in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04382651 |
| NCT04389333 | Feasibility of Non-contact Magnetically-controlled Capsule Endoscopy During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04389333 |
| NCT04385199 | Convalescent Plasma for Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04385199 |
| NCT04392973 | FAvipiravir and HydroxyChloroquine Combination Therapy | https://ClinicalTrials.gov/show/NCT04392973 |
| NCT04391140 | Prone Positioning and High-flow Nasal Cannula in COVID-19 Induced ARDS | https://ClinicalTrials.gov/show/NCT04391140 |
| NCT04385017 | Role of Inflammasomes in COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04385017 |
| NCT04385836 | Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | https://ClinicalTrials.gov/show/NCT04385836 |
| NCT04446104 | A Preventive Treatment for Migrant Workers at High-risk of Covid-19 | https://ClinicalTrials.gov/show/NCT04446104 |
| NCT04442191 | Convalescent Plasma as a Possible Treatment for COVID-19 | https://ClinicalTrials.gov/show/NCT04442191 |
| NCT04393636 | Digital Cardiac Counseling Trial: DCC Trial | https://ClinicalTrials.gov/show/NCT04393636 |
| NCT04388514 | Blood Ozonization in Patients With SARS-CoV-2 Respiratory Failure | https://ClinicalTrials.gov/show/NCT04388514 |
| NCT04387409 | Study to Assess VPM1002 in Reducing Healthcare Professionals’ Absenteeism in COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04387409 |
| NCT04386850 | Oral 25-hydroxyvitamin D3 and COVID-19 | https://ClinicalTrials.gov/show/NCT04386850 |
| NCT04384900 | Accelerated Prone Position Ventilation of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04384900 |
| NCT04386291 | Meditation and Kundalini Yoga for Heightened Anxiety Related to COVID-19 | https://ClinicalTrials.gov/show/NCT04386291 |
| NCT04386616 | A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04386616 |
| NCT04412330 | Optimizing Outcomes With Physical Therapy Treatment for IndividuALs Surviving an ICU Admission for Covid-19 | https://ClinicalTrials.gov/show/NCT04412330 |
| NCT04387253 | Study of Late Fetal Loss in Poitou-Charentes. GYNE-COVID | https://ClinicalTrials.gov/show/NCT04387253 |
| NCT04391127 | Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04391127 |
| NCT04390191 | Early CPAP in COVID-19 Confirmed or Suspected Patients | https://ClinicalTrials.gov/show/NCT04390191 |
| NCT04389944 | Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04389944 |
| NCT04389385 | COVID-19 Specific T Cell Derived Exosomes (CSTC-Exo) | https://ClinicalTrials.gov/show/NCT04389385 |
| NCT04400838 | Investigating a Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04400838 |
| NCT04387292 | Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic | https://ClinicalTrials.gov/show/NCT04387292 |
| NCT04386668 | Let It Out (LIO) and COVID19: Testing an Online Emotional Disclosure-based Intervention During the COVID19 Pandemic | https://ClinicalTrials.gov/show/NCT04386668 |
| NCT04392414 | Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04392414 |
| NCT04390412 | Low Dose Radiotherapy in COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04390412 |
| NCT04389840 | Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure | https://ClinicalTrials.gov/show/NCT04389840 |
| NCT04388826 | COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111 | https://ClinicalTrials.gov/show/NCT04388826 |
| NCT04388683 | Inhaled Nitric Oxide for Preventing Progression in COVID-19 | https://ClinicalTrials.gov/show/NCT04388683 |
| NCT04416919 | Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment | https://ClinicalTrials.gov/show/NCT04416919 |
| NCT04405076 | Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older | https://ClinicalTrials.gov/show/NCT04405076 |
| NCT04420390 | Low Dose Radiotherapy for COVID-19 Pneumonitis | https://ClinicalTrials.gov/show/NCT04420390 |
| NCT04390516 | Respiratory Decompensation and Model for the Triage of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04390516 |
| NCT04390503 | Convalescent Plasma for COVID-19 Close Contacts | https://ClinicalTrials.gov/show/NCT04390503 |
| NCT04389450 | Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04389450 |
| NCT04397718 | Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization | https://ClinicalTrials.gov/show/NCT04397718 |
| NCT04395144 | COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss | https://ClinicalTrials.gov/show/NCT04395144 |
| NCT04394182 | Ultra Low Doses of Therapy With Radiation Applicated to COVID-19 | https://ClinicalTrials.gov/show/NCT04394182 |
| NCT04393948 | Lung Irradiation for COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04393948 |
| NCT04392323 | Incidence of COVID-19 Test Conversion in Post-surgical Patients | https://ClinicalTrials.gov/show/NCT04392323 |
| NCT04392232 | A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection | https://ClinicalTrials.gov/show/NCT04392232 |
| NCT04392141 | Colchicine Plus Phenolic Monoterpenes to Treat COVID-19 | https://ClinicalTrials.gov/show/NCT04392141 |
| NCT04391179 | Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19 | https://ClinicalTrials.gov/show/NCT04391179 |
| NCT04395105 | Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial | https://ClinicalTrials.gov/show/NCT04395105 |
| NCT04393727 | Transfusion of Convalescent Plasma for the Early Treatment of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04393727 |
| NCT04407208 | Convalescent Plasma Therapy in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04407208 |
| NCT04396106 | Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04396106 |
| NCT04393246 | mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms | https://ClinicalTrials.gov/show/NCT04393246 |
| NCT04407130 | Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection. | https://ClinicalTrials.gov/show/NCT04407130 |
| NCT04398004 | Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early | https://ClinicalTrials.gov/show/NCT04398004 |
| NCT04394793 | Low Dose Radiation Therapy for Covid-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04394793 |
| NCT04394442 | Hydroxychloroquine in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04394442 |
| NCT04405999 | Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease | https://ClinicalTrials.gov/show/NCT04405999 |
| NCT04403269 | NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER, COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE | https://ClinicalTrials.gov/show/NCT04403269 |
| NCT04402918 | Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy | https://ClinicalTrials.gov/show/NCT04402918 |
| NCT04399317 | Flow Controlled Ventilation in ARDS Associated With COVID-19 | https://ClinicalTrials.gov/show/NCT04399317 |
| NCT04395807 | Helmet CPAP Versus HFNC in COVID-19 | https://ClinicalTrials.gov/show/NCT04395807 |
| NCT04394117 | Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease | https://ClinicalTrials.gov/show/NCT04394117 |
| NCT04393792 | SINUS WASH Pilot Study in Adults Testing Positive for COVID-19 | https://ClinicalTrials.gov/show/NCT04393792 |
| NCT04393038 | ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04393038 |
| NCT04416360 | Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak | https://ClinicalTrials.gov/show/NCT04416360 |
| NCT04407286 | Vitamin D Testing and Treatment for COVID 19 | https://ClinicalTrials.gov/show/NCT04407286 |
| NCT04402203 | Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh | https://ClinicalTrials.gov/show/NCT04402203 |
| NCT04399746 | Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19 | https://ClinicalTrials.gov/show/NCT04399746 |
| NCT04399005 | The Efficacy Comparing Daily and After-each-case Room Disinfection. | https://ClinicalTrials.gov/show/NCT04399005 |
| NCT04397562 | A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04397562 |
| NCT04397510 | Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury | https://ClinicalTrials.gov/show/NCT04397510 |
| NCT04399252 | Effect of Lactobacillus on the Microbiome of Household Contacts Exposed to COVID-19 | https://ClinicalTrials.gov/show/NCT04399252 |
| NCT04399967 | COVID-19 Brief Advice and Chat-based Support for Smoking Cessation Via “Quit to Win” Contest 2020 | https://ClinicalTrials.gov/show/NCT04399967 |
| NCT04397757 | COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2. | https://ClinicalTrials.gov/show/NCT04397757 |
| NCT04397692 | Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial) | https://ClinicalTrials.gov/show/NCT04397692 |
| NCT04441684 | Seroprevalence of SARS-CoV-2 in Strasbourg University Hospital, Strasbourg, France (COVID-19) | https://ClinicalTrials.gov/show/NCT04441684 |
| NCT04403477 | Convalescent Plasma Therapy in Severe COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04403477 |
| NCT04402970 | Dornase Alfa for ARDS in Patients With SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04402970 |
| NCT04401293 | Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04401293 |
| NCT04398277 | A Daily Coping Toolkit for Medical Personnel and First-Responders During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04398277 |
| NCT04397666 | RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19 | https://ClinicalTrials.gov/show/NCT04397666 |
| NCT04397523 | Efficacy and Safety of COVID-19 Convalescent Plasma | https://ClinicalTrials.gov/show/NCT04397523 |
| NCT04413006 | Self-compassion for Chronic Pain Virtual Group Treatment Program | https://ClinicalTrials.gov/show/NCT04413006 |
| NCT04412538 | Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 | https://ClinicalTrials.gov/show/NCT04412538 |
| NCT04410549 | Pulmonary Optical Coherence Tomography in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04410549 |
| NCT04401202 | Nigella Sativa in COVID-19 | https://ClinicalTrials.gov/show/NCT04401202 |
| NCT04400305 | “Increasing Physical Activity in Canadian Adults Who Have Been Affected by COVID-19 Social Distancing Restrictions: A Feasibility Trial of an Online Intervention” | https://ClinicalTrials.gov/show/NCT04400305 |
| NCT04399980 | Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation | https://ClinicalTrials.gov/show/NCT04399980 |
| NCT04399889 | hCT-MSCs for COVID19 ARDS | https://ClinicalTrials.gov/show/NCT04399889 |
| NCT04399681 | The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19 | https://ClinicalTrials.gov/show/NCT04399681 |
| NCT04399109 | Evaluation of a Remote Monitoring Smartphone Application and Care Model of COVID-19 Patients in the Community (ReCOVER) | https://ClinicalTrials.gov/show/NCT04399109 |
| NCT04400058 | Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression | https://ClinicalTrials.gov/show/NCT04400058 |
| NCT04411602 | Feasibility Study of Anti-SARS-CoV-2 Plasma Transfusions in COVID-19 Patients With SRD | https://ClinicalTrials.gov/show/NCT04411602 |
| NCT04410016 | Evaluation of Staff COVID-19 Wellbeing Centres in a Healthcare Workplace: COVID-WELL Study | https://ClinicalTrials.gov/show/NCT04410016 |
| NCT04408183 | GLS-1200Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19) in Health Care Personnel | https://ClinicalTrials.gov/show/NCT04408183 |
| NCT04407390 | Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly | https://ClinicalTrials.gov/show/NCT04407390 |
| NCT04402983 | The Effectiveness of Telerehabilitation-Based Physiotherapy in COVID 19 Patients | https://ClinicalTrials.gov/show/NCT04402983 |
| NCT04402879 | CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals | https://ClinicalTrials.gov/show/NCT04402879 |
| NCT04402866 | TD-0903 for ALI Associated With COVID-19 | https://ClinicalTrials.gov/show/NCT04402866 |
| NCT04402840 | Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS) | https://ClinicalTrials.gov/show/NCT04402840 |
| NCT04402060 | A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04402060 |
| NCT04404361 | PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer | https://ClinicalTrials.gov/show/NCT04404361 |
| NCT04401579 | Adaptive COVID-19 Treatment Trial 2 (ACTT-II) | https://ClinicalTrials.gov/show/NCT04401579 |
| NCT04411433 | Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04411433 |
| NCT04406493 | Monitoring COVID-19 Patients’ Lung Fluid Using Impedance Technique | https://ClinicalTrials.gov/show/NCT04406493 |
| NCT04403100 | Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: “The Hope Coalition - 1” | https://ClinicalTrials.gov/show/NCT04403100 |
| NCT04429711 | Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04429711 |
| NCT04412356 | Timing of Tracheotomy in Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04412356 |
| NCT04408456 | Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19 | https://ClinicalTrials.gov/show/NCT04408456 |
| NCT04406246 | Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide | https://ClinicalTrials.gov/show/NCT04406246 |
| NCT04403685 | Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers | https://ClinicalTrials.gov/show/NCT04403685 |
| NCT04417335 | Reducing COVID-19 Related Hospital Admission in Elderly by BCG Vaccination | https://ClinicalTrials.gov/show/NCT04417335 |
| NCT04408209 | Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04408209 |
| NCT04407182 | Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19 | https://ClinicalTrials.gov/show/NCT04407182 |
| NCT04405908 | SCB-2019 as COVID-19 Vaccine | https://ClinicalTrials.gov/show/NCT04405908 |
| NCT04430608 | Remote Continues Glucose Monitoring During the COVID-19 Pandemic in Quarantined Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04430608 |
| NCT04410562 | Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy | https://ClinicalTrials.gov/show/NCT04410562 |
| NCT04409496 | Chat-based Support for Preveting Smoking Relapse | https://ClinicalTrials.gov/show/NCT04409496 |
| NCT04405570 | A Safety, Tolerability and Efficacy of EIDD-2801 to Eliminate Infectious Virus Detection in Persons With COVID-19 | https://ClinicalTrials.gov/show/NCT04405570 |
| NCT04405544 | Determination of Acute Encephalopathy Predictors in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04405544 |
| NCT04405310 | Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial | https://ClinicalTrials.gov/show/NCT04405310 |
| NCT04405739 | The Safety of EIDD-2801 and Its Effect on Viral Shedding of SARS-CoV-2 (The END-COVID Study) | https://ClinicalTrials.gov/show/NCT04405739 |
| NCT04414618 | A Study of Opaganib in Coronavirus Disease 2019 Pneumonia | https://ClinicalTrials.gov/show/NCT04414618 |
| NCT04410692 | Can the Prediction Market Improve Predictions of COVID-19? | https://ClinicalTrials.gov/show/NCT04410692 |
| NCT04410159 | Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04410159 |
| NCT04407689 | InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort | https://ClinicalTrials.gov/show/NCT04407689 |
| NCT04444271 | Mesenchymal Stem Cell Infusion for COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04444271 |
| NCT04457609 | Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04457609 |
| NCT04416308 | COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne (AntiCoV-HB) | https://ClinicalTrials.gov/show/NCT04416308 |
| NCT04409743 | Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04409743 |
| NCT04409522 | Evaluation of Therapeutic Effects of Melatonin by Inhibition of NLRP3 Inflammasome in COVID19 Patients | https://ClinicalTrials.gov/show/NCT04409522 |
| NCT04409327 | Phase 3 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes | https://ClinicalTrials.gov/show/NCT04409327 |
| NCT04409262 | A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04409262 |
| NCT04408131 | Morbi-mortality by COVID-19 Among Homeless People in Marseille: a Cohort Study | https://ClinicalTrials.gov/show/NCT04408131 |
| NCT04417257 | Study of LAU-7b for the Treatment of COVID-19 Disease in Adults | https://ClinicalTrials.gov/show/NCT04417257 |
| NCT04412486 | COVID-19 Convalescent Plasma (CCP) Transfusion | https://ClinicalTrials.gov/show/NCT04412486 |
| NCT04433546 | PB1046, a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS). | https://ClinicalTrials.gov/show/NCT04433546 |
| NCT04409509 | Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID‑19) | https://ClinicalTrials.gov/show/NCT04409509 |
| NCT04427098 | Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04427098 |
| NCT04424901 | Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04424901 |
| NCT04415073 | A Phase 2 Study to Evaluate Axatilimab for Hospitalized Patients With Respiratory Involvement Secondary to COVID-19 | https://ClinicalTrials.gov/show/NCT04415073 |
| NCT04412343 | The Seniors COvid-19 Pandemic and Exercise Study | https://ClinicalTrials.gov/show/NCT04412343 |
| NCT04412057 | Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury | https://ClinicalTrials.gov/show/NCT04412057 |
| NCT04412018 | An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19 | https://ClinicalTrials.gov/show/NCT04412018 |
| NCT04411667 | Study of Standard of Care Plus Intravenous Immunoglobulin (IVIG) Compared to Standard of Care Alone in the Treatment of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04411667 |
| NCT04410458 | Recruit Blood Donors Via SMS During Epidemic of COVID-19 （Repeat Trial） | https://ClinicalTrials.gov/show/NCT04410458 |
| NCT04411628 | A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19 | https://ClinicalTrials.gov/show/NCT04411628 |
| NCT04416139 | Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19 | https://ClinicalTrials.gov/show/NCT04416139 |
| NCT04412239 | To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04412239 |
| NCT04414371 | Tools for Wellbeing COVID-19 National Study of Undergraduate Students | https://ClinicalTrials.gov/show/NCT04414371 |
| NCT04415086 | Treatment of Patients With COVID-19 With Convalescent Plasma | https://ClinicalTrials.gov/show/NCT04415086 |
| NCT04414267 | Bacillus Calmette-guérin Vaccination to Prevent COVID-19 | https://ClinicalTrials.gov/show/NCT04414267 |
| NCT04414124 | A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04414124 |
| NCT04412772 | A RCT - Safety & Efficacy of Tocilizumab - Tx of Severe COVID-19: ARCHITECTS | https://ClinicalTrials.gov/show/NCT04412772 |
| NCT04412668 | Study to Evaluate the Safety and Efficacy of ATYR1923 In Patients With Severe Pneumonia Related to COVID-19 | https://ClinicalTrials.gov/show/NCT04412668 |
| NCT04412291 | A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study | https://ClinicalTrials.gov/show/NCT04412291 |
| NCT04412785 | Cyclosporine in Patients With Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04412785 |
| NCT04417270 | Reliability of the Freestyle Libre CGM in the Inpatient Setting During the COVID-19 Surge | https://ClinicalTrials.gov/show/NCT04417270 |
| NCT04420247 | Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19 | https://ClinicalTrials.gov/show/NCT04420247 |
| NCT04413968 | COVID-19 Infection and Transmission in Exposed, Confined and Community-based Infants | https://ClinicalTrials.gov/show/NCT04413968 |
| NCT04426305 | Community Health Workers Against COVID19 | https://ClinicalTrials.gov/show/NCT04426305 |
| NCT04425616 | SafeFit Trial: Virtual Clinics to Deliver Universal Interventions in People With Cancer | https://ClinicalTrials.gov/show/NCT04425616 |
| NCT04421404 | Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04421404 |
| NCT04416334 | PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 70 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS | https://ClinicalTrials.gov/show/NCT04416334 |
| NCT04453852 | Monovalent Recombinant COVID19 Vaccine | https://ClinicalTrials.gov/show/NCT04453852 |
| NCT04418518 | A Trial of CONvalescent Plasma for Hospitalized Adults With Acute COVID-19 Respiratory Illness | https://ClinicalTrials.gov/show/NCT04418518 |
| NCT04435808 | Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19 | https://ClinicalTrials.gov/show/NCT04435808 |
| NCT04424212 | ICBT for Mental Health Problems Related to the Coronavirus Pandemic | https://ClinicalTrials.gov/show/NCT04424212 |
| NCT04421391 | QuadraMune(TM) for Prevention of COVID-19 | https://ClinicalTrials.gov/show/NCT04421391 |
| NCT04420741 | Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure | https://ClinicalTrials.gov/show/NCT04420741 |
| NCT04424797 | Prone Positioning on Admission for Hospitalized COVID-19 Pneumonia Protocol | https://ClinicalTrials.gov/show/NCT04424797 |
| NCT04422613 | Characterization of Persistent Pulmonary Abnormalities Following COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04422613 |
| NCT04421664 | Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada) | https://ClinicalTrials.gov/show/NCT04421664 |
| NCT04420806 | Effects of COVID-19 Lockdown in Exercising Early Postmenopausal Women | https://ClinicalTrials.gov/show/NCT04420806 |
| NCT04420338 | SeroCOVIDial Study: Assessment of COVID-19 Seroconversion in Patients on Chronic Hemodialysis and in Their Caregivers, a Cohort Study | https://ClinicalTrials.gov/show/NCT04420338 |
| NCT04420299 | Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19 | https://ClinicalTrials.gov/show/NCT04420299 |
| NCT04427566 | Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise | https://ClinicalTrials.gov/show/NCT04427566 |
| NCT04421027 | A Study of Baricitinib (LY3009104) in Participants With COVID-19 | https://ClinicalTrials.gov/show/NCT04421027 |
| NCT04441918 | Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects | https://ClinicalTrials.gov/show/NCT04441918 |
| NCT04423289 | Telematic Monitoring Through a Mobile Application of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04423289 |
| NCT04422561 | Prophylactic Ivermectin in COVID-19 Contacts | https://ClinicalTrials.gov/show/NCT04422561 |
| NCT04425915 | Efficacy of Convalescent Plasma Therapy in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04425915 |
| NCT04424082 | External Dead Space in Ventilated COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04424082 |
| NCT04422353 | Video Dance Class and Unsupervised Physical Activity During Covid-19 Pandemic in People With Parkinson’s Disease | https://ClinicalTrials.gov/show/NCT04422353 |
| NCT04425707 | Ivermectin In Treatment of COVID 19 Patients | https://ClinicalTrials.gov/show/NCT04425707 |
| NCT04426695 | Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04426695 |
| NCT04426292 | SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel During the 2020 COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04426292 |
| NCT04425629 | Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04425629 |
| NCT04425538 | A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19). | https://ClinicalTrials.gov/show/NCT04425538 |
| NCT04425005 | Home-based Exercise Training During Covid-19 Pandemic in Post-bariatric | https://ClinicalTrials.gov/show/NCT04425005 |
| NCT04423991 | Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning | https://ClinicalTrials.gov/show/NCT04423991 |
| NCT04445246 | Inhaled Iloprost for Suspected COVID-19 Respiratory Failure | https://ClinicalTrials.gov/show/NCT04445246 |
| NCT04434131 | Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19 | https://ClinicalTrials.gov/show/NCT04434131 |
| NCT04429854 | Donated Antibodies Working Against nCoV | https://ClinicalTrials.gov/show/NCT04429854 |
| NCT04428099 | Healthy Lifestyle Promotion as Adjunctive Teletherapy for Treatment-resistant Major Depression | https://ClinicalTrials.gov/show/NCT04428099 |
| NCT04425252 | Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04425252 |
| NCT04426318 | COVID-19 and the Healthy Minds Program for Educators | https://ClinicalTrials.gov/show/NCT04426318 |
| NCT04458948 | Open Label Non-comparative Trial of the Combination of Hydroxychloroquine and Azithromycin in the Treatment of Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04458948 |
| NCT04427501 | A Study of LY3819253 (LY-CoV555) in Participants With Early Mild to Moderate COVID-19 Illness | https://ClinicalTrials.gov/show/NCT04427501 |
| NCT04429867 | Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease | https://ClinicalTrials.gov/show/NCT04429867 |
| NCT04427137 | Accelerated LFR for Bipolar Patients During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04427137 |
| NCT04435717 | Efficacy of Tocilizumab in Modifying the Inflammatory Parameters of Patients With COVID-19 (COVITOZ-01) | https://ClinicalTrials.gov/show/NCT04435717 |
| NCT04432051 | The Use of Lung Ultrasonography in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04432051 |
| NCT04441424 | Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients | https://ClinicalTrials.gov/show/NCT04441424 |
| NCT04433949 | Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04433949 |
| NCT04432298 | Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Patients With Acute COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04432298 |
| NCT04431180 | Recruit Blood Donors Via SMS During Epidemic of COVID-19 #Second Repeat Trial# | https://ClinicalTrials.gov/show/NCT04431180 |
| NCT04462757 | SCIL-1Ra in COVID-19 Feasibility & PK/PD | https://ClinicalTrials.gov/show/NCT04462757 |
| NCT04431856 | CO-PARENT: COVID-19 - Parent Action in Response to Emotions and Needs for Treatment | https://ClinicalTrials.gov/show/NCT04431856 |
| NCT04445272 | Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04445272 |
| NCT04434248 | An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04434248 |
| NCT04435353 | Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19 | https://ClinicalTrials.gov/show/NCT04435353 |
| NCT04432987 | Dornase Alpha for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04432987 |
| NCT04432805 | Descriptive and Evaluation Study of the Use of Pulmonary Ultrasound in the Initial Management of Pregnant Women in the Context of COVID-19 | https://ClinicalTrials.gov/show/NCT04432805 |
| NCT04444674 | COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection | https://ClinicalTrials.gov/show/NCT04444674 |
| NCT04438694 | Use of Convalescent Plasma for Treatment of Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04438694 |
| NCT04449718 | Vitamin D Supplementation in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04449718 |
| NCT04445194 | Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine | https://ClinicalTrials.gov/show/NCT04445194 |
| NCT04437875 | An Open Study of the Safety, Tolerability and Immunogenicity of “Gam-COVID-Vac Lyo” Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04437875 |
| NCT04436471 | An Open Study of the Safety, Tolerability and Immunogenicity of the Drug “Gam-COVID-Vac” Vaccine Against COVID-19 | https://ClinicalTrials.gov/show/NCT04436471 |
| NCT04435379 | Study to Assess VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04435379 |
| NCT04438070 | COVID Screening Strategies in Homeless Shelters | https://ClinicalTrials.gov/show/NCT04438070 |
| NCT04437823 | Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04437823 |
| NCT04442958 | Effectiveness of Convalescent Immune Plasma Therapy | https://ClinicalTrials.gov/show/NCT04442958 |
| NCT04444596 | Conjunctival Swab vs Nasopharyngeal Swab in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04444596 |
| NCT04443881 | Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS) | https://ClinicalTrials.gov/show/NCT04443881 |
| NCT04443673 | Glycine Supplement for Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04443673 |
| NCT04441632 | Effect of Positive Attitudes on Behavior and Wellness | https://ClinicalTrials.gov/show/NCT04441632 |
| NCT04438980 | Glucocorticoids in COVID-19 (CORTIVID) | https://ClinicalTrials.gov/show/NCT04438980 |
| NCT04449276 | A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults | https://ClinicalTrials.gov/show/NCT04449276 |
| NCT04441385 | Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19). | https://ClinicalTrials.gov/show/NCT04441385 |
| NCT04445454 | Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04445454 |
| NCT04445389 | Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults | https://ClinicalTrials.gov/show/NCT04445389 |
| NCT04445311 | Ivermectin in Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04445311 |
| NCT04442152 | Impact of COVID-19 on Family Dynamics on Bandebereho Study Participants | https://ClinicalTrials.gov/show/NCT04442152 |
| NCT04445597 | Unraveling the Mechanisms of Olfactory Dysfunction in COVID-19 | https://ClinicalTrials.gov/show/NCT04445597 |
| NCT04444700 | A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04444700 |
| NCT04445285 | Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure | https://ClinicalTrials.gov/show/NCT04445285 |
| NCT04445376 | Effect of Physical Therapy Exercises on Cardiorespiratory Fitness Level in COVID19 Patients After Recovery. | https://ClinicalTrials.gov/show/NCT04445376 |
| NCT04447534 | Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04447534 |
| NCT04447404 | DUR-928 in Subjects With SARS-CoV-2 With Acute Liver or Kidney Injury | https://ClinicalTrials.gov/show/NCT04447404 |
| NCT04445935 | Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial | https://ClinicalTrials.gov/show/NCT04445935 |
| NCT04456361 | Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19 | https://ClinicalTrials.gov/show/NCT04456361 |
| NCT04448769 | Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19) | https://ClinicalTrials.gov/show/NCT04448769 |
| NCT04458363 | Convalescent Plasma in Pediatric COVID-19 | https://ClinicalTrials.gov/show/NCT04458363 |
| NCT04449588 | Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS | https://ClinicalTrials.gov/show/NCT04449588 |
| NCT04454606 | The New Silicone N99 Half-Piece Respirator | https://ClinicalTrials.gov/show/NCT04454606 |
| NCT04452565 | NA-83, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04452565 |
| NCT04464486 | Remote COVID-19 Symptom Tracking for Cancer Patients at Home During the Pandemic | https://ClinicalTrials.gov/show/NCT04464486 |
| NCT04463264 | Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04463264 |
| NCT04452435 | Safety and Efficacy of C21 in Subjects With COVID-19 | https://ClinicalTrials.gov/show/NCT04452435 |
| NCT04451889 | Probe-based Confocal Laser Endomicroscopy in Critically Ill COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04451889 |
| NCT04458298 | A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients | https://ClinicalTrials.gov/show/NCT04458298 |
| NCT04457388 | Tele-Yoga Therapy for Chronic Pain | https://ClinicalTrials.gov/show/NCT04457388 |
| NCT04460027 | W-SUDs for COVID-19 | https://ClinicalTrials.gov/show/NCT04460027 |
| NCT04458246 | Home-based Aerobic Training Among Adolescents With Chronic Diseases During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04458246 |
| NCT04461925 | Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs | https://ClinicalTrials.gov/show/NCT04461925 |
| NCT04460534 | Detection of COVID-19 (SARS-CoV-2) in the Semen of COVID+ Patients (Positive RT-PCR on a Nasopharyngeal Swab) | https://ClinicalTrials.gov/show/NCT04460534 |
| NCT04457726 | Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04457726 |
| NCT04465604 | Hypertonic Saline for COVID-19 Symptoms | https://ClinicalTrials.gov/show/NCT04465604 |
| NCT04463849 | Effects of COVID-19 Infection on Beta-cell Function in Euglycemic Patients | https://ClinicalTrials.gov/show/NCT04463849 |
| NCT04459247 | Short Term, High Dose Vitamin D Supplementation for COVID-19 | https://ClinicalTrials.gov/show/NCT04459247 |
| NCT04459962 | Covid-19 Breath Test | https://ClinicalTrials.gov/show/NCT04459962 |
| NCT04459325 | Tigerase® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04459325 |
| NCT04466540 | Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04466540 |
| NCT04463420 | Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04463420 |
| NCT04464395 | Study of CPI-006 as Immunotherapy for Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04464395 |
| NCT04463004 | Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation | https://ClinicalTrials.gov/show/NCT04463004 |
| NCT04462627 | Reduction of COVID 19 Transmission to Health Care Professionals | https://ClinicalTrials.gov/show/NCT04462627 |
| NCT04466670 | Hemostasis in COVID-19: an Adaptive Clinical Trial | https://ClinicalTrials.gov/show/NCT04466670 |
| NCT04463472 | Study of COVID-19 DNA Vaccine (AG0301-COVID19) | https://ClinicalTrials.gov/show/NCT04463472 |
| NCT04466605 | Effect of Tele-Yoga Therapy on Patients With Chronic Musculoskeletal Pain During Covid-19 Lockdown | https://ClinicalTrials.gov/show/NCT04466605 |
| NCT04466280 | Efficacy and Safety of Mucoadhesive Sustained Release, Mucodentol, in Comparison With Hydroxychloroquine to Prevent COVID-19 | https://ClinicalTrials.gov/show/NCT04466280 |
| NCT04465695 | An Open-label Trial on Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19 | https://ClinicalTrials.gov/show/NCT04465695 |
Observational Studies
| nct_id | brief_title | link |
|---|---|---|
| NCT04245631 | Development of a Simple, Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV | https://ClinicalTrials.gov/show/NCT04245631 |
| NCT04256395 | Efficacy of a Self-test and Self-alert Mobile Applet in Detecting Susceptible Infection of COVID-19 | https://ClinicalTrials.gov/show/NCT04256395 |
| NCT04260308 | A Survey of Psychological Status of Medical Workers and Residents in the Context of 2019 Novel Coronavirus Pneumonia | https://ClinicalTrials.gov/show/NCT04260308 |
| NCT04255940 | 2019-nCoV Outbreak and Cardiovascular Diseases | https://ClinicalTrials.gov/show/NCT04255940 |
| NCT04259892 | Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19. | https://ClinicalTrials.gov/show/NCT04259892 |
| NCT04283396 | Study for Novel Coronavirus Pneumonia (NCP) | https://ClinicalTrials.gov/show/NCT04283396 |
| NCT04279782 | Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection | https://ClinicalTrials.gov/show/NCT04279782 |
| NCT04274322 | Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool | https://ClinicalTrials.gov/show/NCT04274322 |
| NCT04275947 | The COVID-19 Mobile Health Study (CMHS) | https://ClinicalTrials.gov/show/NCT04275947 |
| NCT04279899 | The Investigation of the Neonates With or With Risk of COVID-19 | https://ClinicalTrials.gov/show/NCT04279899 |
| NCT04279795 | Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations | https://ClinicalTrials.gov/show/NCT04279795 |
| NCT04284046 | CT Scores Predict Mortality in 2019-nCoV Pneumonia | https://ClinicalTrials.gov/show/NCT04284046 |
| NCT04292327 | Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus | https://ClinicalTrials.gov/show/NCT04292327 |
| NCT04285801 | Critically Ill Patients With COVID-19 in Hong Kong: a Multicentre Observational Cohort Study | https://ClinicalTrials.gov/show/NCT04285801 |
| NCT04292340 | Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04292340 |
| NCT04290780 | COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus | https://ClinicalTrials.gov/show/NCT04290780 |
| NCT04306497 | TCM Differentiation and Treatment Protocol of COVID-19 | https://ClinicalTrials.gov/show/NCT04306497 |
| NCT04292964 | Prognostic Factors of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04292964 |
| NCT04312464 | Myocardial Damage in COVID-19 | https://ClinicalTrials.gov/show/NCT04312464 |
| NCT04302688 | Accurate Classification System for Patients With COVID-19 Pneumonitis | https://ClinicalTrials.gov/show/NCT04302688 |
| NCT04306705 | Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19 | https://ClinicalTrials.gov/show/NCT04306705 |
| NCT04307459 | Acute Respiratory Failure and COVID-19 in Real Life | https://ClinicalTrials.gov/show/NCT04307459 |
| NCT04316884 | Mechanisms for Organ Dysfunction in Covid-19 | https://ClinicalTrials.gov/show/NCT04316884 |
| NCT04312100 | Sequential Oxygen Therapy Strategy for Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04312100 |
| NCT04319315 | Social Media Effect on Knowledge Dissemination During COVID-19 Virus Outbreak | https://ClinicalTrials.gov/show/NCT04319315 |
| NCT04316299 | Acute Kidney Injury in Patients Hospitalized With COVID-19 | https://ClinicalTrials.gov/show/NCT04316299 |
| NCT04314817 | Adverse Events Related to Treatments Used Against Coronavirus Disease 2019 | https://ClinicalTrials.gov/show/NCT04314817 |
| NCT04314232 | Mechanisms for Covid-19 Disease Complications | https://ClinicalTrials.gov/show/NCT04314232 |
| NCT04313946 | Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays | https://ClinicalTrials.gov/show/NCT04313946 |
| NCT04347369 | A Retrospective Study of Neural Network Model to Dynamically Quantificate the Severity in COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04347369 |
| NCT04321265 | Outcomes and Prognostic Factors in COVID-19 | https://ClinicalTrials.gov/show/NCT04321265 |
| NCT04318366 | COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor | https://ClinicalTrials.gov/show/NCT04318366 |
| NCT04316949 | Predictors of Respiratory Failure in SARS-Cov-2 Infection | https://ClinicalTrials.gov/show/NCT04316949 |
| NCT04320017 | Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19 | https://ClinicalTrials.gov/show/NCT04320017 |
| NCT04318301 | Hypertension in Patients Hospitalized With COVID-19 | https://ClinicalTrials.gov/show/NCT04318301 |
| NCT04319172 | Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant Recipients | https://ClinicalTrials.gov/show/NCT04319172 |
| NCT04322513 | Biomarkers for Identification of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04322513 |
| NCT04322487 | Simple, Safe, Same: Lung Ultrasound for COVID-19 | https://ClinicalTrials.gov/show/NCT04322487 |
| NCT04321369 | Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals | https://ClinicalTrials.gov/show/NCT04321369 |
| NCT04320732 | Risk Factors for Community- and Workplace Transmission of COVID-19 | https://ClinicalTrials.gov/show/NCT04320732 |
| NCT04320511 | Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2 | https://ClinicalTrials.gov/show/NCT04320511 |
| NCT04325919 | Coronavirus Disease 2019 (COVID-19) Study of Hospitalized Patients in Hong Kong | https://ClinicalTrials.gov/show/NCT04325919 |
| NCT04323787 | Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry | https://ClinicalTrials.gov/show/NCT04323787 |
| NCT04322279 | Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. COVID19. | https://ClinicalTrials.gov/show/NCT04322279 |
| NCT04322188 | An Observational Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications | https://ClinicalTrials.gov/show/NCT04322188 |
| NCT04327180 | PREdiction of DIagnosed Covid-19 infecTion in IUC Patients | https://ClinicalTrials.gov/show/NCT04327180 |
| NCT04324684 | Prognostic Factors Keeping Track for COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04324684 |
| NCT04324047 | Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04324047 |
| NCT04323644 | Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg) | https://ClinicalTrials.gov/show/NCT04323644 |
| NCT04324736 | “COVID-19 and Diabetes Outcomes” | https://ClinicalTrials.gov/show/NCT04324736 |
| NCT04332913 | Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related Pneumonia | https://ClinicalTrials.gov/show/NCT04332913 |
| NCT04327804 | A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research | https://ClinicalTrials.gov/show/NCT04327804 |
| NCT04326725 | Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia | https://ClinicalTrials.gov/show/NCT04326725 |
| NCT04326387 | Evaluation of Novel Diagnostic Tests for COVID-19 | https://ClinicalTrials.gov/show/NCT04326387 |
| NCT04325646 | Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in France | https://ClinicalTrials.gov/show/NCT04325646 |
| NCT04331106 | Survey of the Anxiety Associated With the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04331106 |
| NCT04328454 | Clinical Characteristics and Prognostic Factors of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04328454 |
| NCT04327531 | Evaluation of Covid 19 Knowledge Anxiety and Expectation Levels of Turkish Physicians, Survey Study | https://ClinicalTrials.gov/show/NCT04327531 |
| NCT04329546 | Understanding COVID-19 | https://ClinicalTrials.gov/show/NCT04329546 |
| NCT04336384 | Impact of Covid-19 in Congenital Heart Disease | https://ClinicalTrials.gov/show/NCT04336384 |
| NCT04332016 | COVID-19 Biological Samples Collection | https://ClinicalTrials.gov/show/NCT04332016 |
| NCT04330261 | Clinical Characteristics and Outcomes of Pediatric COVID-19 | https://ClinicalTrials.gov/show/NCT04330261 |
| NCT04330521 | Impact of the Coronavirus (COVID-19) on Patients With Cancer | https://ClinicalTrials.gov/show/NCT04330521 |
| NCT04337983 | Hemodynamic Characteristics of Patients With SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04337983 |
| NCT04340219 | Oncology-patient-reported Anxiety, Mood, and QoL During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04340219 |
| NCT04335188 | COVID-19 Registry Rhineland-Palatinate (Germany) | https://ClinicalTrials.gov/show/NCT04335188 |
| NCT04331886 | An Observational Study of Patients With Coronavirus Disease 2019 | https://ClinicalTrials.gov/show/NCT04331886 |
| NCT04331509 | COVID-19 Symptom Tracker | https://ClinicalTrials.gov/show/NCT04331509 |
| NCT04333862 | Assessment of Covid-19 Infection Rates in Healthcare Workers Using a Desynchronization Strategy | https://ClinicalTrials.gov/show/NCT04333862 |
| NCT04333849 | Telephony Or Videophony for Isolated elDerly in Maine-Et-Loire 49 During COVID-19 | https://ClinicalTrials.gov/show/NCT04333849 |
| NCT04335630 | Cardiovascular Manifestations of COVID-19 | https://ClinicalTrials.gov/show/NCT04335630 |
| NCT04336215 | Rutgers COVID-19 Cohort Study | https://ClinicalTrials.gov/show/NCT04336215 |
| NCT04334252 | Descriptive Study Regarding Ambulant Screening During COVID-19 Pandemia | https://ClinicalTrials.gov/show/NCT04334252 |
| NCT04344925 | Non Invasive Positive Pressure Ventilation to Minimize Aerosolization for COVID 19 | https://ClinicalTrials.gov/show/NCT04344925 |
| NCT04340921 | The Role of Adaptive Immunity in COVID-19 Associated Myocardial Injury | https://ClinicalTrials.gov/show/NCT04340921 |
| NCT04337190 | Impact of Angiotensin II Receptor Blockers Treatment in Patients With COVID 19 (COVID-ARA2) | https://ClinicalTrials.gov/show/NCT04337190 |
| NCT04337151 | Blood Titanium Analysis of Patients With MAGEC Spine Rods in the COVID-19 Environment | https://ClinicalTrials.gov/show/NCT04337151 |
| NCT04337047 | Distress in Crisis Situations During COVID-19 | https://ClinicalTrials.gov/show/NCT04337047 |
| NCT04336761 | Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France | https://ClinicalTrials.gov/show/NCT04336761 |
| NCT04336657 | Corona-Like Illness: Did we Got it Before WHO Announcement of the Disease? | https://ClinicalTrials.gov/show/NCT04336657 |
| NCT04335747 | COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases | https://ClinicalTrials.gov/show/NCT04335747 |
| NCT04335162 | Cardiovascular Complications and COVID-19 (CovCardioVasc) | https://ClinicalTrials.gov/show/NCT04335162 |
| NCT04334954 | SARS-COV2 Pandemic Serosurvey and Blood Sampling | https://ClinicalTrials.gov/show/NCT04334954 |
| NCT04342702 | A Study on the Prospective Cohort Library of COVID-19 in Southeran | https://ClinicalTrials.gov/show/NCT04342702 |
| NCT04338672 | The Impact of the Covid-19 Outbreak on Emergency Room Attendances of Surgical Patients | https://ClinicalTrials.gov/show/NCT04338672 |
| NCT04337424 | Evaluation of Quickly Diagnostic Saliva Tests for SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04337424 |
| NCT04337320 | Maternal And Neonatal Outcome of Pregnant Patients With COVID-19 in Istanbul, Turkey: A Single-Center, Retrospective, Descriptive Study | https://ClinicalTrials.gov/show/NCT04337320 |
| NCT04366765 | COVID-19 Survival - The COVIVA Study | https://ClinicalTrials.gov/show/NCT04366765 |
| NCT04346602 | A Study on the Clinical and Psychological Characteristics of Patients With COVID-2019 | https://ClinicalTrials.gov/show/NCT04346602 |
| NCT04339998 | Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS) | https://ClinicalTrials.gov/show/NCT04339998 |
| NCT04339387 | COVID-19 Risk Stratification | https://ClinicalTrials.gov/show/NCT04339387 |
| NCT04337762 | Beat COVID-19 - Observational Trial | https://ClinicalTrials.gov/show/NCT04337762 |
| NCT04337502 | Clinical and Radiomic Model of COVID-19 | https://ClinicalTrials.gov/show/NCT04337502 |
| NCT04347408 | Seroprevalence of SARS-Cov-2 Antibodies in Children | https://ClinicalTrials.gov/show/NCT04347408 |
| NCT04343742 | Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19 | https://ClinicalTrials.gov/show/NCT04343742 |
| NCT04342637 | COVID-19 Endoscopy Survey | https://ClinicalTrials.gov/show/NCT04342637 |
| NCT04339634 | Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy | https://ClinicalTrials.gov/show/NCT04339634 |
| NCT04339608 | Max COVID19- Study | https://ClinicalTrials.gov/show/NCT04339608 |
| NCT04338945 | Impact of Pandemic COVID-19 on Surgical Specialities Residents in Italy | https://ClinicalTrials.gov/show/NCT04338945 |
| NCT04338932 | COVID-19 and Deep Venous Thrombosis | https://ClinicalTrials.gov/show/NCT04338932 |
| NCT04347928 | Respiratory and Hemodynamic Changes Induced in Mechanically Ventilated Patients for COVID-19 | https://ClinicalTrials.gov/show/NCT04347928 |
| NCT04347460 | Establishing a COVID-19 Prospective Cohort for Identification of Secondary HLH | https://ClinicalTrials.gov/show/NCT04347460 |
| NCT04343339 | Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment | https://ClinicalTrials.gov/show/NCT04343339 |
| NCT04342884 | COVID-19 Community Research Partnership | https://ClinicalTrials.gov/show/NCT04342884 |
| NCT04342104 | NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure | https://ClinicalTrials.gov/show/NCT04342104 |
| NCT04341714 | Efficiency and Satisfaction With Telephone Consultation in Neuro-urology: Experience of the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04341714 |
| NCT04339686 | Multicentric Retrospective Observational Study of Thoracic Scanner Performance in COVID Screening. | https://ClinicalTrials.gov/show/NCT04339686 |
| NCT04343404 | Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19 | https://ClinicalTrials.gov/show/NCT04343404 |
| NCT04352634 | The Covid-19 HEalth caRe wOrkErS (HEROES) Study | https://ClinicalTrials.gov/show/NCT04352634 |
| NCT04342195 | Acquiring Convalescent Specimens for COVID-19 Antibodies | https://ClinicalTrials.gov/show/NCT04342195 |
| NCT04339790 | Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers | https://ClinicalTrials.gov/show/NCT04339790 |
| NCT04358952 | Myocardial Involvement of Severe Acute Respiratory Syndrome-Cov-2 (Covid19) Infected Patients | https://ClinicalTrials.gov/show/NCT04358952 |
| NCT04357847 | Assessment of Endothelial and Haemostatic Changes During Severe SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04357847 |
| NCT04352556 | COVID19-hematological Malignancies: the Italian Hematology Alliance | https://ClinicalTrials.gov/show/NCT04352556 |
| NCT04350710 | Description of Respiratory Mechanics in Patients With SARS-CoV-2 Associated ARDS | https://ClinicalTrials.gov/show/NCT04350710 |
| NCT04347824 | Predict Adverse Events by Covid-19 Nephritis | https://ClinicalTrials.gov/show/NCT04347824 |
| NCT04344327 | Early Risk Stratification of Patient Hospitalized for SARS-CoV2 Infection: Critical COVID-19 France CCF | https://ClinicalTrials.gov/show/NCT04344327 |
| NCT04344197 | Surgery During Covid-19: The Role of Asymptomatic Patients, a Survey | https://ClinicalTrials.gov/show/NCT04344197 |
| NCT04344145 | Exhaustion and Needs in Frontline COVID-19 Healthcare Workers: Cross-sectional Study in a Belgian Population | https://ClinicalTrials.gov/show/NCT04344145 |
| NCT04344119 | Assessment of Chilbains Occuring During Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04344119 |
| NCT04343898 | Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04343898 |
| NCT04343781 | National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19 | https://ClinicalTrials.gov/show/NCT04343781 |
| NCT04346342 | PRactice of VENTilation in COVID-19 Patients (PRoVENT-COVID) | https://ClinicalTrials.gov/show/NCT04346342 |
| NCT04347850 | A Cohort of Patients With Possible or Confirmed SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04347850 |
| NCT04381312 | Direct and Indirect Impact of COVID-19 In Older Populations | https://ClinicalTrials.gov/show/NCT04381312 |
| NCT04352517 | Influence Physical Activity Psychological Responses COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04352517 |
| NCT04347070 | Implementation of Physiotherapy on COVID-19 Patients in ICU | https://ClinicalTrials.gov/show/NCT04347070 |
| NCT04346212 | Oropharyngeal Dysphagia in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04346212 |
| NCT04345640 | The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver. | https://ClinicalTrials.gov/show/NCT04345640 |
| NCT04345315 | Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent. | https://ClinicalTrials.gov/show/NCT04345315 |
| NCT04345159 | Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease | https://ClinicalTrials.gov/show/NCT04345159 |
| NCT04344171 | CovidDB: The Covid-19 Inpatient Database | https://ClinicalTrials.gov/show/NCT04344171 |
| NCT04346121 | Non-COVID Patient-safety Incidents Reported by General Practitioners in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study.cRisis | https://ClinicalTrials.gov/show/NCT04346121 |
| NCT04351711 | Immunological Profiling of Patients With COVID-19 in Respiratory Distress | https://ClinicalTrials.gov/show/NCT04351711 |
| NCT04344964 | Endoscopy-related Phone Consultation During the COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04344964 |
| NCT04353934 | The Ariel University Survey on Dietary Changes and Anxiety During the Coronavirus Pandemic | https://ClinicalTrials.gov/show/NCT04353934 |
| NCT04347694 | Study to Determine the Immunization Status Among Nephrological Health Care Personnel Against SARS-CoV-2 in a Single Center Over the Course of 12 Months During the Worldwide COVID-19 Pandemic. | https://ClinicalTrials.gov/show/NCT04347694 |
| NCT04373889 | COVID-19 Among Healthcare Workers in Belgian Hospitals | https://ClinicalTrials.gov/show/NCT04373889 |
| NCT04356560 | COVID-19 Surveillance of Patients and Healthcare Workers in a Hospital Department | https://ClinicalTrials.gov/show/NCT04356560 |
| NCT04354584 | Compartmental Inflammation in Mechanically Ventilated Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04354584 |
| NCT04352582 | COVID-19 and Vaccination Attitudes | https://ClinicalTrials.gov/show/NCT04352582 |
| NCT04349163 | Resilience Evaluation of Caregivers During the SARS-CoV2 Epidemic Period : Prospective Cohort. | https://ClinicalTrials.gov/show/NCT04349163 |
| NCT04349202 | Beaumont Health Large-scale Automated Serologic Testing for COVID-19 | https://ClinicalTrials.gov/show/NCT04349202 |
| NCT04348214 | Screening & Risk Assessment of Healthcare Workers & Infection Control in University & COVID-19 Quarantine Hospitals | https://ClinicalTrials.gov/show/NCT04348214 |
| NCT04346264 | CoVid-19 - Infection and Antibody Formation in the Viennese Population | https://ClinicalTrials.gov/show/NCT04346264 |
| NCT04346056 | Retrospective Study on Severe Respiratory Illness to Access the Presence of COVID-19 | https://ClinicalTrials.gov/show/NCT04346056 |
| NCT04348552 | Non-COVID Patient-safety Incidents Reported by Primary Care Professionals in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study | https://ClinicalTrials.gov/show/NCT04348552 |
| NCT04344977 | Collection of Anti-SARS-CoV-2 Immune Plasma | https://ClinicalTrials.gov/show/NCT04344977 |
| NCT04386369 | Evaluation of Airway Pressure Release Ventilation in COVID-19 ARDS | https://ClinicalTrials.gov/show/NCT04386369 |
| NCT04352699 | Outcomes of Urological Surgery During Periods of Social COVID-19 Containemnt: is it Reasonable to Limit Access to Surgical Care for All? | https://ClinicalTrials.gov/show/NCT04352699 |
| NCT04352491 | An Online Survey to Understand Feelings Related to COVID-19 Among ILBS Patients With Liver Disease | https://ClinicalTrials.gov/show/NCT04352491 |
| NCT04351568 | Professional and Ethical Challenges of Social Media Usage in Providing Healthcare Services During the Period of 19 Covid Pandemics; | https://ClinicalTrials.gov/show/NCT04351568 |
| NCT04351399 | Psychological Impact of Quarantine in Rheumatoid Arthritis Patient During COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04351399 |
| NCT04350073 | Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID) | https://ClinicalTrials.gov/show/NCT04350073 |
| NCT04349540 | Role of Immune and Inflammatory Response in Recipients of Allogeneic Haematopoietic Stem Cell Transplantation (SCT) Affected by Severe COVID19 | https://ClinicalTrials.gov/show/NCT04349540 |
| NCT04347876 | Outcome of COVID-19 Cases Based on Tuberculin Test: Can Previous BCG Alter the Prognosis? | https://ClinicalTrials.gov/show/NCT04347876 |
| NCT04386109 | Neonatal Complications of Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04386109 |
| NCT04353609 | Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare Diseases | https://ClinicalTrials.gov/show/NCT04353609 |
| NCT04353401 | WGS ANALYSIS OF SARS-COV-2 POSITIVE PATIENTS | https://ClinicalTrials.gov/show/NCT04353401 |
| NCT04353011 | Psychological Impact of Quarantine in Chronic Pain Patient During COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04353011 |
| NCT04351633 | Psychological Impact of Quarantine in Osteoporosis Patient During COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04351633 |
| NCT04351503 | A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19 | https://ClinicalTrials.gov/show/NCT04351503 |
| NCT04351139 | Impact of the COVID-19 Pandemic in Gynecological Oncology | https://ClinicalTrials.gov/show/NCT04351139 |
| NCT04348240 | Transmissibility and Viral Load of SARS-CoV-2 in Oral Secretions | https://ClinicalTrials.gov/show/NCT04348240 |
| NCT04355741 | Gut Microbiota, “Spark and Flame” of COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04355741 |
| NCT04376905 | Extra Vascular Lung Water and Pulmonary Permeability in Critically Ill Patients With SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04376905 |
| NCT04373109 | Stroke Rehabilitation Outcome During COVID-19 Lockdown | https://ClinicalTrials.gov/show/NCT04373109 |
| NCT04367129 | Electrocardiogram Analysis in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04367129 |
| NCT04366154 | Impact of the COVID-19 Infectious Epidemic on the Management of Oncology and Onco-hematology Patients and on the Psychological Consequences for Patients and Caregivers | https://ClinicalTrials.gov/show/NCT04366154 |
| NCT04360538 | Long Term Outcomes of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04360538 |
| NCT04357769 | COVID-19 Pandemic Burden in Severe Mental Disease Patients | https://ClinicalTrials.gov/show/NCT04357769 |
| NCT04357418 | Psychological Outcome of COVID-19 Lockdown on Psychiatric Hospital Staff and Close Relatives | https://ClinicalTrials.gov/show/NCT04357418 |
| NCT04356443 | Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04356443 |
| NCT04355442 | Evolution of Facial Trauma During COVID Containment Measures | https://ClinicalTrials.gov/show/NCT04355442 |
| NCT04354792 | Asymptomatic COVID-19 Infection Among Healthcare Workers | https://ClinicalTrials.gov/show/NCT04354792 |
| NCT04353141 | International Lung UltraSound Analysis (ILUSA) Study | https://ClinicalTrials.gov/show/NCT04353141 |
| NCT04352842 | Echocardiographic Manifestation in Patient With COVID-19 （EARLY-MYO COVID-19） | https://ClinicalTrials.gov/show/NCT04352842 |
| NCT04356950 | Analysis of the Coagulopathy Developed by COVID-19 Infected Patients | https://ClinicalTrials.gov/show/NCT04356950 |
| NCT04351659 | Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04351659 |
| NCT04367402 | COST (COvid STudio) ACTION: Study for the Evaluation of Specific Antibodies Anti Covid-19 Linked to Covid-19 Infection, Symptoms and Genetic Expression of ACE2 Polymorphisms in Patients (COST ACTION) | https://ClinicalTrials.gov/show/NCT04367402 |
| NCT04367363 | Social Media and COVID-19 | https://ClinicalTrials.gov/show/NCT04367363 |
| NCT04366921 | European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID-19 Patients in ECMO | https://ClinicalTrials.gov/show/NCT04366921 |
| NCT04361786 | Acral Cutaneous Thrombotic Vasculopathy and Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04361786 |
| NCT04357041 | COVID-19 Survey Study on Dietary Intake, Physical Activity and Overall Well-being | https://ClinicalTrials.gov/show/NCT04357041 |
| NCT04356378 | Long Term Physical Functional Limitations in Daily Living in SARS-CoV2 Infected Patients Hospitalized in the Acute Phase Then Requiring Rehabilitation | https://ClinicalTrials.gov/show/NCT04356378 |
| NCT04355715 | Combination of Chest Scanography and Nasal Viral Detection Test to Detect COVID-19 Positive Patients Before Surgical Intervention in a University Hospital During Coronavirus Pandemia | https://ClinicalTrials.gov/show/NCT04355715 |
| NCT04355702 | Covid-19 in Lupus Patients | https://ClinicalTrials.gov/show/NCT04355702 |
| NCT04355624 | Kidney Involvement in COVID-19 Disease (COVKID) | https://ClinicalTrials.gov/show/NCT04355624 |
| NCT04355611 | Epidemiological Characteristics of COVID-19 in Patients With MS or NMO | https://ClinicalTrials.gov/show/NCT04355611 |
| NCT04355481 | Dissemination of SARS-COV-2 (COVID-19) in the Environment of Infected Patients Admitted to Intensive Care Unit | https://ClinicalTrials.gov/show/NCT04355481 |
| NCT04354857 | Qualitative and Quantitative Evaluation of Anosmia Over Time in Clinically Symptomatic Patients Tested for COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04354857 |
| NCT04354779 | Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel. | https://ClinicalTrials.gov/show/NCT04354779 |
| NCT04354766 | COVID-19 : Neutralizing Human Monoclonal Antibodies Against SARS-Cov-2 | https://ClinicalTrials.gov/show/NCT04354766 |
| NCT04354753 | AiM COVID for Covid 19 Tracking and Prediction | https://ClinicalTrials.gov/show/NCT04354753 |
| NCT04358380 | Liver Injury in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04358380 |
| NCT04365166 | Study of Clinical and Immune Severity Profiles of Patients Infected With SARS-Cov2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04365166 |
| NCT04363333 | Obstructive Sleep Apnea & Covid-19 Outcomes | https://ClinicalTrials.gov/show/NCT04363333 |
| NCT04359914 | Neurocognitive Impairment in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04359914 |
| NCT04356885 | COVID-19 and Psychotic Symptoms in France | https://ClinicalTrials.gov/show/NCT04356885 |
| NCT04355871 | Characteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain | https://ClinicalTrials.gov/show/NCT04355871 |
| NCT04357535 | Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives | https://ClinicalTrials.gov/show/NCT04357535 |
| NCT04385069 | COVID-19 Hyperinflammation Syndrome (COV-HI): Protocol for a Rapidly Executed Cohort Study | https://ClinicalTrials.gov/show/NCT04385069 |
| NCT04384029 | The Geneva Covid-19 CVD Study | https://ClinicalTrials.gov/show/NCT04384029 |
| NCT04376853 | CoronaWatch - Early Detection of Cardiovascular Risks in COVID-19 Via SmartWatch | https://ClinicalTrials.gov/show/NCT04376853 |
| NCT04374123 | COVID-19 Serology Screening and Strict Protocol in the Endoscopy Unit | https://ClinicalTrials.gov/show/NCT04374123 |
| NCT04362345 | Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04362345 |
| NCT04361877 | Cardiovascular Prevention During COVID-19 Pandemic Lockdown in Young Adults (COLA Trial) | https://ClinicalTrials.gov/show/NCT04361877 |
| NCT04360954 | Evaluation of Antibody Tests for COVID-19 | https://ClinicalTrials.gov/show/NCT04360954 |
| NCT04359849 | Sequencing and Tracking of Phylogeny in COVID-19 Study | https://ClinicalTrials.gov/show/NCT04359849 |
| NCT04359836 | A Study to Explore the Role of Gut Flora in COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04359836 |
| NCT04359407 | Prone Positioning and Regional Ventilation in Mechanically Ventilated COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04359407 |
| NCT04358536 | Classification of COVID-19 Infection in Posteroanterior Chest X-rays | https://ClinicalTrials.gov/show/NCT04358536 |
| NCT04358510 | COVID-19 Mortality Prediction Model | https://ClinicalTrials.gov/show/NCT04358510 |
| NCT04358029 | Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04358029 |
| NCT04357938 | Risk Stratification With Chest CT to Rule-out Suspected SARS-CoV-2 Infections | https://ClinicalTrials.gov/show/NCT04357938 |
| NCT04357574 | Assessing the System for High-Intensity Evaluation During Radiotherapy During Changes in Response to COVID-19 | https://ClinicalTrials.gov/show/NCT04357574 |
| NCT04403009 | The Clinical Difference Between the Nonfatal Patients and the Fatal Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04403009 |
| NCT04397835 | Psychological Impact of COVID-19 Quarantine and Worsening of Cardiovascular Risk in the French General Population | https://ClinicalTrials.gov/show/NCT04397835 |
| NCT04375748 | Hospital Registry of Acute Myocarditis: Evolution of the Proportion of Positive SARS-COV-2 (COVID19) Cases | https://ClinicalTrials.gov/show/NCT04375748 |
| NCT04366024 | A Novel Nomogram to Predict Severity of COVID-19 | https://ClinicalTrials.gov/show/NCT04366024 |
| NCT04365959 | The Prone Position in Covid-19 Affected Patients | https://ClinicalTrials.gov/show/NCT04365959 |
| NCT04363008 | COVID 19 Biomarkers | https://ClinicalTrials.gov/show/NCT04363008 |
| NCT04360850 | Use of Telehealth Technology by Mental Health Care Professionals in Times of COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04360850 |
| NCT04359693 | Impact of COVID-19 Infection on the Incidence of Ventilator-acquired Infections | https://ClinicalTrials.gov/show/NCT04359693 |
| NCT04359121 | COVID-19 and the Developement of Phobic Fears of Disease | https://ClinicalTrials.gov/show/NCT04359121 |
| NCT04358640 | Anxiety and Work Resilience Among Tertiary University Hospital Workers During the COVID-19 Outbreak: An Online Survey | https://ClinicalTrials.gov/show/NCT04358640 |
| NCT04356365 | The Mental Health Status of the General Population During the COVID-19 Pandemic and Its Association With Adherence to Government-initiated Non-pharmacological Epidemiological Interventions (NPI’s) | https://ClinicalTrials.gov/show/NCT04356365 |
| NCT04357431 | COVID-19 Among Egyptian Health Care Providers | https://ClinicalTrials.gov/show/NCT04357431 |
| NCT04393233 | Drug Management of Rheumatoid Arthritis in Covid-19 Context : Impact on Therapeutic De-escalation | https://ClinicalTrials.gov/show/NCT04393233 |
| NCT04371848 | Impact of the COVID-19 Pandemic on Diet Quality and Food Insecurity: a NutriQuébec Sub-study | https://ClinicalTrials.gov/show/NCT04371848 |
| NCT04369807 | Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04369807 |
| NCT04366934 | Study of the Pathogenesis of Olfactory Disorders in COVID-19 | https://ClinicalTrials.gov/show/NCT04366934 |
| NCT04362995 | St. Jude Tracking of Viral and Host Factors Associated With COVID-19 | https://ClinicalTrials.gov/show/NCT04362995 |
| NCT04362943 | Clinical-epidemiological Characterization of COVID-19 Disease in Hospitalized Older Adults | https://ClinicalTrials.gov/show/NCT04362943 |
| NCT04361565 | Frequency and Clinical Evolution of Olfactory and Taste Disorders in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04361565 |
| NCT04361019 | Physical Activity in University Students Around COVID-19 Confinement | https://ClinicalTrials.gov/show/NCT04361019 |
| NCT04360863 | The Impact of COVID-19 Pandemic on the Smoking Behaviour of Young Smokers and the Youth Quitline Service in Hong Kong | https://ClinicalTrials.gov/show/NCT04360863 |
| NCT04360733 | Precision Immunology to Determine the Immune Response in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04360733 |
| NCT04360707 | Solid Organ Transplant Recipients With SARS-CoV-2 French Registry | https://ClinicalTrials.gov/show/NCT04360707 |
| NCT04360278 | Plasma Collection From Convalescent and/or Immunized Donors for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04360278 |
| NCT04371250 | Study of Resilience and Loneliness in Youth (18 - 25 Years Old) During the COVID-19 Pandemic Lock-down Measures. | https://ClinicalTrials.gov/show/NCT04371250 |
| NCT04361123 | Atrium COVID-19 Syndromic and Serologic Surveillance | https://ClinicalTrials.gov/show/NCT04361123 |
| NCT04396600 | The Professional Peer Resilience Initiative | https://ClinicalTrials.gov/show/NCT04396600 |
| NCT04381286 | Transpulmonary Driving Pressure in ARDS COVID19 Patients | https://ClinicalTrials.gov/show/NCT04381286 |
| NCT04366778 | Thrombosis and Covid-19 | https://ClinicalTrials.gov/show/NCT04366778 |
| NCT04363788 | Needle Stick Injuries in Emergency Medical Service Practice | https://ClinicalTrials.gov/show/NCT04363788 |
| NCT04363268 | ACCESS A Master Digital Surveillance Protocol for COVID-19 | https://ClinicalTrials.gov/show/NCT04363268 |
| NCT04363099 | Multicentre Observational Study on Management COVID 19 Positive Outpatients in a French Cluster. | https://ClinicalTrials.gov/show/NCT04363099 |
| NCT04362319 | Burnout and Medical Errors in the Anaesthesiology Fraternity During Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04362319 |
| NCT04362150 | Long-term Impact of Infection With Novel Coronavirus (COVID-19) | https://ClinicalTrials.gov/show/NCT04362150 |
| NCT04368793 | Clinical Effects of Internet Assisted Pulmonary Rehabilitation of COVID-2019 Pneumonia Patients After Discharge | https://ClinicalTrials.gov/show/NCT04368793 |
| NCT04377815 | Finding Out if COVID-19 Infection Can be pREdicted by ChAnges in Smell and/or Taste | https://ClinicalTrials.gov/show/NCT04377815 |
| NCT04370678 | Changes in Preference for Surgery of Patients Signed up for Arthroscopic Procedures | https://ClinicalTrials.gov/show/NCT04370678 |
| NCT04366167 | Patient Recovery From Heart Surgery During the Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04366167 |
| NCT04365595 | SARS-CoV-2 Associated Respiratory Failure Recovery (COVID-19 CAir) | https://ClinicalTrials.gov/show/NCT04365595 |
| NCT04365335 | Stress Biomarkers Leading to Professional Burnout Among People Involved in a Mobile Intensive Care Unit During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04365335 |
| NCT04364698 | Observational Cohort of COVID-19 Patients at Raymond-Poincare | https://ClinicalTrials.gov/show/NCT04364698 |
| NCT04362930 | Cohort of Patients With Covid-19 Presenting Neurological or Psychiatric Disorders (CoCo-Neurosciences) | https://ClinicalTrials.gov/show/NCT04362930 |
| NCT04371315 | Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children | https://ClinicalTrials.gov/show/NCT04371315 |
| NCT04362865 | Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04362865 |
| NCT04365764 | Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study | https://ClinicalTrials.gov/show/NCT04365764 |
| NCT04365725 | Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections | https://ClinicalTrials.gov/show/NCT04365725 |
| NCT04365634 | A Single-center Retrospective Study to Find Prediction Factors Related to Mortality of COVID-19 Patients. | https://ClinicalTrials.gov/show/NCT04365634 |
| NCT04365361 | The Psychological Impact of the COVID-19 on Students. | https://ClinicalTrials.gov/show/NCT04365361 |
| NCT04365348 | The Psychological Impact of COVID-19 Outbreak on COVID-19 Survivors and Their Families | https://ClinicalTrials.gov/show/NCT04365348 |
| NCT04382534 | A Cross-sectional and Cohort Study of COVID-19 Patients With Post - Discharge Dysfunction | https://ClinicalTrials.gov/show/NCT04382534 |
| NCT04373811 | One-Year Quality of Life and Functional Prognosis of COVID-19 Patients in Post-ICU Setting | https://ClinicalTrials.gov/show/NCT04373811 |
| NCT04368637 | Acute Cardiovascular Events Triggered by COVID-19-Related Stress | https://ClinicalTrials.gov/show/NCT04368637 |
| NCT04367064 | To Study the Clinical Characteristics and Treatment Outcome of COVID-19 Patients Admitted in Hospitals of Max Healthcare (SCOPe Study) | https://ClinicalTrials.gov/show/NCT04367064 |
| NCT04365881 | Loneliness During the NPIs for the COVID-19 Pandemic in Norway: Risk Factors and Associations With Psychopathology | https://ClinicalTrials.gov/show/NCT04365881 |
| NCT04365530 | Become of Patients Infected or Suspected of Being Infected by Covid-19 and Supported by the GHPSJ and the Establishments of the Paris Plaisance Hospital City | https://ClinicalTrials.gov/show/NCT04365530 |
| NCT04383470 | Collaborative Outcomes Study on Health and Functioning During Infection Times During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04383470 |
| NCT04368897 | In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity | https://ClinicalTrials.gov/show/NCT04368897 |
| NCT04367896 | COVID-19 OUTBREAK AND SOLID ORGAN TRANSPLANTATION (SOT) : AN INTERNATIONAL WEB-BASED SURVEY | https://ClinicalTrials.gov/show/NCT04367896 |
| NCT04368351 | Bacteriotherapy in the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04368351 |
| NCT04368026 | SARS-CoV-2 and Surgery | https://ClinicalTrials.gov/show/NCT04368026 |
| NCT04367805 | COVID-19 Infection in Patients With Hepatocellular Carcinoma | https://ClinicalTrials.gov/show/NCT04367805 |
| NCT04367792 | Cardiac Injury in COVID-19: a Pathology Study | https://ClinicalTrials.gov/show/NCT04367792 |
| NCT04367740 | ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19 | https://ClinicalTrials.gov/show/NCT04367740 |
| NCT04366752 | Thrombo Embolic Events in Critical Care Patients With Covid-19 Serious Acute Pneumopathy | https://ClinicalTrials.gov/show/NCT04366752 |
| NCT04375670 | COVID19-FOIE National Observatory | https://ClinicalTrials.gov/show/NCT04375670 |
| NCT04371354 | Outcomes of Covid-19 Protective Measures in Endoscopy | https://ClinicalTrials.gov/show/NCT04371354 |
| NCT04370249 | Construction of a Composite Clinical-echo Score Predictive of a Risk of Short-term Aggravation of Respiratory Impairment in Patients Suspected of Covid-19 | https://ClinicalTrials.gov/show/NCT04370249 |
| NCT04369989 | Observational Study of COVID-19 Treatment Efficacy | https://ClinicalTrials.gov/show/NCT04369989 |
| NCT04368390 | Neuroradiolological Analysis of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04368390 |
| NCT04368338 | Lung Ultrasound to Diagnose COVID-19 | https://ClinicalTrials.gov/show/NCT04368338 |
| NCT04367883 | Influenza Vaccination, ACEI and ARB in the Evolution of SARS-Covid19 Infection | https://ClinicalTrials.gov/show/NCT04367883 |
| NCT04367870 | COVID-19 Detection Test in Oncology | https://ClinicalTrials.gov/show/NCT04367870 |
| NCT04367337 | Health Behavior Change During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04367337 |
| NCT04385212 | Outcomes in Hospitalized Older Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04385212 |
| NCT04374422 | COVID-19 Pandemic and Female Sexual Behavior | https://ClinicalTrials.gov/show/NCT04374422 |
| NCT04372576 | Epidemiology and Outcome of Ventilator-associated Pneumonia Among Critically Ill COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04372576 |
| NCT04372472 | SQuISH-COVID: A Pilot Study | https://ClinicalTrials.gov/show/NCT04372472 |
| NCT04372056 | The COVID-ICU Healthcare Professional Study | https://ClinicalTrials.gov/show/NCT04372056 |
| NCT04370275 | Accuracy of Lung Ultrasound in the Diagnosis of covid19 Pneumonia | https://ClinicalTrials.gov/show/NCT04370275 |
| NCT04370197 | Covid-19 Epidemic on Acute Stroke Management | https://ClinicalTrials.gov/show/NCT04370197 |
| NCT04370119 | Screening for SARS-CoV-2-Infections and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers | https://ClinicalTrials.gov/show/NCT04370119 |
| NCT04369859 | Obstetric and Perinatal Outcomes of Women With COVID-19 | https://ClinicalTrials.gov/show/NCT04369859 |
| NCT04368884 | Observational Study to Assess the Seroconversion Status of Health Care Workers and Suspected or Confirmed Cases of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04368884 |
| NCT04368871 | Radiographic Findings and Their Temporal Changes in COVID-19 Positive Changes Patients: A Prospective Study | https://ClinicalTrials.gov/show/NCT04368871 |
| NCT04370210 | Sleep Quality During COVID-19 Containment in Children Whether or Not Usually Followed in Child Psychiatry | https://ClinicalTrials.gov/show/NCT04370210 |
| NCT04371432 | Genetics of COVID-19 Susceptibility and Manifestations | https://ClinicalTrials.gov/show/NCT04371432 |
| NCT04380987 | Luxembourg Cohort of Positive Patients for COVID-19: a Stratification Study to Predict Patient Prognosis | https://ClinicalTrials.gov/show/NCT04380987 |
| NCT04379089 | Neurologic Manifestations of COVID 19 in Children | https://ClinicalTrials.gov/show/NCT04379089 |
| NCT04376580 | Use of the Nasal Cannula During COVID-19 | https://ClinicalTrials.gov/show/NCT04376580 |
| NCT04375410 | Consequences of Intensified Handwash and Hand Disinfection Among Children During the COVID19 Pandemic | https://ClinicalTrials.gov/show/NCT04375410 |
| NCT04374071 | Early Short Course Corticosteroids in COVID-19 | https://ClinicalTrials.gov/show/NCT04374071 |
| NCT04373486 | Incidence of Acute Pulmonary Embolism in Covid-19 Patients on CT Angiography and Relationship to D-dimer Levels | https://ClinicalTrials.gov/show/NCT04373486 |
| NCT04371679 | Changes in Cardiac and Pulmonary Hemodynamics as Predictor of Outcome in Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04371679 |
| NCT04371562 | Predicting Death and ICU Admission in COVID-19 Patients in ED | https://ClinicalTrials.gov/show/NCT04371562 |
| NCT04371471 | Covid-19 Pandemic Triage Score | https://ClinicalTrials.gov/show/NCT04371471 |
| NCT04375761 | COVID-19: Human Epidemiology and Response to SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04375761 |
| NCT04373148 | Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19 | https://ClinicalTrials.gov/show/NCT04373148 |
| NCT04377581 | COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior | https://ClinicalTrials.gov/show/NCT04377581 |
| NCT04384471 | Covid-19 Pandemic: Patients’ Experience in T1D | https://ClinicalTrials.gov/show/NCT04384471 |
| NCT04378777 | Immunophenotyping Assessment in a COVID-19 Cohort | https://ClinicalTrials.gov/show/NCT04378777 |
| NCT04377035 | The Role of Ultrasound in COVID-19 | https://ClinicalTrials.gov/show/NCT04377035 |
| NCT04374656 | Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04374656 |
| NCT04374058 | Less Frequency Hemodialysis and COVID-19 | https://ClinicalTrials.gov/show/NCT04374058 |
| NCT04373798 | C-reactive Protein Levels Among Individuals With COVID-19 | https://ClinicalTrials.gov/show/NCT04373798 |
| NCT04377412 | Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04377412 |
| NCT04374617 | Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04374617 |
| NCT04374513 | Community Pharmacists Behaviour During Covid-19 | https://ClinicalTrials.gov/show/NCT04374513 |
| NCT04374097 | Level and Predictors of Trauma-symptoms Among Health Workers and Public Service Providers During the COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04374097 |
| NCT04375176 | Monocytes and NK Cells Activity in Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04375176 |
| NCT04375137 | Correlation Between Oxidative Stress Status and COVID-19 Severity | https://ClinicalTrials.gov/show/NCT04375137 |
| NCT04388813 | Predictors of Severe COVID-19 Outcomes | https://ClinicalTrials.gov/show/NCT04388813 |
| NCT04382417 | Prospective Observational Cohort Study of Critically Ill Patients With Covid-19 in Sweden | https://ClinicalTrials.gov/show/NCT04382417 |
| NCT04381819 | Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of COVID-19 | https://ClinicalTrials.gov/show/NCT04381819 |
| NCT04380896 | COVID-19 Staff Testing of Antibody Responses Study (Co-Stars) | https://ClinicalTrials.gov/show/NCT04380896 |
| NCT04379310 | Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019) | https://ClinicalTrials.gov/show/NCT04379310 |
| NCT04379245 | COVID-19 Infection in Patients Infected With HIV and/or on PrEP | https://ClinicalTrials.gov/show/NCT04379245 |
| NCT04379232 | Surgical Activity During the Covid-19 Pandemic: Results for 112 Patients in a French Tertiary Care Center | https://ClinicalTrials.gov/show/NCT04379232 |
| NCT04377607 | Haemoglobin Concentration on COVID-19 | https://ClinicalTrials.gov/show/NCT04377607 |
| NCT04377074 | Parental Stress During the COVID-19 Pandemic and Its Association With Depression and Anxiety | https://ClinicalTrials.gov/show/NCT04377074 |
| NCT04376996 | Slovenian National COVID-19 Prevalence Study | https://ClinicalTrials.gov/show/NCT04376996 |
| NCT04376944 | Barrier Measures to Limit Covid-19.Nosocomial Transmission: a Cross-sectional Evaluation | https://ClinicalTrials.gov/show/NCT04376944 |
| NCT04376879 | Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19) | https://ClinicalTrials.gov/show/NCT04376879 |
| NCT04376775 | Assessment of the Impact of COVID-19 on Transplant Patients and on Patients Awaiting Transplantation | https://ClinicalTrials.gov/show/NCT04376775 |
| NCT04375709 | Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19); | https://ClinicalTrials.gov/show/NCT04375709 |
| NCT04375501 | A Study of Outcomes in Patients With Fractured Neck of Femur During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04375501 |
| NCT04410718 | Glycaemia and Cardiac Function in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04410718 |
| NCT04382469 | Egyptian Initial Experience About 2019 Novel Corona Virus: Study of 48 Patients in Alexandria-Egypt Using Chest CT | https://ClinicalTrials.gov/show/NCT04382469 |
| NCT04382235 | Non-invasive Ventilatory Support of Patients Affected by COVID-19 | https://ClinicalTrials.gov/show/NCT04382235 |
| NCT04380870 | Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19 | https://ClinicalTrials.gov/show/NCT04380870 |
| NCT04379063 | COVID-19 Pandemic Short Interval National Survey Gauging Psychological Distress | https://ClinicalTrials.gov/show/NCT04379063 |
| NCT04378842 | COVID-19 and ICU-acquired MDR Bacteria | https://ClinicalTrials.gov/show/NCT04378842 |
| NCT04378686 | Serological Testing for COVID-19 (SARS-CoV-2) in ESKD | https://ClinicalTrials.gov/show/NCT04378686 |
| NCT04378595 | Assessing Pediatric Food Insecurity During the COVID-19 Pandemic in Austin | https://ClinicalTrials.gov/show/NCT04378595 |
| NCT04378582 | Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU | https://ClinicalTrials.gov/show/NCT04378582 |
| NCT04377776 | Observational Study Concerning COVID-19 Infection in Transplanted Kidney, Pancreas or Pancreatic Islet Patients | https://ClinicalTrials.gov/show/NCT04377776 |
| NCT04377685 | Prediction of Clinical Course in COVID19 Patients | https://ClinicalTrials.gov/show/NCT04377685 |
| NCT04377490 | Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy | https://ClinicalTrials.gov/show/NCT04377490 |
| NCT04378881 | Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations | https://ClinicalTrials.gov/show/NCT04378881 |
| NCT04377724 | Spread and Course of COVID-19 Infections | https://ClinicalTrials.gov/show/NCT04377724 |
| NCT04416347 | COVID19 Clinical Predictors and Outcome | https://ClinicalTrials.gov/show/NCT04416347 |
| NCT04393155 | Longitudinal COVID-19 Cohort Study | https://ClinicalTrials.gov/show/NCT04393155 |
| NCT04386395 | Immune Changes in Severe COVID-19 Pulmonary Infections | https://ClinicalTrials.gov/show/NCT04386395 |
| NCT04382781 | Immunosupressive Treatment in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04382781 |
| NCT04382508 | Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults. | https://ClinicalTrials.gov/show/NCT04382508 |
| NCT04381273 | Oral Health and Psychosocial Factors During the Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04381273 |
| NCT04379297 | COvid-19 National Survey for Assessing VIral Spread by Nonaffected CarriErs (CON-VINCE) | https://ClinicalTrials.gov/show/NCT04379297 |
| NCT04383899 | Role of Ibuprofen and Other Medicines on Severity of Coronavirus Disease 2019 | https://ClinicalTrials.gov/show/NCT04383899 |
| NCT04383678 | Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04383678 |
| NCT04383652 | Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales | https://ClinicalTrials.gov/show/NCT04383652 |
| NCT04383483 | CoV-ICU Score, Intensive Care Unit, SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04383483 |
| NCT04381351 | Noncoding RNAs in COVID-19 and COVID-19 Related Kidney Dysfunction | https://ClinicalTrials.gov/show/NCT04381351 |
| NCT04380792 | Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital | https://ClinicalTrials.gov/show/NCT04380792 |
| NCT04380779 | Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses | https://ClinicalTrials.gov/show/NCT04380779 |
| NCT04380714 | Changes in the Consumption of Psychoactive Substances During Containment Linked to COVID-19 | https://ClinicalTrials.gov/show/NCT04380714 |
| NCT04385004 | Clinical, Biological and Histological Pulmonary and Renal Damage Associated With the SARS-CoV-2 Syndrome in Patients Admitted in ICU | https://ClinicalTrials.gov/show/NCT04385004 |
| NCT04384055 | Predicting Outcomes for Covid-19 Using Sonography | https://ClinicalTrials.gov/show/NCT04384055 |
| NCT04383886 | Evaluation of Emergency Department (ED) Staff Stress Level During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04383886 |
| NCT04382495 | The Impact of COVID-19 Pandemic on Cancer Care | https://ClinicalTrials.gov/show/NCT04382495 |
| NCT04382196 | Impact of COVID-19 on Mental Health of Health Care Workers | https://ClinicalTrials.gov/show/NCT04382196 |
| NCT04383730 | Inhaled Sedation in COVID-19-related Acute Respiratory Distress Syndrome (ISCA): an International Research Data Study in the Recent Context of Widespread Disease Resulting From the 2019 (SARS-CoV2) Coronavirus Pandemics (COVID-19) | https://ClinicalTrials.gov/show/NCT04383730 |
| NCT04382794 | Sitagliptin Treatment in Diabetic COVID-19 Positive Patients | https://ClinicalTrials.gov/show/NCT04382794 |
| NCT04383444 | Surveillance of Individuals Following SARS-CoV-2 Exposure | https://ClinicalTrials.gov/show/NCT04383444 |
| NCT04385238 | Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04385238 |
| NCT04384250 | Genetic Basis of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04384250 |
| NCT04383626 | Fear Among Dentists During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04383626 |
| NCT04431310 | Seroconversion Among Staff at a Large Acute Care Hospital in Denmark During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04431310 |
| NCT04409535 | Effects of the COVID-19 Health Emergency on Biopsychosocial Health | https://ClinicalTrials.gov/show/NCT04409535 |
| NCT04389320 | Antimalarial and Covid 19 in Rheumatoid Arthritis | https://ClinicalTrials.gov/show/NCT04389320 |
| NCT04387786 | Dornase Alfa Administered to Patients With COVID-19 (DACOVID) | https://ClinicalTrials.gov/show/NCT04387786 |
| NCT04386720 | Measurement of Airway Opening Pressure (AOP) in Patients With Acute Respiratory Distress Syndrom and With or Without Covid 19. | https://ClinicalTrials.gov/show/NCT04386720 |
| NCT04386551 | Detection of COVID-19 in Saliva Collection | https://ClinicalTrials.gov/show/NCT04386551 |
| NCT04385823 | Use of High Flow Nasal Cannula Oxygen and Covid-19 Acute Hypoxemic Respiratory Failure | https://ClinicalTrials.gov/show/NCT04385823 |
| NCT04385160 | Myeloproliferative Neoplasms (MPN) and COVID-19 | https://ClinicalTrials.gov/show/NCT04385160 |
| NCT04384926 | Outcomes of Elective Cancer Surgery During the COVID-19 Pandemic Crisis | https://ClinicalTrials.gov/show/NCT04384926 |
| NCT04384887 | “Investigation of the Relationship Between New Coronary Virus Disease (COVID-19) and Anxiety and Depressive Symptoms in Pregnant Women” | https://ClinicalTrials.gov/show/NCT04384887 |
| NCT04385147 | Advanced Endoscopy During COVID-19 | https://ClinicalTrials.gov/show/NCT04385147 |
| NCT04388670 | Epidemiological and Clinical Characteristics of Critically Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04388670 |
| NCT04388579 | Screening Patients for a Strategic Shift to Pulmonary Telerehabilitation Because of COVID-19 | https://ClinicalTrials.gov/show/NCT04388579 |
| NCT04387279 | The Impact of COVID-19 on the Health Care Utilization of Inflammatory Bowel Disease | https://ClinicalTrials.gov/show/NCT04387279 |
| NCT04386460 | Covid-19 and Prevention of Malnutrition After Confinement by Dentists | https://ClinicalTrials.gov/show/NCT04386460 |
| NCT04387214 | COVID-19 Pandemic and Academic Performance of Veterinary Students | https://ClinicalTrials.gov/show/NCT04387214 |
| NCT04392401 | COVID-19 - Study of the Kinetics of the Immune Response During the Intensive Care Unit Stay in Adult Patients Infected With SARS-CoV-2: Multicentric Non Interventional Study | https://ClinicalTrials.gov/show/NCT04392401 |
| NCT04389645 | Interferon Gamma Induced Protein 10 (IP-10) in a Clinical Decision Support Protocol in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04389645 |
| NCT04389567 | Famotidine Outpatient COVID-19 Treatment Study | https://ClinicalTrials.gov/show/NCT04389567 |
| NCT04388657 | COVID-19, bLOod Coagulation and Thrombosis | https://ClinicalTrials.gov/show/NCT04388657 |
| NCT04387838 | Study of the SARS-COV-2 (COVID-19) Serological Profile of an Army Training Hospital Staff | https://ClinicalTrials.gov/show/NCT04387838 |
| NCT04387799 | Determinants of COVID-19 Pneumonia (MC-19) | https://ClinicalTrials.gov/show/NCT04387799 |
| NCT04387643 | Protecting Health Care Workers During the COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04387643 |
| NCT04406324 | COVID-19: Respiratory and Sleep Follow-up | https://ClinicalTrials.gov/show/NCT04406324 |
| NCT04388618 | Investigating Anosmia and Ageusia in COVID-19 Adult Patients in Saudi Arabia | https://ClinicalTrials.gov/show/NCT04388618 |
| NCT04387656 | NCI COVID-19 in Cancer Patients, NCCAPS Study | https://ClinicalTrials.gov/show/NCT04387656 |
| NCT04410835 | Psychological Impact of the Corona Virus (SARS-CoV-2) and COVID-19 Pandemic in Individuals With Psychiatric Disorders | https://ClinicalTrials.gov/show/NCT04410835 |
| NCT04393428 | Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04393428 |
| NCT04392089 | Effects of Cardiovascular and Pulmonary Optimization on Cerebral Oxygenation in COVID-19 Patients With Severe ARDS | https://ClinicalTrials.gov/show/NCT04392089 |
| NCT04391738 | Association Between BMI and COVID-19 | https://ClinicalTrials.gov/show/NCT04391738 |
| NCT04390126 | COVID-19 Related Lockdown Effects On Chronic Diseases | https://ClinicalTrials.gov/show/NCT04390126 |
| NCT04389658 | Contagiousness and Immunogenicity Status of COVID-19 in Asymptomatic Population (COVID-19 CONDITION) | https://ClinicalTrials.gov/show/NCT04389658 |
| NCT04389515 | Postoperative Recovery Index, Patient Expectations and Satisfaction With Prenatal Care Instrument in Pregnant Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04389515 |
| NCT04389489 | Postpartum Sexual Function in Pregnant Women With COVID-19 | https://ClinicalTrials.gov/show/NCT04389489 |
| NCT04389463 | Patient Outcome of Cardiac Surgery During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04389463 |
| NCT04391881 | Oral Manifestation of COVID 19 Patient: A Cross Sectional Study on Egyptian Population | https://ClinicalTrials.gov/show/NCT04391881 |
| NCT04395833 | National Survey on the Lockdown of Children With Disabilities | https://ClinicalTrials.gov/show/NCT04395833 |
| NCT04394026 | Imaging Feature of SARS-CoV2 Infection | https://ClinicalTrials.gov/show/NCT04394026 |
| NCT04393402 | Lung Ultrasound Score in Covid 19 Infectious Disease in Critical Care (LUS-COVID19) | https://ClinicalTrials.gov/show/NCT04393402 |
| NCT04392388 | Health, Perception, Practices, Relations and Social Inequalities in the General Population During the Covid-19 Crisis | https://ClinicalTrials.gov/show/NCT04392388 |
| NCT04392245 | Proctologic Practice and Covid-19 | https://ClinicalTrials.gov/show/NCT04392245 |
| NCT04391166 | Validity of at Home Visual Acuity Measurements for Telemedicine During Corona Virus (COVID-19) Pandemic | https://ClinicalTrials.gov/show/NCT04391166 |
| NCT04453670 | Neuropathology in Adults Intensive Care Unit Patients With COVID 19 | https://ClinicalTrials.gov/show/NCT04453670 |
| NCT04391816 | COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study | https://ClinicalTrials.gov/show/NCT04391816 |
| NCT04394195 | sFlt1: a Biomarker of Organ Dysfunction in Critically-ill Patients With COVID-19? | https://ClinicalTrials.gov/show/NCT04394195 |
| NCT04393558 | Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms | https://ClinicalTrials.gov/show/NCT04393558 |
| NCT04396197 | Physical Activity Levels in COVID-19 Patients Admitted to Intensive Care | https://ClinicalTrials.gov/show/NCT04396197 |
| NCT04414319 | Severe Acute Respiratory Syndrome-Coronavirus-2 and Loss of Autonomy in the Elderly | https://ClinicalTrials.gov/show/NCT04414319 |
| NCT04410263 | Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches | https://ClinicalTrials.gov/show/NCT04410263 |
| NCT04409197 | Evaluation of Changes in Weight, Sleep, and Other Psycho-behavioural Parameters During Covid-19 Confinement in Subjects Monitored by the RNPC Network | https://ClinicalTrials.gov/show/NCT04409197 |
| NCT04401241 | How Routine Biomarkers and Blood Leucocytes Count Can Assist Diagnosis of COVID-19 in Emergency Department | https://ClinicalTrials.gov/show/NCT04401241 |
| NCT04396353 | EXercise TRAining and Sedentary Lifestyle on Clinical Outcomes in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04396353 |
| NCT04396210 | Patients Perspectives on Discontinuation of Their Fertility Treatment Due to the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04396210 |
| NCT04395859 | Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents | https://ClinicalTrials.gov/show/NCT04395859 |
| NCT04395482 | Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury | https://ClinicalTrials.gov/show/NCT04395482 |
| NCT04394429 | Endotracheal Tube Obstruction in Covid-19 Patients Requiring Mechanical Ventilation | https://ClinicalTrials.gov/show/NCT04394429 |
| NCT04394078 | Impact of COVID-19 Pandemic on Depression and Quality of Life | https://ClinicalTrials.gov/show/NCT04394078 |
| NCT04393974 | COVID-19 and Cancer Patients | https://ClinicalTrials.gov/show/NCT04393974 |
| NCT04397939 | Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04397939 |
| NCT04397900 | Blood Collection Study From COVID-19 Convalescents Previously Hospitalized to Identify Immunogenic Viral Epitopes | https://ClinicalTrials.gov/show/NCT04397900 |
| NCT04397848 | Mental Health Outcomes in Healthcare Workers During COVID-19 | https://ClinicalTrials.gov/show/NCT04397848 |
| NCT04397822 | COVID-19: Study of INFLAmmasome and PLAtelets Functions | https://ClinicalTrials.gov/show/NCT04397822 |
| NCT04397588 | Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19 | https://ClinicalTrials.gov/show/NCT04397588 |
| NCT04395924 | Maternal-foetal Transmission of SARS-Cov-2 | https://ClinicalTrials.gov/show/NCT04395924 |
| NCT04395755 | Impact of COVID-19 on Psychological Status in Case of IVF Interrupted or Postponed | https://ClinicalTrials.gov/show/NCT04395755 |
| NCT04395664 | Arrhythmias in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04395664 |
| NCT04395391 | Home Usability Study of the SARS-CoV-2 (COVID-19) Test | https://ClinicalTrials.gov/show/NCT04395391 |
| NCT04395300 | Sleep Quality in Healthcare Personnel During COVID-19 | https://ClinicalTrials.gov/show/NCT04395300 |
| NCT04405466 | A Study to Assess the Feasibility of Screening for SARS-CoV-2 Among Healthy Workers | https://ClinicalTrials.gov/show/NCT04405466 |
| NCT04395885 | Sexual Function During COVID 19 Pandemic | https://ClinicalTrials.gov/show/NCT04395885 |
| NCT04394884 | Pathogenesis of BTK-mediated Hyper-Inflammatory Responses in COVID-19 (RESPOND) | https://ClinicalTrials.gov/show/NCT04394884 |
| NCT04412460 | Echocardiography in Patients With Covid-19 | https://ClinicalTrials.gov/show/NCT04412460 |
| NCT04411511 | COVID-19, Obesity and Lifestyle in Children | https://ClinicalTrials.gov/show/NCT04411511 |
| NCT04403607 | Cardiac Imaging in SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04403607 |
| NCT04400812 | Attitude and Perception Towards COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04400812 |
| NCT04400461 | Short-term Physical Function Outcomes in Severe COVID-19 Patients Admitted to ICU for Invasive Mechanical Ventilation | https://ClinicalTrials.gov/show/NCT04400461 |
| NCT04397172 | Intensive Care Associated Complications and Outcome of Acute Respiratory Distress Syndrome Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04397172 |
| NCT04427280 | Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04427280 |
| NCT04425382 | Darunavir/Cobicistat vs. Lopinavir/Ritonavir in COVID-19 Pneumonia in Qatar | https://ClinicalTrials.gov/show/NCT04425382 |
| NCT04402229 | Psychological Impact of the Covid-19 Pandemic on Student Nurses | https://ClinicalTrials.gov/show/NCT04402229 |
| NCT04401371 | Distance Learning for Dental Student During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04401371 |
| NCT04401228 | Predictive Models for Intensive Care Admission and Death of COVID-19 | https://ClinicalTrials.gov/show/NCT04401228 |
| NCT04401085 | COVID-19: Herd Immunity Study in the Czech Republic | https://ClinicalTrials.gov/show/NCT04401085 |
| NCT04400006 | Ozone Therapy in the Prevention of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04400006 |
| NCT04403035 | Comparison of the ID NOW and Accula Point-of-Care Assays for Detection of COVID-19 | https://ClinicalTrials.gov/show/NCT04403035 |
| NCT04410939 | COVID-19 PCR Test Results in Asymptomatic Pregnants | https://ClinicalTrials.gov/show/NCT04410939 |
| NCT04404062 | Validation of COVID-19 Tests | https://ClinicalTrials.gov/show/NCT04404062 |
| NCT04402853 | SARS Cov-2 in Conjunctival Secretion | https://ClinicalTrials.gov/show/NCT04402853 |
| NCT04402814 | IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With Nasopharyngeal PCR Testing. | https://ClinicalTrials.gov/show/NCT04402814 |
| NCT04401449 | Cardiopulmonary Inflammation and Multi-System Imaging During the Clinical Course of COVID-19 Infection in Asymptomatic and Symptomatic Persons | https://ClinicalTrials.gov/show/NCT04401449 |
| NCT04401098 | Changing Of Egyptian Population Behaviour Towards COVID 19 Outbreak | https://ClinicalTrials.gov/show/NCT04401098 |
| NCT04401072 | Attitude of Egyptian Population Toward COVID 19 in Ramadan | https://ClinicalTrials.gov/show/NCT04401072 |
| NCT04400877 | Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04400877 |
| NCT04401436 | COVID-19 Associated Lymphopenia Pathogenesis Study in Blood (CALYPSO) | https://ClinicalTrials.gov/show/NCT04401436 |
| NCT04403880 | Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19 | https://ClinicalTrials.gov/show/NCT04403880 |
| NCT04407299 | COVID-19 Impact on Rheumatic Patients | https://ClinicalTrials.gov/show/NCT04407299 |
| NCT04413071 | Cardiac COVID-19 Health Care Workers | https://ClinicalTrials.gov/show/NCT04413071 |
| NCT04406545 | Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of COVID-19. | https://ClinicalTrials.gov/show/NCT04406545 |
| NCT04406233 | Muscle Mass and Strength as Predictors of Time to Discharge in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04406233 |
| NCT04403438 | Familial Mediterranean Fever and Behçet: Analysis Before and After Covid19 Pandemic | https://ClinicalTrials.gov/show/NCT04403438 |
| NCT04403386 | Prospective Natural History Study of Smoking, Immune Cell Profiles, Epigenetics and COVID-19 | https://ClinicalTrials.gov/show/NCT04403386 |
| NCT04403061 | Th1/Th2/Th17/TREG and TLRs Activation/KIR for COVID 19 Prediction of Outcome | https://ClinicalTrials.gov/show/NCT04403061 |
| NCT04402827 | Different Susceptibility to SARS CoV-2 Infection Among Health Care Workers Highly Exposed to COVID-19. | https://ClinicalTrials.gov/show/NCT04402827 |
| NCT04404179 | Setting up a COVID-19 Care Facility at a Prison in Pakistan | https://ClinicalTrials.gov/show/NCT04404179 |
| NCT04406558 | Psychological Impact of the Health Measures Generated by the COVID19 in Adolescents | https://ClinicalTrials.gov/show/NCT04406558 |
| NCT04403932 | Increased Risk of Severe Coronavirus Disease 2019 in Patients With Vitamin D Deficiency | https://ClinicalTrials.gov/show/NCT04403932 |
| NCT04403828 | Impact of COVID-19 on Personal Protection Among Dentist in Egypt | https://ClinicalTrials.gov/show/NCT04403828 |
| NCT04413435 | Clinical Characteristics of Critically Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04413435 |
| NCT04410107 | Lung Function, Exercise Capacity and Health-Related Quality of Life After Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04410107 |
| NCT04408222 | Awake Proning in COVID-19 Patients With Hypoxemic Respiratory Failure | https://ClinicalTrials.gov/show/NCT04408222 |
| NCT04407143 | Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04407143 |
| NCT04406844 | An Observational Study to Identify the Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic and the Resulting Lockdown | https://ClinicalTrials.gov/show/NCT04406844 |
| NCT04405973 | Clinical Scores for Outcome Prediction in Patients With Severe COVID-19 Pneumonia Requiring ECMO | https://ClinicalTrials.gov/show/NCT04405973 |
| NCT04405869 | Thromboembolic Events in Severe COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04405869 |
| NCT04405726 | Prognostic Factors of COVID19 | https://ClinicalTrials.gov/show/NCT04405726 |
| NCT04404270 | Study of SARS-CoV2 Virus (COVID-19) Seroprevalence in the Population of Creil Air Force Base (BA110) | https://ClinicalTrials.gov/show/NCT04404270 |
| NCT04404244 | Extraordinary Measures for Egyptian Children With Hemato-Oncological Disorders During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04404244 |
| NCT04435106 | Compassionate Use of Opaganib in Patients With Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04435106 |
| NCT04416100 | Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04416100 |
| NCT04411576 | Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare | https://ClinicalTrials.gov/show/NCT04411576 |
| NCT04409899 | The Utility of Enhanced Pre and Post-surgical Work-out to Prevent the Spread of COVID-19 in a Large Urology Department | https://ClinicalTrials.gov/show/NCT04409899 |
| NCT04406090 | Endovascular Thrombectomy in COVID-19 Infected Patients | https://ClinicalTrials.gov/show/NCT04406090 |
| NCT04405232 | Coagulopathy in COVID19 - A Multi-Centre Observational Study in UK | https://ClinicalTrials.gov/show/NCT04405232 |
| NCT04406038 | Study of the Spread of COVID-19 in Saint Petersburg, Russia | https://ClinicalTrials.gov/show/NCT04406038 |
| NCT04408170 | Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 (FALCON-C19) | https://ClinicalTrials.gov/show/NCT04408170 |
| NCT04445259 | Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 and High Risk of Acute Kidney Injury | https://ClinicalTrials.gov/show/NCT04445259 |
| NCT04423640 | Analysis of the Inflammatory Response and the Development of Humoral and Cellular Immunity in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04423640 |
| NCT04414410 | Echocardiography in Critically-ill Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04414410 |
| NCT04413058 | Menstrual Cycle Characteristics of Healthcare Professionals | https://ClinicalTrials.gov/show/NCT04413058 |
| NCT04412473 | COVID-19 Respiratory Distress and Antithrombotic Drugs in Subject’s Habits | https://ClinicalTrials.gov/show/NCT04412473 |
| NCT04408378 | Change in the Ratio of Mean Platelet Volume (MPV) to Platellet(PLT) in Covid-19 Pneumonia Patients | https://ClinicalTrials.gov/show/NCT04408378 |
| NCT04408326 | Efficacy and Safety of Angiotensin II Use in Coronavirus Disease(COVID)-19 Patients With Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04408326 |
| NCT04407663 | Outpatient Clinic in Obesity Care During COVID-19 Outbreak: Physically Far, Virtually Near | https://ClinicalTrials.gov/show/NCT04407663 |
| NCT04407585 | Testing the Accuracy of a Digital Test to Diagnose Covid-19 | https://ClinicalTrials.gov/show/NCT04407585 |
| NCT04407572 | Evaluation of the Relationship Between Zinc Vitamin D and b12 Levels in the Covid-19 Positive Pregnant Women | https://ClinicalTrials.gov/show/NCT04407572 |
| NCT04407559 | COVID-SErology in Rheumatoid Arthritis (COVID-19) | https://ClinicalTrials.gov/show/NCT04407559 |
| NCT04407546 | Role of Children in Transmission of COVID-19 to Immunocompromised Patients | https://ClinicalTrials.gov/show/NCT04407546 |
| NCT04407533 | Dietary Intake and Eating Habits During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04407533 |
| NCT04407494 | Diagnostic Value of Patient - Reported and Clinically Verified Olfactory Disorders (COVID-19) | https://ClinicalTrials.gov/show/NCT04407494 |
| NCT04407468 | Awake Prone Positioning and Oxygen Therapy in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04407468 |
| NCT04407429 | Vienna Versus SARS-CoV-2 Virus Study | https://ClinicalTrials.gov/show/NCT04407429 |
| NCT04407273 | STATIN THERAPY AND COVID-19 INFECTION | https://ClinicalTrials.gov/show/NCT04407273 |
| NCT04407260 | The Use of Oxygen Hoods as Compared to Conventional High-flow Oxygen Delivery Systems, the Effects on Oxygenation, Intubation and Mortality Rates in Hypoxic Patients With COVID-19. | https://ClinicalTrials.gov/show/NCT04407260 |
| NCT04407117 | Appendicitis During the National Lockdown During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04407117 |
| NCT04406571 | Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer | https://ClinicalTrials.gov/show/NCT04406571 |
| NCT04425213 | Obesity and Mortality of Critically Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04425213 |
| NCT04418609 | Neuro-COVID-19: Neurological Complications of COVID-19 | https://ClinicalTrials.gov/show/NCT04418609 |
| NCT04409275 | LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION | https://ClinicalTrials.gov/show/NCT04409275 |
| NCT04408001 | Study of Kinetics and Efficacy of the Immune Response Against COVID-19 Among Hospital Staff | https://ClinicalTrials.gov/show/NCT04408001 |
| NCT04407923 | Drug Management of Juvenile Idiopathic Arthritis in Covid-19 Context : Impact on Therapeutical Managment | https://ClinicalTrials.gov/show/NCT04407923 |
| NCT04409249 | Prognosis in Pregnant With COVID-19 | https://ClinicalTrials.gov/show/NCT04409249 |
| NCT04416373 | COVID-19 and Pregnancy Outcomes | https://ClinicalTrials.gov/show/NCT04416373 |
| NCT04416256 | COVID-19 Pandemic and Worldwide Organ Procurement | https://ClinicalTrials.gov/show/NCT04416256 |
| NCT04412031 | Prediction of Unfavourable Outcome in Newly Covid-19 Hospitalized Patient | https://ClinicalTrials.gov/show/NCT04412031 |
| NCT04411784 | PROTECT-ASUC: Covid-19 Pandemic Response Of assessmenT, EndosCopy and Treatment in Acute Severe Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT04411784 |
| NCT04411459 | Risk Factors for Prolonged Invasive Mechanical Ventilation in COVID-19 Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04411459 |
| NCT04410484 | PREPARE-IBD: Physician Responses to Disease Flares and Patient Adaptation in Relation to Events in Inflammatory Bowel Disease During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04410484 |
| NCT04410432 | Immune Response and Risk of Serious Infection to SARS-Cov2 | https://ClinicalTrials.gov/show/NCT04410432 |
| NCT04412304 | Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04412304 |
| NCT04412278 | Impact of COVID-19 Pandemic on Perceived Exercise Benefits and Barriers | https://ClinicalTrials.gov/show/NCT04412278 |
| NCT04412265 | Frailty in Elderly Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04412265 |
| NCT04411147 | A Longitudinal Study of COVID-19 Sequelae and Immunity | https://ClinicalTrials.gov/show/NCT04411147 |
| NCT04448418 | The Impact of COVID-19 Outbreak on Trans-population’s Health in Italy | https://ClinicalTrials.gov/show/NCT04448418 |
| NCT04418544 | Vocal Feature Analysis Algorithm | https://ClinicalTrials.gov/show/NCT04418544 |
| NCT04416061 | The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04416061 |
| NCT04413045 | Novel COVID-19, A National Analysis | https://ClinicalTrials.gov/show/NCT04413045 |
| NCT04412746 | Covid-19 and Diabetes in West of Algeria | https://ClinicalTrials.gov/show/NCT04412746 |
| NCT04412655 | Primary Angioplasty for STEMI During COVID-19 Pandemic (ISACS-STEMI COVID-19) Registry | https://ClinicalTrials.gov/show/NCT04412655 |
| NCT04418193 | Patient Preference Trial for COVID-19 (PPT-COVID) | https://ClinicalTrials.gov/show/NCT04418193 |
| NCT04414657 | USZ BioResource COVID | https://ClinicalTrials.gov/show/NCT04414657 |
| NCT04443075 | Alterations of Gut Microbiome in the Frontline Medical Staff Under the Stress | https://ClinicalTrials.gov/show/NCT04443075 |
| NCT04422535 | Effects on the Qt Interval of COVID-19 Coronavirus Infection | https://ClinicalTrials.gov/show/NCT04422535 |
| NCT04422418 | Impact of Burnout on Cardiovascular and Immune Biomarkers in Healthcare Professionals - Covid-19 Pandemic in Abu Dhabi | https://ClinicalTrials.gov/show/NCT04422418 |
| NCT04418284 | Online Learning of Veterinary Anatomy During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04418284 |
| NCT04427345 | Predictive Factors COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04427345 |
| NCT04424992 | The Natural History of Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04424992 |
| NCT04422873 | The Impact of COVID-19 on Dialysis Users | https://ClinicalTrials.gov/show/NCT04422873 |
| NCT04422769 | Needs of Persons With Spinal Cord Injury (SCI) | https://ClinicalTrials.gov/show/NCT04422769 |
| NCT04420416 | Mental Health and Academic Performance in COVID-19 | https://ClinicalTrials.gov/show/NCT04420416 |
| NCT04419545 | Covid Radiographic Images Data-set for A.I | https://ClinicalTrials.gov/show/NCT04419545 |
| NCT04418245 | CT Biomarkers Identification by Artificial Intelligence for COVID-19 Prognosis | https://ClinicalTrials.gov/show/NCT04418245 |
| NCT04420637 | Impact of the Covid-19 Pandemic on Gastrointestinal and Liver Diseases | https://ClinicalTrials.gov/show/NCT04420637 |
| NCT04419571 | Peri-Operative NLR in Emergency General Surgery During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04419571 |
| NCT04424355 | Magnetic Resonance Imaging to Detect Signs of Viral Pneumonia in Patients With Coronavirus Infection. | https://ClinicalTrials.gov/show/NCT04424355 |
| NCT04420312 | Prevalence and Characteristics of Pulmonary Embolism on COVID-19 Patients Presenting Respiratory Symptoms | https://ClinicalTrials.gov/show/NCT04420312 |
| NCT04420286 | Study of the Increase in ICU Beds Capacity During COVID-19 Pandemic in France | https://ClinicalTrials.gov/show/NCT04420286 |
| NCT04419870 | Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity During the COVID19 Pandemic | https://ClinicalTrials.gov/show/NCT04419870 |
| NCT04427969 | Early Prone Position on Coronavirus Disease 2019 Pneumonia | https://ClinicalTrials.gov/show/NCT04427969 |
| NCT04425889 | COVID-19 Antibodies Among Healthcare Workers | https://ClinicalTrials.gov/show/NCT04425889 |
| NCT04424836 | HFNC Treatment in COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04424836 |
| NCT04424771 | Post-traumatic Stress Disease in Health Workers During COVID-19 Pandemia | https://ClinicalTrials.gov/show/NCT04424771 |
| NCT04423692 | Knowledge About Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04423692 |
| NCT04422522 | Fibromyalgia During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04422522 |
| NCT04426266 | Psychological Effects of the COVID-19 Pandemic on the Hungarian Adult Population | https://ClinicalTrials.gov/show/NCT04426266 |
| NCT04425863 | IVERMECTIN Aspirin Dexametasone and Enoxaparin as Treatment of Covid 19 | https://ClinicalTrials.gov/show/NCT04425863 |
| NCT04425850 | USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19 | https://ClinicalTrials.gov/show/NCT04425850 |
| NCT04424849 | Thorax Computed Tomography Severity Score and Outcome in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04424849 |
| NCT04423978 | Implications of Covid-19 on the Lifestyle Changes | https://ClinicalTrials.gov/show/NCT04423978 |
| NCT04422574 | COVID 19 Serology in Pulmonologists | https://ClinicalTrials.gov/show/NCT04422574 |
| NCT04422340 | Senior-COVID-Rea Multicentric Survey | https://ClinicalTrials.gov/show/NCT04422340 |
| NCT04424004 | MURDOCK Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study | https://ClinicalTrials.gov/show/NCT04424004 |
| NCT04423770 | COVID-19 Related Health and Infection Control Practices Among Dentists | https://ClinicalTrials.gov/show/NCT04423770 |
| NCT04427735 | Effect of Covid-19 Epidemic on Primary PCI in Patients With STEMI | https://ClinicalTrials.gov/show/NCT04427735 |
| NCT04426253 | Identification of Genetic Factors Determining Disease Course in the New Type of Coronavirus Infection, COVID-19 | https://ClinicalTrials.gov/show/NCT04426253 |
| NCT04425044 | AiM Covid Self Monitoring | https://ClinicalTrials.gov/show/NCT04425044 |
| NCT04431414 | A Study of Immune Responses to the Virus That Causes COVID-19 | https://ClinicalTrials.gov/show/NCT04431414 |
| NCT04424446 | Saliva/Nares as Source of Detection for SARS-CoV-2 at NIH | https://ClinicalTrials.gov/show/NCT04424446 |
| NCT04430023 | Epidemiological and Demographic Data From 150 Patients Diagnosed With Coronavirus Disease 2019 Pneumonia | https://ClinicalTrials.gov/show/NCT04430023 |
| NCT04429620 | Prospective Assay for SARS-CoV-2 (COVID-19) Antibody Detection Indirectly by Immunofluorescence: SARS-CoV2 IIF Method | https://ClinicalTrials.gov/show/NCT04429620 |
| NCT04427358 | RT-PCR SARS-CoV-2 at 1 Month of COVID-19 Infection in the Geriatric Population | https://ClinicalTrials.gov/show/NCT04427358 |
| NCT04427332 | Smell and Taste Disorders in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04427332 |
| NCT04427267 | Assessment of Thermal Condition of Health Workers Who Use Personal Protective Equipment From Biological Hazards During Their Work With COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04427267 |
| NCT04431284 | Impact of COVID-19 Lockdown on Obesity and Eating Behaviors | https://ClinicalTrials.gov/show/NCT04431284 |
| NCT04427176 | Evaluation of ARFC Masks Equipped With CF5 Filter in the Care Unit to Allow a Wider Distribution of FFP2 Masks (Covid-19). | https://ClinicalTrials.gov/show/NCT04427176 |
| NCT04447222 | Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors | https://ClinicalTrials.gov/show/NCT04447222 |
| NCT04430322 | Covid-19 at the Regional Medical Center Metz-Thionville: a Descriptive Study | https://ClinicalTrials.gov/show/NCT04430322 |
| NCT04430062 | Short-term Outcome of Covid-19 Surgical Patients: Case-series of a High-risk Area Community Hospital | https://ClinicalTrials.gov/show/NCT04430062 |
| NCT04441502 | Identification of Predictors for the Evolution of COVID-19 Related Pneumonia by Transcriptomic and Seroproteomic | https://ClinicalTrials.gov/show/NCT04441502 |
| NCT04436484 | Immune Biomarkers of Outcome From COVID-19 | https://ClinicalTrials.gov/show/NCT04436484 |
| NCT04435327 | Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19) | https://ClinicalTrials.gov/show/NCT04435327 |
| NCT04435119 | Covid-19 and Vitamin D in Nursing-home | https://ClinicalTrials.gov/show/NCT04435119 |
| NCT04434157 | Association of the Neutrophil/Lymphocyte Ratio With Clinical Complications and Mortality in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04434157 |
| NCT04433754 | The Development of Pancreatic Injury in the Course of Severe Acute Respiratory Syndrome Coronavirus 2 Infection | https://ClinicalTrials.gov/show/NCT04433754 |
| NCT04433000 | Reliability of a Pocket Sized Ultrasound Scanner in the Evaluation Covid-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04433000 |
| NCT04432870 | Patients’ Preferences About Rescheduling Colonoscopies Delayed Due to COVID-19: Cross Sectional Study | https://ClinicalTrials.gov/show/NCT04432870 |
| NCT04459975 | Acute Kidney Injury and Renal Outcomes for COVID-19 Patients in Intensive Care Units | https://ClinicalTrials.gov/show/NCT04459975 |
| NCT04434118 | Hydroxychloroquine May Reduce Risk of COVID-19 Infection in Rheumatoid Arthritis Patients: | https://ClinicalTrials.gov/show/NCT04434118 |
| NCT04433039 | COVID19 Versus H1N1: Radiological Challenge During Next Influenza Season Rising | https://ClinicalTrials.gov/show/NCT04433039 |
| NCT04432948 | Maternal Psychological Implications of Covid-19 Pandemic and Possible Effect on Anaesthetic Management. | https://ClinicalTrials.gov/show/NCT04432948 |
| NCT04437121 | Dietary and Lifestyle Habits During the Pandemic of COVID-19 in Greece | https://ClinicalTrials.gov/show/NCT04437121 |
| NCT04435080 | Physical Rehabilitation in ICU in ARDS Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04435080 |
| NCT04435028 | Ketotifen: as a Cardioprotective Agent in Breast Cancer Patients Receiving Anthracycline-containing Chemotherapy | https://ClinicalTrials.gov/show/NCT04435028 |
| NCT04434261 | Oncological Surgery in Times of COVID-19: Effectiveness of Preoperative Screening for Sars-Cov-2 | https://ClinicalTrials.gov/show/NCT04434261 |
| NCT04451694 | Nutritional Follow up After Hospital Discharge for Coronavirus Disease-19 | https://ClinicalTrials.gov/show/NCT04451694 |
| NCT04456010 | COVID-19 in ART: Perception and Experience | https://ClinicalTrials.gov/show/NCT04456010 |
| NCT04438967 | Brain Health in the Time of COVID-19 | https://ClinicalTrials.gov/show/NCT04438967 |
| NCT04437342 | Postpartum Depression in the Covid-19 Pandemic and the Impact of Anaesthesia | https://ClinicalTrials.gov/show/NCT04437342 |
| NCT04443712 | Screening for Patients Admitted to Ain-Shams University Hospitals for SARS-COV-2 (COVID19) | https://ClinicalTrials.gov/show/NCT04443712 |
| NCT04441489 | Assessment of Lung Inflammation With FDG PET/CT in COVID-19 | https://ClinicalTrials.gov/show/NCT04441489 |
| NCT04438629 | Evaluation of Immune Response in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04438629 |
| NCT04435223 | Lipid Metabolism in COVID-19 Severe Pneumonia Compared With Severe Pneumonia Caused by Other Pathogen | https://ClinicalTrials.gov/show/NCT04435223 |
| NCT04448782 | Characterization of Reverse Triggering and Other Asynchronies in COVID-19 Patients Under Invasive Mechanical Ventilation | https://ClinicalTrials.gov/show/NCT04448782 |
| NCT04447209 | Dietary Diversity of Young Children During CoVID-19 Outbreak: A Longitudinal Study | https://ClinicalTrials.gov/show/NCT04447209 |
| NCT04447131 | Effect of COVID-19 on Platelet Aggregation | https://ClinicalTrials.gov/show/NCT04447131 |
| NCT04441476 | Ethical and Psychological Support for Health Care Professions in Intensive Care Units in the COVID19 Pandemic Context: Adequacy With Needs and Psychological Impact Crisis and Post-crisis | https://ClinicalTrials.gov/show/NCT04441476 |
| NCT04439084 | COVID-19 in Patients With Chronic Liver Diseases | https://ClinicalTrials.gov/show/NCT04439084 |
| NCT04438954 | Investigation of Fatigue, Physical Activity, Sleep Quality and Anxiety Levels | https://ClinicalTrials.gov/show/NCT04438954 |
| NCT04438941 | Contribution of a Prone Team in Intensive Care During the Covid-19 Epidemic | https://ClinicalTrials.gov/show/NCT04438941 |
| NCT04437940 | Evaluation of Vaginal Fluid for Covid-19 Positivity in Women With Positive Nasofarengeal Covid-19 Test | https://ClinicalTrials.gov/show/NCT04437940 |
| NCT04448717 | Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children | https://ClinicalTrials.gov/show/NCT04448717 |
| NCT04442789 | Sequelae of Sars-CoV-2 Infections | https://ClinicalTrials.gov/show/NCT04442789 |
| NCT04441814 | FOUND - Ancillary Study to Smile Protocol NCT03654105 | https://ClinicalTrials.gov/show/NCT04441814 |
| NCT04440098 | Isolated During COVID-19: Effects of COVID-19’s Social Restrictions on Loneliness and Psychosocial Symptomatology | https://ClinicalTrials.gov/show/NCT04440098 |
| NCT04438993 | The COVID-19 Disease and CARdiac Events Study | https://ClinicalTrials.gov/show/NCT04438993 |
| NCT04459351 | PHenotyping patiENts Admitted to Hospital With cOvid-19 Infection and idenTifYing Prognostic markErs | https://ClinicalTrials.gov/show/NCT04459351 |
| NCT04445506 | Short Term Corticosteroids in SARS-CoV2 Patients | https://ClinicalTrials.gov/show/NCT04445506 |
| NCT04444661 | Effects of COVID-19 Induced Deconditioning After Long-term High Intensity Resistance Exercise | https://ClinicalTrials.gov/show/NCT04444661 |
| NCT04448405 | Covid-19 Lockdown and Deviant Sexual Fantasies | https://ClinicalTrials.gov/show/NCT04448405 |
| NCT04462120 | IL-12RB and TNF-alpha Gene Polymorphism and Susceptibility and Progress of Covid-19 SARS-CoV-2: A Case Control Study | https://ClinicalTrials.gov/show/NCT04462120 |
| NCT04446169 | COVID-19 (SARS-CoV-2) in Urine and Semen | https://ClinicalTrials.gov/show/NCT04446169 |
| NCT04444557 | Effect of COvid-19 on Mental Health in Syrian and Turkish Maintenance HemoDialysis Patients: COST-HD Study | https://ClinicalTrials.gov/show/NCT04444557 |
| NCT04452682 | The Impact of COVID-19 Pandemic on Critical Limb Threatening Ischemia and Emergency Vascular Practice | https://ClinicalTrials.gov/show/NCT04452682 |
| NCT04446338 | Immune Status SARS-CoV-2 in a Sample of a Tertiary Eye Health Centre | https://ClinicalTrials.gov/show/NCT04446338 |
| NCT04445961 | Respiratory Mechanics and Gas Exchange in Patients With COVID-19 and Hypoxemic Acute Respiratory Failure | https://ClinicalTrials.gov/show/NCT04445961 |
| NCT04445233 | COVID-19 Household Transmission Study | https://ClinicalTrials.gov/show/NCT04445233 |
| NCT04444531 | Clinical Improvement and COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04444531 |
| NCT04445441 | An Observational Study to Assess the Protocol for the COVID-19 Treatment in Burkina Faso | https://ClinicalTrials.gov/show/NCT04445441 |
| NCT04459533 | Sparing in Neuromuscular Blockade in COVID 19 ICU | https://ClinicalTrials.gov/show/NCT04459533 |
| NCT04444401 | Registry on NEN Patients and COVID-19 | https://ClinicalTrials.gov/show/NCT04444401 |
| NCT04450017 | Clinical Features of Severe Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04450017 |
| NCT04449978 | TARGet Kids! COVID-19 Study of Children and Families | https://ClinicalTrials.gov/show/NCT04449978 |
| NCT04449731 | Changes in Dietary Behaviours During the COVID-19 Outbreak Confinement in the Adult Population (COVIDiet_Int) | https://ClinicalTrials.gov/show/NCT04449731 |
| NCT04448054 | Imaging SARS-CoV-2 Involvement of Leptomeninges, Olfactory and Limbic Areas | https://ClinicalTrials.gov/show/NCT04448054 |
| NCT04445870 | Oncology Care Pathway’s Modifications Impact During COVID-19 Pandemic : the ONCOCARE-COV Study | https://ClinicalTrials.gov/show/NCT04445870 |
| NCT04452422 | Deep Venous Thrombosis in Non-severe COVID-19 Patients Hospitalized for a Neurovascular Pathology | https://ClinicalTrials.gov/show/NCT04452422 |
| NCT04447144 | Nutritional Habits, and Coronavirus Disease 2019 (COVID-19) Outcome | https://ClinicalTrials.gov/show/NCT04447144 |
| NCT04446286 | Bicentric Study on the Use of ECMO-VV or VA for Severe ARDS Associated With Covid-19 | https://ClinicalTrials.gov/show/NCT04446286 |
| NCT04448145 | Determinants of SARS-COV2 (COVID-19) Persistence After Convalescence | https://ClinicalTrials.gov/show/NCT04448145 |
| NCT04447638 | Percutaneous Tracheostomy With COVID-19 | https://ClinicalTrials.gov/show/NCT04447638 |
| NCT04449094 | Emergence of the COVID 19 Epidemic in the City of Nice | https://ClinicalTrials.gov/show/NCT04449094 |
| NCT04449081 | Knowledge, Attitude and Practice of Dental Students About COVID-19 | https://ClinicalTrials.gov/show/NCT04449081 |
| NCT04451577 | Epidemiologic, Clinical, Molecular Characteristics of Hospital Employees With or Without Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04451577 |
| NCT04448704 | Understanding the Mental Health of Migrant Workers During the COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04448704 |
| NCT04453527 | The CASCADE Study - Measures of Complement Activation and Inflammation in Patients With Covid-19 | https://ClinicalTrials.gov/show/NCT04453527 |
| NCT04453501 | Anti Infective Agents Impact in COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04453501 |
| NCT04452630 | Cardiovascular Consequences After COVID-19 | https://ClinicalTrials.gov/show/NCT04452630 |
| NCT04452617 | Safety of Short-term Hydroxychloroquine Plus Azithromycin Treatment in Critically Ill Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04452617 |
| NCT04451993 | Physical Activity Level in Patients With OSAS During Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04451993 |
| NCT04458337 | SURgical Outcomes in COvid Patients - the SUROCO Multicenter Cohort Study (COVID-19) | https://ClinicalTrials.gov/show/NCT04458337 |
| NCT04459819 | Respiratory Physiotherapy in Severe COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04459819 |
| NCT04452708 | HFNC and NIV for COVID-19 Complicated by Respiratory Failure | https://ClinicalTrials.gov/show/NCT04452708 |
| NCT04452695 | Acceptability of Telehealth Triage Using Robotic Systems in COVID-19 | https://ClinicalTrials.gov/show/NCT04452695 |
| NCT04453982 | Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1b | https://ClinicalTrials.gov/show/NCT04453982 |
| NCT04453969 | Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1a | https://ClinicalTrials.gov/show/NCT04453969 |
| NCT04453566 | Effect of COVID-19 Pandemic on Perceived Stress, Anxiety, Mood, and Training Quality in Elite Athletes. | https://ClinicalTrials.gov/show/NCT04453566 |
| NCT04456075 | Risk Prediction and Therapy Monitoring in Patients With SARS-Cov-2 Infection / COVID 19 | https://ClinicalTrials.gov/show/NCT04456075 |
| NCT04463628 | Impacts of the Covid-19 Epidemic and Associated Lockdown Measures on the Management, Health and Behaviors of Cystic Fibrosis Patients During the 2020 Epidemic | https://ClinicalTrials.gov/show/NCT04463628 |
| NCT04454333 | COVID-19 in Pain Perspective | https://ClinicalTrials.gov/show/NCT04454333 |
| NCT04453280 | Antibody Detection in COVID-19 Cured Patients (SARS-CoV-2-CZ-Immunity) | https://ClinicalTrials.gov/show/NCT04453280 |
| NCT04456556 | Combined Endophthalmitis and Orbital Cellulitis in Patients With Novel Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04456556 |
| NCT04457570 | Excess Risk of Morbi-mortality Due to COVID-19 in Patients With Cancer | https://ClinicalTrials.gov/show/NCT04457570 |
| NCT04459403 | Psychiatric Disturbances and COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04459403 |
| NCT04460274 | Forecast Number of Covid-19 Cases Worldwide | https://ClinicalTrials.gov/show/NCT04460274 |
| NCT04459312 | National Covid-19 Surveillance Physicians | https://ClinicalTrials.gov/show/NCT04459312 |
| NCT04460469 | Anxiety Level and Oral Hygiene Practice in Dental Students During Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04460469 |
| NCT04463706 | COVID19 Severity Prediction and Health Services Research Evaluation | https://ClinicalTrials.gov/show/NCT04463706 |
| NCT04462393 | Characteristics and Outcomes of Patients Admitted to Swedish Intensive Care Units for COVID-19 | https://ClinicalTrials.gov/show/NCT04462393 |
| NCT04460599 | Neurological Features During COVID19 | https://ClinicalTrials.gov/show/NCT04460599 |
| NCT04465981 | Investigation of Antibody and Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) or COVID-19 Proteins | https://ClinicalTrials.gov/show/NCT04465981 |
| NCT04466462 | Cross-sectional Study of COVID-19 Infection in Hospital Health Personnel | https://ClinicalTrials.gov/show/NCT04466462 |
| NCT04465058 | Characteristics of Critically Ill COVID 19 Patients | https://ClinicalTrials.gov/show/NCT04465058 |
| NCT04463758 | Covid-19 in Pregnancy: a French Population-based Cohort of Women and Newborns | https://ClinicalTrials.gov/show/NCT04463758 |
| NCT04466982 | Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection | https://ClinicalTrials.gov/show/NCT04466982 |
| NCT04466644 | COVID-19: A Prevalence Study of Two ART Centres After the Pandemic Lockdown in the USA (COVID-19 Free Clinics) | https://ClinicalTrials.gov/show/NCT04466644 |
Registrires
| nct_id | brief_title | link |
|---|---|---|
| NCT04314271 | The Observational Study of Cardiac and Pulmonary Ultrasound and Evaluation of Treatment of Severe Patients With Novel Coronavirus Pneumonia | https://ClinicalTrials.gov/show/NCT04314271 |
| NCT04318314 | COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04318314 |
| NCT04315870 | Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy. | https://ClinicalTrials.gov/show/NCT04315870 |
| NCT04323592 | Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome | https://ClinicalTrials.gov/show/NCT04323592 |
| NCT04319016 | Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy | https://ClinicalTrials.gov/show/NCT04319016 |
| NCT04320472 | Acute Encephalopathy in Critically Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04320472 |
| NCT04321811 | Behavior, Environment And Treatments for Covid-19 | https://ClinicalTrials.gov/show/NCT04321811 |
| NCT04323839 | COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY) | https://ClinicalTrials.gov/show/NCT04323839 |
| NCT04325412 | Cardiac complicAtions in Patients With SARS Corona vIrus 2 regisTrY | https://ClinicalTrials.gov/show/NCT04325412 |
| NCT04327570 | In-depth Immunological Investigation of COVID-19. | https://ClinicalTrials.gov/show/NCT04327570 |
| NCT04327479 | Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04327479 |
| NCT04327674 | The Use of Focused Lung Ultrasound in Patients Suspected of COVID-19 | https://ClinicalTrials.gov/show/NCT04327674 |
| NCT04329559 | COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study | https://ClinicalTrials.gov/show/NCT04329559 |
| NCT04336956 | Covid-19 Pediatric Observatory | https://ClinicalTrials.gov/show/NCT04336956 |
| NCT04331574 | Renin-Angiotensin System Inhibitors and COVID-19 | https://ClinicalTrials.gov/show/NCT04331574 |
| NCT04331171 | Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients’ Triage | https://ClinicalTrials.gov/show/NCT04331171 |
| NCT04333953 | COVID-19 in Patients With HIV | https://ClinicalTrials.gov/show/NCT04333953 |
| NCT04341766 | Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid (Coronavirus Disease) 19 | https://ClinicalTrials.gov/show/NCT04341766 |
| NCT04334291 | International COVID19 Clinical Evaluation Registry, | https://ClinicalTrials.gov/show/NCT04334291 |
| NCT04333875 | Morbidity and Mortality Due to Deferral of Aortic Valve Replacement in Patients With Severe Aortic Stenosis | https://ClinicalTrials.gov/show/NCT04333875 |
| NCT04336345 | Outcomes of Patients With COVID-19 in the Intensive Care Unit | https://ClinicalTrials.gov/show/NCT04336345 |
| NCT04347278 | Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 Registry | https://ClinicalTrials.gov/show/NCT04347278 |
| NCT04335773 | COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology | https://ClinicalTrials.gov/show/NCT04335773 |
| NCT04345536 | Prospective Quality Register of Patients With Confirmed Covid-19 at Oslo University Hospital | https://ClinicalTrials.gov/show/NCT04345536 |
| NCT04337346 | Evaluation of Covid 19 Anxiety in Endometriosis Patients | https://ClinicalTrials.gov/show/NCT04337346 |
| NCT04354519 | The United Kingdom Multiple Sclerosis Register Covid-19 Substudy | https://ClinicalTrials.gov/show/NCT04354519 |
| NCT04353583 | Renal Outcome in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04353583 |
| NCT04340466 | French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study | https://ClinicalTrials.gov/show/NCT04340466 |
| NCT04344249 | Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04344249 |
| NCT04344002 | LunG canceR pAtients coVId19 Disease (GRAVID) | https://ClinicalTrials.gov/show/NCT04344002 |
| NCT04349982 | ICU Trial in Critical Ill COVIDâ€19 Patients | https://ClinicalTrials.gov/show/NCT04349982 |
| NCT04348227 | How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country’s ICU? | https://ClinicalTrials.gov/show/NCT04348227 |
| NCT04344912 | Impact of COVID19 Outbreak in Cardiac Acute Care | https://ClinicalTrials.gov/show/NCT04344912 |
| NCT04348942 | A COVID-19 Symptom, Exposure and Immune Response Registry | https://ClinicalTrials.gov/show/NCT04348942 |
| NCT04347993 | A Prospective “Universal” Observational Database for COVID-19 | https://ClinicalTrials.gov/show/NCT04347993 |
| NCT04347798 | IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT | https://ClinicalTrials.gov/show/NCT04347798 |
| NCT04378452 | Assessment of the Psycho-social Impact of COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04378452 |
| NCT04357275 | The RIsk Stratification in COVID-19 Patients in the ICU Registry | https://ClinicalTrials.gov/show/NCT04357275 |
| NCT04354818 | Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA) | https://ClinicalTrials.gov/show/NCT04354818 |
| NCT04354701 | COVID-19 and Cancer Consortium Registry | https://ClinicalTrials.gov/show/NCT04354701 |
| NCT04352764 | ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings | https://ClinicalTrials.gov/show/NCT04352764 |
| NCT04351529 | Austrian COVID-19 Registry | https://ClinicalTrials.gov/show/NCT04351529 |
| NCT04356586 | Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms | https://ClinicalTrials.gov/show/NCT04356586 |
| NCT04366206 | Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est | https://ClinicalTrials.gov/show/NCT04366206 |
| NCT04357639 | Impact of Long-term Protease Inhibitors in Patients Living With HIV on the Incidence of COVID-19 ( COVIP ) | https://ClinicalTrials.gov/show/NCT04357639 |
| NCT04380766 | Covid-19 Pandemic and Pancreatic Surgery in Italy | https://ClinicalTrials.gov/show/NCT04380766 |
| NCT04359927 | Long-term Effects of Coronavirus Disease 2019 on the Cardiovascular System: CV COVID-19 Registry | https://ClinicalTrials.gov/show/NCT04359927 |
| NCT04359602 | COVID-19 Recovered Volunteer Research Participant Pool Registry | https://ClinicalTrials.gov/show/NCT04359602 |
| NCT04374110 | Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04374110 |
| NCT04361591 | COVID-19 in Liver Transplant Recipients | https://ClinicalTrials.gov/show/NCT04361591 |
| NCT04361500 | Registry of COVID-19 Patients Treated With the Seraph 100 Microbind Affinity Blood Filter | https://ClinicalTrials.gov/show/NCT04361500 |
| NCT04366986 | International Registry of Coronavirus (COVID-19) Exposure in Pregnancy | https://ClinicalTrials.gov/show/NCT04366986 |
| NCT04364984 | ARB, ACEi, DRi in COVID-19 | https://ClinicalTrials.gov/show/NCT04364984 |
| NCT04363632 | Prospective Analysis of Morbi-mortality of Patients With Cancers in Active Phase of Treatment Suspected or Diagnosed of a SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04363632 |
| NCT04433871 | COVID-19 in Pediatric Oncology and Hematology Centers in France | https://ClinicalTrials.gov/show/NCT04433871 |
| NCT04365322 | Study of Specific Viral Immune Responses Induced by SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04365322 |
| NCT04393142 | Serologic Testing of Household Contacts of Confirmed Cases of COVID-19 | https://ClinicalTrials.gov/show/NCT04393142 |
| NCT04368975 | ARDS Caused by COVID-19 | https://ClinicalTrials.gov/show/NCT04368975 |
| NCT04370821 | COVID-19 CHAMPS Study of Healthcare, First Responder and Service Workers | https://ClinicalTrials.gov/show/NCT04370821 |
| NCT04368234 | Duke COVID-19 Shared Data and Specimen Repository | https://ClinicalTrials.gov/show/NCT04368234 |
| NCT04368143 | COVID-19 Immune Repertoire Sequencing | https://ClinicalTrials.gov/show/NCT04368143 |
| NCT04367714 | Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19 | https://ClinicalTrials.gov/show/NCT04367714 |
| NCT04380727 | Almitrine and COVID-19 Related Hypoxemia | https://ClinicalTrials.gov/show/NCT04380727 |
| NCT04370067 | HUNgarian COronaVirus Disease-19 Epidemiological Research | https://ClinicalTrials.gov/show/NCT04370067 |
| NCT04368065 | Registry to Study Factors That May Impact COVID-19 Occurrence and Severity | https://ClinicalTrials.gov/show/NCT04368065 |
| NCT04367857 | ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers | https://ClinicalTrials.gov/show/NCT04367857 |
| NCT04367350 | Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement | https://ClinicalTrials.gov/show/NCT04367350 |
| NCT04372199 | SEVERITY SCORE FOR COVID-19 PNEUMONIA | https://ClinicalTrials.gov/show/NCT04372199 |
| NCT04371328 | Emergency Management in a Dedicated Respiratory Unit of Patients With a Possible COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04371328 |
| NCT04374045 | Testing for Dysautonomia in Patients Hospitalized for SARS-CoV-2 Infection (COVID-19) : COVIDANS Study | https://ClinicalTrials.gov/show/NCT04374045 |
| NCT04373759 | Cardiac Arrest Incidence and Outcome Among Patients With COVID-19 in French ICUs | https://ClinicalTrials.gov/show/NCT04373759 |
| NCT04371744 | QT-Logs : Artificial Intelligence for QT Interval Analysis of ECG From Smartwatches in Patient Receiving Treatment for Covid-19 | https://ClinicalTrials.gov/show/NCT04371744 |
| NCT04379440 | Geriatric Population COVID-19 Observational Study (GEROCOVIDobs) | https://ClinicalTrials.gov/show/NCT04379440 |
| NCT04383457 | Covid-19 Triage Using Camera-based AI | https://ClinicalTrials.gov/show/NCT04383457 |
| NCT04379544 | Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19 | https://ClinicalTrials.gov/show/NCT04379544 |
| NCT04376398 | Survey: COVID-19 Patients Managed in the Operating Theatre of Belgian Hospitals | https://ClinicalTrials.gov/show/NCT04376398 |
| NCT04390555 | The Global PCHF-COVICAV Registry | https://ClinicalTrials.gov/show/NCT04390555 |
| NCT04388605 | Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic | https://ClinicalTrials.gov/show/NCT04388605 |
| NCT04388436 | Post Covid-19 Cardiopulmonary and Immunological Changes | https://ClinicalTrials.gov/show/NCT04388436 |
| NCT04386265 | Compassionate Use of Hyperbaric Oxygen Therapy | https://ClinicalTrials.gov/show/NCT04386265 |
| NCT04389996 | COVID-19 Pandemic Impact on Patients With Cancer - a Danish Survey | https://ClinicalTrials.gov/show/NCT04389996 |
| NCT04388631 | Detection Rate of SARS-CoV-2 in Male Genitourinary System and Its Impact on Male Reproductive Health. | https://ClinicalTrials.gov/show/NCT04388631 |
| NCT04397575 | The GCO-002 CACOVID-19 Cohort: a French Nationwide Multicenter Study of COVID-19 Infected Cancer Patients | https://ClinicalTrials.gov/show/NCT04397575 |
| NCT04387929 | Detection of Anti-COVID-19 Antibody Levels in an Hospital Population | https://ClinicalTrials.gov/show/NCT04387929 |
| NCT04389554 | D-dimer Levels in Pregnant With COVID-19 | https://ClinicalTrials.gov/show/NCT04389554 |
| NCT04391686 | Resting Energy Expenditure of the COronaVirus (COVID19) Patient in Reanimation Context | https://ClinicalTrials.gov/show/NCT04391686 |
| NCT04394000 | Impact of an Intensified Thromboprofylaxis Protocol in COVID-19 | https://ClinicalTrials.gov/show/NCT04394000 |
| NCT04393324 | The Critical Care Response to the COVID-19 Pandemic in Madrid | https://ClinicalTrials.gov/show/NCT04393324 |
| NCT04394390 | Do Vitamin D Levels Really Correlated With Disease Severity in COVID-19 Patients? | https://ClinicalTrials.gov/show/NCT04394390 |
| NCT04408339 | COVID-19 in Cancer Patients: Evaluation of Clinical Course and Impact on Oncological Care Including Biobanking | https://ClinicalTrials.gov/show/NCT04408339 |
| NCT04395794 | SARS-CoV-2 Disguise Study | https://ClinicalTrials.gov/show/NCT04395794 |
| NCT04401033 | Increased Risk of SARS-CoronaVirus-2 (SARS-CoV-2) Infection Associated With Endoscopy (DECORE Study) | https://ClinicalTrials.gov/show/NCT04401033 |
| NCT04453748 | The Assessment of the Prevalence, Clinical Course and Treatment of COVID-19 Complications | https://ClinicalTrials.gov/show/NCT04453748 |
| NCT04401540 | Characteristics of Neonatal Covid-19 in Turkey | https://ClinicalTrials.gov/show/NCT04401540 |
| NCT04403672 | Performance Evaluation of RealDetectâ„¢ COVID-19 RT-PCR Kit for the Detection of SARS-CoV-2 Virus | https://ClinicalTrials.gov/show/NCT04403672 |
| NCT04411563 | Epigenetic Tools as Prognostic Predictors in Covid19 | https://ClinicalTrials.gov/show/NCT04411563 |
| NCT04412382 | Covid-19: Possible Role of Neutrophil Extracellular Traps | https://ClinicalTrials.gov/show/NCT04412382 |
| NCT04410471 | Humoral Immunity Against SARS-CoV-2 in Liver Transplanted Patients After COVID-19 in Comparison With Immunocompetent Patients | https://ClinicalTrials.gov/show/NCT04410471 |
| NCT04412317 | Use of PCR-Sars-CoV-2 in Children | https://ClinicalTrials.gov/show/NCT04412317 |
| NCT04416009 | Extracellular Water in Covid 19 Pneumonia | https://ClinicalTrials.gov/show/NCT04416009 |
| NCT04412551 | Lung Ultrasound for Assessment of Patients With Moderate to Severe Covid-19 | https://ClinicalTrials.gov/show/NCT04412551 |
| NCT04418557 | COVID-19 and Obstetric Transmission | https://ClinicalTrials.gov/show/NCT04418557 |
| NCT04422444 | Post Intensive Care Syndrome in COVID19 Patients | https://ClinicalTrials.gov/show/NCT04422444 |
| NCT04422587 | Evaluation of the COVID-19 Infection Response in Patients Admitted to the Emergency Department for Dyspnea | https://ClinicalTrials.gov/show/NCT04422587 |
| NCT04425759 | Prevalence and Risk Factors of SARS-CoV-2 Antibody Responses (COVID-19) | https://ClinicalTrials.gov/show/NCT04425759 |
| NCT04423003 | Endoscopic Interventions in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04423003 |
| NCT04422470 | Registry of Patients With Hematologic Disease and COVID-19 in Russia | https://ClinicalTrials.gov/show/NCT04422470 |
| NCT04434144 | A Comparative Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh | https://ClinicalTrials.gov/show/NCT04434144 |
| NCT04429477 | Cerebral Compliance Impairment in COVID-19 | https://ClinicalTrials.gov/show/NCT04429477 |
| NCT04426084 | Cardiovascular Risk Factors and Severe COVID-19. A Nationwide Registry-based Case-Control Study | https://ClinicalTrials.gov/show/NCT04426084 |
| NCT04430374 | Registry for a Cardiovascular Patient Who COVID-19 Infection in Qatar and Gulf | https://ClinicalTrials.gov/show/NCT04430374 |
| NCT04433364 | COPE - COVID-19 in Pregnancy and Early Childhood | https://ClinicalTrials.gov/show/NCT04433364 |
| NCT04435041 | Remote-by-Default Care in the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04435041 |
| NCT04444310 | Antibody Responses in Contacts of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04444310 |
| NCT04443140 | Preeclampsia-like Syndrome Induced by COVID-19: Is it a Real Public Health Issue in Pregnancy During the Pandemic? | https://ClinicalTrials.gov/show/NCT04443140 |
| NCT04449042 | The PAWS-COVID-19 (Pediatric AirWay complicationS COVID-19) Registry | https://ClinicalTrials.gov/show/NCT04449042 |
| NCT04445402 | Pediatrics HOT COVID-19 Database in NY Tristate | https://ClinicalTrials.gov/show/NCT04445402 |
| NCT04466306 | Pediatric Acute Kidney Injury in COVID-19 | https://ClinicalTrials.gov/show/NCT04466306 |
| NCT04450277 | Delivery of Protocolised Emergency Surgical Care During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04450277 |
| NCT04453579 | Bariatric Surgery During Lockdown, Impact of COVID-19 on Physical and Mental Health | https://ClinicalTrials.gov/show/NCT04453579 |
| NCT04455347 | Cardiac and Thoracic Imaging in Pediatric Patients With Evidence of Systemic Inflammation COVID19 Linked | https://ClinicalTrials.gov/show/NCT04455347 |
| NCT04457505 | One Year Follow-ups of Patients Admitted to Spanish Intensive Care Units Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04457505 |
| NCT04459689 | COVID-19 in PID Survey | https://ClinicalTrials.gov/show/NCT04459689 |
| NCT04459364 | The Prevalence of Pulmonary Hypertension in Patients With COVID-19. | https://ClinicalTrials.gov/show/NCT04459364 |
| NCT04465474 | Coronavirus Disease 2019 (COVID-19) During Pregnancy: Prevalence of Seroconversion, Effect on Maternal and Perinatal Outcomes and Risk of Vertical Transmission | https://ClinicalTrials.gov/show/NCT04465474 |
| NCT04463862 | Air Pollution and COVID-19 Mortality in Geriatric Patients: a Multicenter Study | https://ClinicalTrials.gov/show/NCT04463862 |